Spreadsheet: 6e93aaba-7ce1-460e-b1ca-21bc26e97900
Sheet: Sheet1

Test ID | Type | Published Name | Reporting Name | CPT Units | CPT Code | Always Performed | Orderable Separately | Testing Algorithm
19701 | Test | Biliary Tract Malignancy, FISH Only | Biliary Tract Malignancy, FISH Only |  |  |  |  | When this test is ordered, 19229 Biliary Tract Malignancy, FISH will be performed.
19229 | [NAME] | Biliary Tract Malignancy, FISH | Biliary Tract Malignancy, FISH | 4 | 88368 | Yes | No
19988 | Test | Pulmonary Cytology with FISH for the Detection of Lung Cancer on Bronchial Brushing | Bronchial Brush Cytology with FISH |  |  |  |  | When this test is ordered, pulmonary cytology and bronchial brushing FISH tests will always be performed at an additional charge.
88526 | [NAME] | Pulmonary Cytology, Bronchial Brushing | Pulmonary Cytology, Bronchial Brush | 1 | 88112 | Yes | No
88665 | [NAME] | FISH for the Detection of Lung Cancer, Bronchial Brushing | FISH, Bronchial Brush | 4 | 88368 | Yes | No
4339 | Test | Dermatopathology Exam of Tissue | Dermatopathology Exam of Ts |  |  |  |  | When this test is ordered, 1 of the 3 reflex tests will be performed and charged. Each additional stain will be charged separately.
50033 | [NAME] | Level II Surg Path Gross and Micro Exam | Level II Surg Path w/Gross,Micro Ex | 1 | 88302 | No | No
50034 | [NAME] | Level III Surg Path | Level III Surg Path | 1 | 88304 | No | No
88305 | [NAME] | Level IV Surg Path | Level IV Surg Path | 1 | 88305 | No | No
5439 | Test | Surgical Pathology Consultation | Surgical Pathology Consultation |  |  |  |  | When this test is ordered, 1 of the 3 reflex tests will be performed and charged. Each additional stain will be charged separately.   Note: Special stains performed outside Mayo Medical Laboratories and included with the case may be repeated and charged at the reviewing pathologist's discretion. In addition, testing requested by referring physician (immunostains, molecular studies, etc.) may not be performed if deemed unnecessary by Mayo pathologist. For all surgical pathology consultations, auxiliary testing is ordered at the discretion of the Mayo pathologist.
83614 | [NAME] | Pathology Consultation, Outside Slides | [NAME], Outside Slide | 1 | 88321 | No | No
86113 | [NAME] | Pathology Consultation, with Comprehensive Review of History | [NAME], w/Comp Rvw of History | 1 | 88325 | No | No
88323 | [NAME] | Pathology Consultation, with Slide Preparation | [NAME], w/Slide Prep | 1 | 88323 | No | No
5468 | Test | Dermatopathology Consultation, Slides for | Dermatopathology Consult, Slides |  |  |  |  | When this test is ordered, 1 of the 5 reflex tests will be performed and charged. Each additional stain will be charged separately.
86113 | [NAME] | Pathology Consultation, with Comprehensive Review of History | [NAME], w/Comp Rvw of History | 1 | 88325 | No | No
88387 | [NAME] | Dermatopathology Slide MML Anatomic Pathology | [NAME] MML AP | 1 | 88321 | No | No
89203 | [NAME] | MML Block Dermatology | MML Block Derm | 1 | 88323 | No | No
89204 | [NAME] | Dermatology Block MML Anatomic Pathology | Derm Block MML AP | 1 | 88323 | No | No
89205 | [NAME] | MML Slide Dermatopathology | MML Slide Derm | 1 | 88321 | No | No
60198 | Test | HER2, Gastric/Esophageal, Semi-Quantitative Immunohistochemistry, Manual | [NAME], Manual | 1 | 88360 |  |  | Cases that are equivocal (2+) by immunohistochemical stain will reflex to HER2 FISH at an additional charge.
[NAME] | [NAME] | HER2 Amplification Associated with Gastroesophageal Cancer, FISH, Tissue | [NAME], Gastroesophageal FISH |  | PROFILE | No | Yes
60694 | Test | FOXL2 Mutation (C402G) Analysis by PCR and Pyrosequencing | FOXL2 Mutation (C402G) Analysis | 1 | 81479 |  |  | This test is performed in conjunction with 60254 Anatomic Pathology Special Studies Review.
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
60714 | Test | USP6 (17p13), [NAME] and Nodular Fasciitis, FISH | USP6 (17p13), FISH | 1 | 88368 |  |  | This test is performed in conjunction with 60254 Anatomic Pathology Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 Anatomic Pathology Special Studies Review could be changed to 5439 Surgical Pathology Consultation, if determined to be more appropriate.
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
61207 | Test | IDH1/IDH2 Mutation Analysis by Pyrosequencing, Paraffin | IDH1/IDH2 Genes, Known Mutations | 2 | 81403 |  |  | This test is performed in conjunction with 60254 Anatomic Pathology Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 Anatomic Pathology Special Studies Review could be changed to 5439 Surgical Pathology Consultation if they determine this is more appropriate.
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
61219 | Test | [NAME] (11q21), Mucoepidermoid Carcinoma (MEC) | [NAME] (11q21), FISH | 1 | 88368 |  |  | This test is performed in conjunction with 60254 Anatomic Pathology Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 Anatomic Pathology Special Studies Review could be changed to 5439 Surgical Pathology Consultation, if determined to be more appropriate.
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
6MAMU | Test | 6-Monoacetylmorphine (6-MAM), [NAME] | 6-MAM, U | 1 | 83925 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
800050 | Test | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 |  |  | If HBs antigen screen is reactive with S/CO ratio of 1.00 to 50.0, then HBsAg confirmation will be performed at an additional charge.
800098 | [NAME] | [NAME], Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
800051 | Test | HIV-1/-2 [NAME], Serum | HIV-1/-2 [NAME], S | 1 | 86703 |  |  | This test begins with HIV-1/-2 antibody screen by the chemiluminescence immunoassay method. If HIV-1/-2 antibody screen chemiluminescence immunoassay result is reactive, then HIV-1/-2 antibody confirmatory evaluation is performed at an additional charge. HIV-1/-2 antibody confirmatory evaluation is a reflex test that includes HIV-1 Western blot assay and, when appropriate and at an additional charge, HIV-2 antibody screen by EIA, HIV-1 antibody confirmation by immunofluorescence assay, and HIV-2 antibody confirmation by line immunoassay.
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
WBAR | [NAME] | HIV-1/-2 Antibody Confirmatory Evaluation, Serum | HIV-1/-2 Ab Confirm Eval, S | 1 | 86689 | No | Yes
HIV2 | [NAME] | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 | No | Yes
HIVFA | [NAME] | HIV-1 Antibody Confirmation by Immunofluorescence, Serum | HIV-1 Ab Confirm by IFA, S | 1 | 86689 | No | Yes
800085 | Test | Acute Hepatitis Profile | Acute Hepatitis Profile |  | PROFILE |  |  | If hepatitis B surface (HBs) antigen is reactive, then HBs antigen confirmation will be performed at an additional charge.
800048 | Component | Hepatitis A IgM Antibody, Serum | Hepatitis A IgM Ab, S | 1 | 86709 | Yes | Yes
800044 | Component | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | Yes | Yes
800046 | Component | Hepatitis C Antibody Screen, Serum | HCV Ab Screen, S | 1 | 86803 | Yes | Yes
800050 | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
800098 | [NAME] | [NAME], Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
800124 | Test | [NAME] with [NAME], Serum | [NAME] w/Reflex RPR, S | 1 | 86780 |  |  | If syphilis IgG is positive, then 800137 Rapid Plasma Reagin Test, Serum will be performed at an additional charge.
800137 | [NAME] | Rapid [NAME] (RPR) Test, Serum | Rapid Plasma Reagin Test, S | 1 | 86592 | No | No
800138 | Test | Chronic Hepatitis Profile (Type Unknown) | Chronic Hepatitis Profile (Unknown) |  | PROFILE |  |  | If HBs antigen is positive, then HBs antigen confirmation will be performed at an additional charge.
800045 | Component | Hepatitis B Surface Antibody, Qualitative/Quantitative, Serum | [NAME], S | 1 | 86706 | Yes | Yes
800046 | Component | Hepatitis C Antibody Screen, Serum | HCV Ab Screen, S | 1 | 86803 | Yes | Yes
800049 | Component | Hepatitis B Core Total Antibodies, Serum | HBc Total Ab, S | 1 | 86704 | Yes | Yes
800050 | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
800098 | [NAME] | [NAME], Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
800159 | Test | Previous Hepatitis Exposure Profile | Previous Hepatitis Exposure Profile |  | PROFILE |  |  | If HBs antigen is positive, then HBs antigen confirmation will be performed at an additional charge.
800049 | Component | Hepatitis B Core Total Antibodies, Serum | HBc Total Ab, S | 1 | 86704 | Yes | Yes
800050 | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
800147 | Component | Hepatitis A Total Antibodies, Serum | Hepatitis A Total Ab, S | 1 | 86708 | Yes | Yes
800046 | Component | Hepatitis C Antibody Screen, Serum | HCV Ab Screen, S | 1 | 86803 | Yes | Yes
800045 | Component | Hepatitis B Surface Antibody, Qualitative/Quantitative, Serum | [NAME], S | 1 | 86706 | Yes | Yes
800098 | [NAME] | [NAME], Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
800195 | Test | Lyme Disease Serology, Serum | Lyme Disease Serology, S | 1 | 86618 |  |  | If Lyme disease serology is positive, then Lyme disease antibody confirmation (by Western blot) will be performed at an additional charge.
LYWB | [NAME] | Lyme Disease Antibody, Immunoblot, Serum | Lyme Disease Ab, Immunoblot, S | 2 | 86617 | No | Yes
800197 | Test | Herpes Simplex Virus (HSV) Antibody Screen, IgM, by EIA, Serum | HSV Ab Screen, IgM, S by EIA | 1 | 86694 |  |  | If herpes simplex virus (HSV) antibody screen, IgM by EIA, is reactive, then HSV antibody, IgM by immunofluorescence assay will be performed at an additional charge.
800218 | [NAME] | Herpes Simplex Virus (HSV) Antibody, IgM, by Immunofluorescence Assay (IFA), Serum | HSV Ab, IgM, S by IFA | 1 | 86694 | No | No
800200 | Test | Herpes Simplex Virus (HSV) Type 1- and Type 2-Specific Antibodies, Serum | HSV Types 1 and 2 Ab, S |  | PROFILE |  |  | If herpes simplex virus (HSV) antibody screen is reactive, then HSV antibody by immunofluorescence assay will be performed at an additional charge.
800207 | Component | Herpes Simplex Virus (HSV) Type 1 Specific Antibodies, Serum | HSV Type 1 Ab, IgG, S | 1 | 86695 | Yes | No
800197 | Component | Herpes Simplex Virus (HSV) Antibody Screen, IgM, by EIA, Serum | HSV Ab Screen, IgM, S by EIA | 1 | 86694 | Yes | Yes
800210 | Component | Herpes Simplex Virus (HSV) Type 2 Specific Antibodies, Serum | HSV Type 2 Ab, IgG, S | 1 | 86696 | Yes | No
800218 | [NAME] | Herpes Simplex Virus (HSV) Antibody, IgM, by Immunofluorescence Assay (IFA), Serum | HSV Ab, IgM, S by IFA | 1 | 86694 | No | No
800228 | Test | Mycoplasma pneumoniae Antibodies, IgG and IgM, Serum | M. [NAME], IgG and IgM, S |  | PROFILE |  |  | If [NAME] pneumoniae antibodies, IgM is positive or equivocal, then Mycoplasma pneumoniae antibodies, IgM by indirect immunofluorescence assay (IFA) will be performed at an additional charge.
800223 | Component | Mycoplasma pneumoniae Antibodies, IgG, Serum | M. [NAME], IgG, S | 1 | 86738 | Yes | No
800230 | Component | Mycoplasma pneumoniae Antibodies, IgM, Serum | M. pneumoniae Ab, IgM, S | 1 | 86738 | Yes | No
800296 | [NAME] | Mycoplasma pneumoniae Antibodies, IgM, Serum by Indirect Immunofluorescence Assay (IFA) | M. pneumoniae Ab, IgM, S by IFA | 1 | 86738 | No | No
800232 | Test | Lyme Disease Serology, Spinal Fluid | Lyme Disease Serology, CSF | 1 | 86618 |  |  | If Lyme disease serology is positive, then Lyme disease Ab, Western Blot will be performed at an additional charge.
CLYWB | [NAME] | Lyme Disease Antibody, Immunoblot, Spinal Fluid | Lyme Disease Ab, Immunoblot, CSF | 2 | 86617 | No | Yes
80027 | Test | B-Cell Lymphoma, FISH, Tissue | B-Cell Lymphoma, FISH, Ts |  | PROFILE |  |  | The number of probes ordered will determine the price of the testing. When this test is ordered, a charge for 2 FISH probes and interpretation is included. If additional probes or the entire panel are ordered, additional probes charges will be added.
80027 | Component |  | Cyto & Mol Cyto, interp | 1 | 88291 | No | No
80027 | Component |  | Analyze 100-300 cells | 1 | 88275 | No | No
80027 | Component |  | [NAME], DNA probe, each | 2 | 88271 | No | No
19435 | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
8874 | [NAME] | Pathology Consultation, Limited Without Review of Patient's Medical Record | [NAME],Lmtd w/o Review of PMR |  |  | Yes | No
19438 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
19861 | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
19440 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
19855 | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
19862 | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
19860 | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
19859 | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
19858 | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
19857 | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
19437 | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
19439 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
19856 | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
19171 | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
19432 | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
19433 | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
19434 | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
19436 | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
19170 | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
19169 | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
800294 | Test | Hepatitis C Antibody Screen with Reflex to HCV RNA by PCR, Serum | HCV [NAME] w/Reflex to HCV PCR, S | 1 | 86803 |  |  | If hepatitis C virus (HCV) antibody screen by chemiluminescence immunoassay is reactive, then HCV RNA by RT-PCR will be performed at an additional charge.
800226 | [NAME] | Hepatitis C Virus (HCV) RNA Detection and Quantification by Real-Time Reverse Transcription-PCR (RT-PCR), Serum | HCV RNA Detect/Quant, S | 1 | 87522 | No | Yes
800301 | Test | Electrophoresis, Protein, Serum | Electrophoresis, Protein, S |  | PROFILE |  |  | If a discrete electrophoresis band is identified, the laboratory will evaluate the serum protein electrophoresis and, if necessary, perform immunofixation at an additional charge.
800305 | Component | Protein Electrophoresis | Protein Electrophoresis | 1 | 84165 | Yes | No
800304 | Component | Total Protein | Total Protein | 1 | 84155 | Yes | Yes
800306 | [NAME] | Immunofixation, Serum | Immunofixation | 1 | 86334 | No | No
8104 | Test | [NAME], Immunohistology | [NAME], Immunohistology | 9 | 88346 |  |  | The first 9 stains are not orderable individually but are performed when 8104 Renal Biopsy, Immunohistology is ordered. In most cases, the first 9 immunofluorescent stains are the only ones required and performed. In certain cases pronase-digested paraffin-based slides can be used for immunofluorescence staining as a salvage technique when there is no [NAME] sample or an inadequate [NAME] sample (eg, no glomeruli). Determining the subtype of IgG antibody found in renal immunofluorescent panel can be helpful in confirming a select few disease processes affecting the kidney. The C4d stain will be setup on [NAME] specimens for transplant/allograft kidney biopsies. The C4d stain can also be ordered separately without the full immunofluorescence panel stains.
60290 | [NAME] | Kappa Paraffin Immunofluorescent Stain, Renal | Kappa Paraffin IF, Renal | 1 | 88346 | No | No
60289 | [NAME] | IgM Paraffin Immunofluorescent Stain, Renal | IgM Paraffin IF, Renal | 1 | 88346 | No | No
60288 | [NAME] | IgG Paraffin Immunofluorescent Stain, Renal | IgG Paraffin IF, Renal | 1 | 88346 | No | No
60302 | [NAME] | IgG Immunofluorescent Stain, Renal | IgG IF, Renal |  |  | Yes | No
84226 | [NAME] | C4d Stain, Renal Allograft Biopsies, Immunofluorescent | Immunofluorescent C4d Stain | 1 | 88347 | No | Yes
60291 | [NAME] | Lambda Paraffin Immunofluorescent Stain, Renal | Lambda Paraffin IF, Renal | 1 | 88346 | No | No
60287 | [NAME] | IgA Paraffin Immunofluorescent Stain, Renal | IgA Paraffin IF, Renal | 1 | 88346 | No | No
60331 | [NAME] | IgG4 Immunofluorescent Stain, Renal | IgG4 IF, Renal | 1 | 88346 | No | No
60330 | [NAME] | IgG3 Immunofluorescent Stain, Renal | IgG3 IF, Renal | 1 | 88346 | No | No
60285 | [NAME] | C1q Paraffin Immunofluorescent Stain, Renal | C1q Paraffin IF, Renal | 1 | 88346 | No | No
60309 | [NAME] | Fibrinogen Immunofluorescent Stain, Renal | Fibrinogen IF, Renal |  |  | Yes | No
60328 | [NAME] | IgG1 Immunofluorescent Stain, Renal | IgG1 IF, Renal | 1 | 88346 | No | No
60329 | [NAME] | IgG2 Immunofluorescent Stain, Renal | IgG2 IF, Renal | 1 | 88346 | No | No
60307 | [NAME] | [NAME], Renal | [NAME], Renal |  |  | Yes | No
60306 | [NAME] | C1q, Immunofluorescent Stain, Renal | C1q IF, Renal |  |  | Yes | No
60308 | [NAME] | Albumin Immunofluorescent Stain, Renal | Albumin IF, Renal |  |  | Yes | No
60305 | [NAME] | Kappa Immunofluorescent Stain, Renal | Kappa IF, Renal |  |  | Yes | No
60304 | [NAME] | Lambda Immunofluorescent Stain, Renal | Lambda IF, Renal |  |  | Yes | No
60303 | [NAME] | IgM Immunofluorescent Stain, Renal | IgM IF, Renal |  |  | Yes | No
60301 | [NAME] | IgA Immunofluorescent Stain, Renal | IgA IF, Renal |  |  | Yes | No
81504 | Test | HER2, Breast, Quantitative Immunohistochemistry, Automated | HER2, [NAME], Automated | 1 | 88361 |  |  | Cases that are equivocal (2+) by immunohistochemical stain will reflex to HER2 FISH at an additional charge.
[NAME] | [NAME] | HER2 Amplification Associated with Breast Cancer, FISH, Tissue | [NAME], Breast Cancer, FISH |  | PROFILE | No | Yes
82091 | Test | Amyloid Protein Identification, Paraffin, LC MS/MS | Amyloid Protein ID, Par, LC-MS/MS |  | PROFILE |  |  | When this test is ordered, the Congo Red stain will always be performed at an additional charge.
82091 | Component |  | MASS SPECTROMETRY QUAL | 1 | 83788 | No | No
82091 | Component |  | Mass and tandem mass spectrometry | 1 | 88380 | No | No
89054 | [NAME] | Congo Red, Stain | Congo Red, Stain | 1 | 88313 | Yes | No
83342 | Test | ThinPrep Screen with Human Papillomavirus (HPV) Reflex | ThinPrep Screen with HPV Reflex | 1 | 88142 |  |  | When this test is ordered, a ThinPrep screen will be performed. If the ThinPrep Pap results include atypical cells of undetermined significance (ASCUS), and the patient is > or =21 years old, a high risk HPV test will be performed. If [NAME] results are abnormal, a pathologist will review the case at an additional charge.
19167 | [NAME] | High Risk HPV DNA Detection | High Risk HPV DNA Detection | 1 | 87621 | No | Yes
82100 | [NAME] | Physician Interpretation of ThinPrep, PAP | [NAME] of ThinPrep, PAP | 1 | G0124 | No | No
83343 | Test | ThinPrep Diagnostic with Human Papillomavirus (HPV) Reflex | ThinPrep Diagnostic with HPV Reflex | 1 | 88142 |  |  | When this test is ordered, a ThinPrep diagnostic will be performed. If the ThinPrep Pap results include atypical cells of undetermined significance (ASCUS), and the patient is > or =21 years old, a high-risk HPV test will be performed. If [NAME] results are abnormal, a pathologist will review the case at an additional charge.
19167 | [NAME] | High Risk HPV DNA Detection | High Risk HPV DNA Detection | 1 | 87621 | No | Yes
88141 | [NAME] | Physician Interpretation of Diagnostic PAP | [NAME] of Diag PAP | 1 | 88141 | No | No
83361 | Test | Synovial Sarcoma by Reverse Transcriptase PCR (RT-PCR), Paraffin | Synovial Sarcoma, RT-PCR, Paraffin | 1 | 81479 |  |  | This test is performed in conjunction with 60254 AP Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 AP Special Studies Review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
83363 | Test | Ewing Sarcoma/Primitive Neuroectodermal Tumors (ES/PNET) by Reverse Transcriptase PCR (RT-PCR), Paraffin | Ewings Sarcoma, RT-PCR, Paraffin | 2 | 81401 |  |  | This test is performed in conjunction with 60254 AP Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 AP Special Studies Review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
83365 | Test | Desmoplastic Small Round Cell Tumor (DSRCT) by Reverse Transcriptase PCR (RT-PCR), Paraffin | DSRCT, RT-PCR, Paraffin | 2 | 81401 |  |  | This test is performed in conjunction with 60254 AP Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 AP Special Studies Review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
83367 | Test | [NAME]) by Reverse Transcriptase PCR (RT-PCR), Paraffin | [NAME], RT-PCR,PF | 1 | 81401 |  |  | This test is performed in conjunction with 60254 AP Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 AP Special Studies Review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
84357 | Test | Biliary Tract Malignancy, Cytology & Molecular Testing | Biliary Tract Malignancy | 1 | 88112 |  |  | When this test is ordered, biliary tract malignancy testing by FISH will always be performed at an additional charge.
19229 | [NAME] | Biliary Tract Malignancy, FISH | Biliary Tract Malignancy, FISH | 4 | 88368 | Yes | No
88905 | Test | PDGFB, 22q13, for Dermatofibrosarcoma Protuberans/Giant Cell Fibroblastoma, FISH | PDGFB, 22q13, FISH | 1 | 88368 |  |  | This test is performed in conjunction with 60254 AP Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 AP Special Studies Review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
88955 | Test | KIT, Mutation Analysis, Exon 8 | KIT, Mutation Analysis, Ex8 | 1 | 81404 |  |  | This test is performed in conjunction with AP special studies review. Additional testing may be performed after review by pathologist and AP special studies review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
88956 | Test | KIT, Mutation Analysis, Exon 13 | KIT, Mutation Analysis, Ex13 | 1 | 81404 |  |  | This test is performed in conjunction with AP special studies review. Additional testing may be performed after review by pathologist and AP special studies review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
88957 | Test | KIT, Mutation Analysis, Exon 17 | KIT, Mutation Analysis, Ex17 | 1 | 81404 |  |  | This test is performed in conjunction with AP special studies review. Additional testing may be performed after review by pathologist and AP special studies review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
88958 | Test | PDGFRA, Mutation Analysis, Exon 14 | PDGFRA, Mutation Analysis, Ex14 | 1 | 81404 |  |  | This test is performed in conjunction with AP special studies review. Additional testing may be performed after review by pathologist and AP special studies review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
89041 | Test | T-Cell Lymphoma, FISH, Tissue | T-Cell Lymphoma, FISH, Ts |  | PROFILE |  |  | This panel includes a mini-pathology consultation to evaluate appropriate FISH probes and translocations to investigate. Panel includes testing for the following anomalies via the probes listed:
89041 | Component |  | DNA Probe, each | 2 | 88271 | No | No
89041 | Component |  | Interphase in situ hybridztn, 100-300 | 1 | 88275 | No | No
89041 | Component |  | Interpretation and Report | 1 | 88291 | No | No
19169 | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
19170 | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
19171 | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
19432 | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
19433 | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
19434 | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
19435 | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
19436 | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
19437 | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
19438 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
19439 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
19440 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
19855 | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
19856 | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
19857 | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
19858 | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
19859 | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
19860 | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
19861 | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
19862 | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
8874 | [NAME] | Pathology Consultation, Limited Without Review of Patient's Medical Record | [NAME],Lmtd w/o Review of PMR |  |  | Yes | No
89045 | Test | BRAF Mutation (T1799A) Analysis by PCR and Sequencing, Thyroid | BRAF Mutation (T1799A) Analysis | 1 | 81210 |  |  | This test is performed in conjunction with 60254 AP Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 AP Special Studies Review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
89118 | Test | ThinPrep Screen with HPV for Women 30 Years and [NAME] | ThinPrep Screen W/HPV>=30yr | 1 | 88142 |  |  | When this test is ordered, a ThinPrep screen and high risk HPV DNA test will be performed. If [NAME] results are abnormal, a pathologist will review the case at an additional charge.
19167 | [NAME] | High Risk HPV DNA Detection | High Risk HPV DNA Detection | 1 | 87621 | Yes | Yes
82100 | [NAME] | Physician Interpretation of ThinPrep, PAP | [NAME] of ThinPrep, PAP | 1 | G0124 | No | No
89119 | Test | ThinPrep Diagnostic with Human Papillomavirus (HPV) for Women 30 Years and [NAME] | ThinPrep Diag w/HPV>=30yr | 1 | 88142 |  |  | When this test is ordered, a ThinPrep diagnostic and a high risk HPV DNA test will be performed. If [NAME] results are abnormal, a pathologist will review the case at an additional charge.
19167 | [NAME] | High Risk HPV DNA Detection | High Risk HPV DNA Detection | 1 | 87621 | Yes | Yes
88141 | [NAME] | Physician Interpretation of Diagnostic PAP | [NAME] of Diag PAP | 1 | 88141 | No | No
89366 | Test | CPM, 12q15, for Well-Differentiated Liposarcoma/Atypical Lipomatous Tumor, FISH | CPM, 12q15, FISH | 2 | 88368 |  |  | This test is performed in conjunction with 60254 AP Special Studies Review. Additional testing may be performed after review by pathologist. Upon approval from the requesting clinician, 60254 AP Special Studies Review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
89669 | Test | KIT, Mutation Analysis, Exon 9 | KIT, Mutation Analysis, Ex9 | 1 | 81404 |  |  | This test is performed in conjunction with AP special studies review. Additional testing may be performed after review by pathologist and AP special studies review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
89670 | Test | KIT, Mutation Analysis, Exon 11 | KIT, Mutation Analysis, Ex11 | 1 | 81404 |  |  | This test is performed in conjunction with AP special studies review. Additional testing may be performed after review by pathologist and AP special studies review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
89671 | Test | PDGFRA, Mutation Analysis, Exon 12 | PDGFRA, [NAME], Ex12 | 1 | 81404 |  |  | This test is performed in conjunction with AP special studies review. Additional testing may be performed after review by pathologist and AP special studies review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
89672 | Test | PDGFRA, Mutation Analysis, Exon 18 | PDGFRA, Mutation Analysis, Ex18 | 1 | 81404 |  |  | This test is performed in conjunction with AP special studies review. Additional testing may be performed after review by pathologist and AP special studies review could be changed to 5439
60254 | [NAME] | Anatomic Pathology Special Studies Review | AP Special Studies Review |  |  | Yes | No
9354 | Test | Cytology Consultation, Miscellaneous | Cytology Consultation, [NAME] |  |  |  |  | When this test is ordered, 1 of the 3 reflex tests will be performed and charged. Each additional stain will be charged separately.
60684 | [NAME] | Cytology Consultation, Outside Slide | Cytology Consult, Outside Slide | 1 | 88321 | No | No
60685 | [NAME] | Cytology Consultation, with Slide Preparation | Cytology Consult, w/Slide Prep | 1 | 88323 | No | No
60686 | [NAME] | Cytology Consultation, with Comprehensive Review of History | Cytology Consult, w/Comp Rvw of His | 1 | 88325 | No | No
A1ATR | Test | Alpha-1-Antitrypsin Deficiency Profile | A1AT Deficiency Profile |  | PROFILE |  |  | If the genotyping and quantitative serum level are discordant, then alpha-1-antitrypsin phenotyping, will be added and performed at an additional charge.
A1ATR | Component |  | [NAME] | 1 | 81332 | No | No
AATQ | Component | Alpha-1-Antitrypsin (A1A), Serum | Alpha-1-Antitrypsin, S | 1 | 82103 | Yes | Yes
A1AT | Component | Alpha-1-Antitrypsin Genotyping, Blood | Alpha-1-Antitrypsin Genotyping, B |  |  | Yes | No
A1ATP | [NAME] | Alpha-1-Antitrypsin (A1A) Phenotyping, Serum | A1AT Phenotype, S | 1 | 82104 | No | Yes
ABID2 | Test | Antibody Identification, [NAME] | Antibody Identification, RBC | 1 | 86870 |  |  | The following tests may also be ordered and performed as part of antibody identification: special red cell antigen typing, antibody elution, antibody absorption, direct Coombs, and monospecific direct Coombs. These additional tests will determine or confirm antibody specificity and allo- vs. autoantibody.
MDCG | [NAME] | Monospecific Direct Coombs IgG, Blood | Monospecific Direct Coombs IgG, B | 1 | 86880 | No | Yes
ABAB | [NAME] | Antibody Absorption | Antibody Absorption | 1 | 86978 | No | No
DCTM | [NAME] | Direct Coombs, Blood | Direct Coombs, B | 1 | 86880 | No | Yes
SPAG | [NAME] | Special Red Cell Antigen Typing | Special Red Cell Ag Typing | 1 | 86905 | No | Yes
ABEL | [NAME] | Antibody Elution | Antibody Elution | 1 | 86860 | No | No
MDCC3 | [NAME] | Monospecific Direct Coombs C3, Blood | Monospecific Direct Coombs C3, B | 1 | 86880 | No | Yes
[NAME] | Test | Antibody Screen, [NAME] | [NAME], RBC | 1 | 86850 |  |  | If the antibody screen is positive, then antibody identification will be performed.   The following tests may also be ordered and performed as part of antibody identification: monospecific direct Coombs, special red cell antigen typing, antibody elution, and antibody absorption.
ABAB | [NAME] | Antibody Absorption | Antibody Absorption | 1 | 86978 | No | No
ABEL | [NAME] | Antibody Elution | Antibody Elution | 1 | 86860 | No | No
ABID2 | [NAME] | Antibody Identification, [NAME] | Antibody Identification, RBC | 1 | 86870 | No | Yes
DCTM | [NAME] | Direct Coombs, Blood | Direct Coombs, B | 1 | 86880 | No | Yes
MDCC3 | [NAME] | Monospecific Direct Coombs C3, Blood | Monospecific Direct Coombs C3, B | 1 | 86880 | No | Yes
MDCG | [NAME] | Monospecific Direct Coombs IgG, Blood | Monospecific Direct Coombs IgG, B | 1 | 86880 | No | Yes
SPAG | [NAME] | Special Red Cell Antigen Typing | Special Red Cell Ag Typing | 1 | 86905 | No | Yes
ABTIH | Test | [NAME], [NAME] | [NAME], RBC |  | PROFILE |  |  | The initial test performed is an antibody identification. If the antibody problem identified is not relevant in hemolytic disease of the newborn, or if titrations are not helpful, the titer will be cancelled and will be replaced by the antibody identification test. Depending upon the antibody identification results, additional tests, ie, monospecific direct Coombs, antibody elution, antibody absorption, and red cell antigen typing may be added and charged. A consultation service is offered, at no charge, regarding the clinical relevance of red cell antibodies.
ABTIH | Component |  | Antibody Titer | 1 | 86886 | No | No
ABTIH | Component |  | Antibody Ident, Erythro | 1 | 86870 | No | No
ABAB | [NAME] | Antibody Absorption | Antibody Absorption | 1 | 86978 | No | No
ABEL | [NAME] | Antibody Elution | Antibody Elution | 1 | 86860 | No | No
ABID2 | [NAME] | Antibody Identification, [NAME] | Antibody Identification, RBC | 1 | 86870 | No | Yes
DCTM | [NAME] | Direct Coombs, Blood | Direct Coombs, B | 1 | 86880 | No | Yes
MDCC3 | [NAME] | Monospecific Direct Coombs C3, Blood | Monospecific Direct Coombs C3, B | 1 | 86880 | No | Yes
MDCG | [NAME] | Monospecific Direct Coombs IgG, Blood | Monospecific Direct Coombs IgG, B | 1 | 86880 | No | Yes
SPAG | [NAME] | Special Red Cell Antigen Typing | Special Red Cell Ag Typing | 1 | 86905 | No | Yes
ACASM | Test | [NAME] | [NAME] | 1 | 82607 |  |  | If vitamin [NAME] is <150 ng/L, then intrinsic factor blocking antibody (IFBA) is performed. If IFBA is negative or indeterminate, then gastrin is performed.     If vitamin B12 is 150 to 400 ng/L, then methylmalonic acid (MMA) is performed. If methylmalonic acid is >0.40 umol/L, then IFBA is performed.
GASTR | [NAME] | Gastrin, Serum | Gastrin, S | 1 | 82941 | No | Yes
MMAPA | [NAME] | Methylmalonic Acid (MMA), Quantitative, Serum | Methylmalonic Acid, QN, S | 1 | 83921 | No | Yes
IFBPA | [NAME] | Intrinsic Factor Blocking Antibody, Serum | Intrinsic Factor Blocking Ab, S | 1 | 86340 | No | Yes
ACT | Test | Actinomyces Culture | Actinomyces Culture | 1 | 87075 |  |  | When this test is ordered, the reflex tests may be performed and charged.
TISSR | [NAME] | Tissue Processing | Tissue Processing | 1 | 87176 | No | No
ISAN | [NAME] | Anaerobe Ident by Sequencing | Anaerobe Ident by Sequencing | 1 | 87153 | No | No
ANAID | [NAME] | Anaerobe Ident | Anaerobe Ident | 1 | 87076 | No | No
ADE | Test | Autoimmune Dysautonomia Evaluation, Serum | Autoimmune Dysautonomia Eval, S |  | PROFILE |  |  | If IFA (ANN1S/83381) patterns are indeterminate, paraneoplastic autoantibody Western blot is performed at an additional charge.   If IFA patterns suggest CRMP-5-IgG, CRMP-5-IgG Western blot is performed at an additional charge.     If IFA patterns suggest amphiphysin antibody, amphiphysin Western blot is performed at an additional charge.     If ACh receptor binding antibody is >0.02 or if striational antibodies are > or =1:60, ACh receptor modulating antibodies and CRMP-5-IgG Western blot are performed at an additional charge.
CCN | Component | N-Type Calcium Channel Antibody, Serum | N-Type Calcium Channel Ab | 1 | 83519 | Yes | No
PAINT | Component | Interpretive Comments | Interpretive Comments |  |  | Yes | No
ANN1S | Component | Antineuronal Nuclear Antibody-Type 1 (ANNA-1), Serum | Anti-Neuronal Nuclear Ab, Type 1 | 1 | 86256 | Yes | No
STR | Component | Striational (Striated Muscle) Antibodies, Serum | Striational (Striated Muscle) Ab, S | 1 | 83520 | Yes | Yes
GD65S | Component | Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Serum | GAD65 Ab Assay, S | 1 | 86341 | Yes | Yes
CCPQ | Component | P/Q-Type Calcium Channel Antibody, Serum | P/Q-Type Calcium Channel Ab | 1 | 83519 | Yes | No
ARBI | Component | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) Binding Ab | 1 | 83519 | Yes | Yes
GANG | Component | Ganglionic Acetylcholine Receptor (Alpha3) Autoantibody, Serum | [NAME], S | 1 | 83519 | Yes | No
VGKC | Component | Neuronal Voltage-Gated Potassium Channel (VGKC) Autoantibody, Serum | Neuronal (V-G) K+ Channel Ab, S | 1 | 83519 | Yes | No
CRMWS | [NAME] | [NAME] Protein-5-IgG (CRMP-5-IgG) Western Blot, Serum | CRMP-5-IgG Western Blot, S | 1 | 84182 | No | No
ABLOT | [NAME] | Amphiphysin Antibody Western Blot, Serum | Amphiphysin Western Blot, S | 1 | 84182 | No | No
WBN | [NAME] | [NAME], Western Blot Confirmation, Serum | Paraneoplastic Autoantibody WBlot,S | 1 | 84182 | No | No
ARMO | [NAME] | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) [NAME] | 1 | 83519 | No | No
ADHP | Test | Familial Hypercholesterolemia/Autosomal Dominant Hypercholesterolemia Genetic Testing Reflex Panel | FH/ADH Genetic Reflex Panel | 1 | 81479 |  |  | If APOB genotype is negative, LDLSP/29284 [NAME], LDLR Full Gene Sequence will be performed at an additional charge.
ADHI | Component | Familial Hypercholesterolemia/Autosomal Dominant Hypercholesterolemia Genetic Interpretation | FH/ADH Genetic Interpretation |  |  | Yes | No
APOBP | Component | Apolipoprotein B-100 Molecular Analysis, R3500Q and R3500W | APOB Genotype |  |  | Yes | Yes
LDLSP | [NAME] | Familial Hypercholesterolemia, LDLR Full Gene Sequencing | [NAME], Full Gene Sequence | 1 | 81479 | No | Yes
[NAME] | [NAME] | Familial Hypercholesterolemia, LDLR Large Deletion/Duplication, Molecular Analysis | [NAME] | 1 | 81479 | No | Yes
ADM13 | Test | ADAMTS13 Activity and Inhibitor Profile | ADAMTS13 Activity and Inhibitor Profile | 1 | 85397 |  |  | Testing begins with ADAMTS13 activity assay to evaluate the percent activity. If the ADAMTS13 activity assay is <30%, an inhibitor screen will be performed to look for specific ADAMTS13 inhibition. If specific inhibition is apparent, the titer of the inhibitor will be determined.
ADMFX | Component | ADAMTS13 Activity Assay | ADAMTS13 Activity Assay |  |  | Yes | No
ADMIN | Component | ADAMTS13 Interpretation | ADAMTS13 Interpretation |  |  | Yes | No
[NAME] | [NAME] | ADAMTS13 Inhibitor Bethesda Titer | ADAMTS13 Inhibitor Bethesda Titer | 1 | 85335 | No | No
ADMIS | [NAME] | ADAMTS13 Inhibitor Screen Assay | ADAMTS13 Inhibitor Screen | 1 | 85335 | No | No
AFPA | Test | Alpha-Fetoprotein, Amniotic Fluid | [NAME], AF | 1 | 82106 |  |  | If alpha-fetoprotein (AFP) is positive, then acetylcholinesterase (AChE) will be performed at an additional charge. Because false-positive AChE may occur from a bloody tap, specimens with positive AChE results will also be tested for the presence of fetal hemoglobin at no additional charge.
ACHE_ | [NAME] | Acetylcholinesterase, [NAME] (AChE-AF), [NAME] | Acetylcholinesterase, AF | 1 | 82013 | No | Yes
AGIDE | Test | Autoimmune Gastrointestinal Dysmotility Evaluation, Serum | Autoimmune GI Dysmotility Eval, S |  | PROFILE |  |  | If IFA (ANN1S/83381) patterns are indeterminate, paraneoplastic autoantibody Western blot is performed at an additional charge.   If IFA patterns suggest CRMP-5-IgG, CRMP-5-IgG Western blot is performed at an additional charge.     If IFA patterns suggest amphiphysin antibody, amphiphysin Western blot is performed at an additional charge.   If ACh receptor binding antibody is >0.02 or if striational antibodies are > or =1:60, ACh receptor modulating antibodies and CRMP-5-IgG Western blot are performed at an additional charge.
ANN1S | Component | Antineuronal Nuclear Antibody-Type 1 (ANNA-1), Serum | Anti-Neuronal Nuclear Ab, Type 1 | 1 | 86256 | Yes | No
GD65S | Component | Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Serum | GAD65 Ab Assay, S | 1 | 86341 | Yes | Yes
GANG | Component | Ganglionic Acetylcholine Receptor (Alpha3) Autoantibody, Serum | [NAME], S | 1 | 83519 | Yes | No
VGKC | Component | Neuronal Voltage-Gated Potassium Channel (VGKC) Autoantibody, Serum | Neuronal (V-G) K+ Channel Ab, S | 1 | 83519 | Yes | No
ARBI | Component | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) Binding Ab | 1 | 83519 | Yes | Yes
STR | Component | Striational (Striated Muscle) Antibodies, Serum | Striational (Striated Muscle) Ab, S | 1 | 83520 | Yes | Yes
CCN | Component | N-Type Calcium Channel Antibody, Serum | N-Type Calcium Channel Ab | 1 | 83519 | Yes | No
PAINT | Component | Interpretive Comments | Interpretive Comments |  |  | Yes | No
ABLOT | [NAME] | Amphiphysin Antibody Western Blot, Serum | Amphiphysin Western Blot, S | 1 | 84182 | No | No
WBN | [NAME] | [NAME], Western Blot Confirmation, Serum | Paraneoplastic Autoantibody WBlot,S | 1 | 84182 | No | No
CRMWS | [NAME] | [NAME] Protein-5-IgG (CRMP-5-IgG) Western Blot, Serum | CRMP-5-IgG Western Blot, S | 1 | 84182 | No | No
ARMO | [NAME] | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) [NAME] | 1 | 83519 | No | No
AGPB | Test | Alpha-Globin Gene Analysis | Alpha-Globin Gene Analysis | 1 | 81257 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
AGXKM | Test | AGXT Gene, Known Mutation | AGXT Gene, Known Mutation | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
AHEPR | Test | Acute Hepatitis Profile with Hepatitis C Virus Reflex | Acute Hepatitis Prof w/HCV Reflex |  | PROFILE |  |  | If hepatitis B surface antigen (HBsAg) is reactive, then HBsAg confirmation will be performed at an additional charge.   If hepatitis C virus (HCV) antibody screen is reactive, then HCV RNA detection and quantification will be performed at an additional charge.
HAVM | Component | Hepatitis A IgM Antibody, Serum | Hepatitis A IgM Ab, S | 1 | 86709 | Yes | Yes
HBIM | Component | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | Yes | Yes
HCPCR | Component | Hepatitis C Antibody Screen with Reflex to HCV RNA by PCR, Serum | HCV [NAME] w/Reflex to HCV PCR, S | 1 | 86803 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HCVQU | [NAME] | Hepatitis C Virus (HCV) RNA Detection and Quantification by Real-Time Reverse Transcription-PCR (RT-PCR), Serum | HCV RNA Detect/Quant, S | 1 | 87522 | No | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
AHPS | Test | Acute Hepatitis Profile | Acute Hepatitis Profile |  | PROFILE |  |  | If hepatitis B surface (HBs) antigen is reactive, then HBs antigen confirmation will be performed at an additional charge.
HBIM | Component | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | Yes | Yes
HAVM | Component | Hepatitis A IgM Antibody, Serum | Hepatitis A IgM Ab, S | 1 | 86709 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HCV | Component | Hepatitis C Antibody Screen, Serum | HCV Ab Screen, S | 1 | 86803 | Yes | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
AHPS | Test | Acute Hepatitis Profile | Acute Hepatitis Profile |  | PROFILE |  |  | If hepatitis B surface (HBs) antigen is reactive, then HBs antigen confirmation will be performed at an additional charge.
HAVM | Component | Hepatitis A IgM Antibody, Serum | Hepatitis A IgM Ab, S | 1 | 86709 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HBIM | Component | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | Yes | Yes
HCV | Component | Hepatitis C Antibody Screen, Serum | HCV Ab Screen, S | 1 | 86803 | Yes | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
AJPWO | Test | Ashkenazi Jewish Mutation Analysis Panel Without Cystic Fibrosis (CF) | Ashkenazi Jewish Panel Without CF |  | PROFILE |  |  | When this test is ordered, hexosaminidase A and total, white blood cells will always be performed at an additional charge.
AJPWO | Component |  | [NAME] | 1 | 81200 | No | No
AJPWO | Component |  | SMPD1 GENE COMMON VARIANTS | 1 | 81330 | No | No
AJPWO | Component |  | MCOLN1 GENE | 1 | 81290 | No | No
AJPWO | Component |  | IKBKAP GENE | 1 | 81260 | No | No
AJPWO | Component |  | HEXA GENE | 1 | 81255 | No | No
AJPWO | Component |  | GBA GENE | 1 | 81251 | No | No
AJPWO | Component |  | FANCC GENE | 1 | 81242 | No | No
AJPWO | Component |  | BLM GENE | 1 | 81209 | No | No
23425 | [NAME] | Hexosaminidase A and Total, Leukocytes/Ashkenazi Jewish | Hexosaminidase A and Tot, WBC/AJ | 2 | 83080 | Yes | No
AMPHU | Test | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
ANAE | Test | Bacterial Culture, Anaerobic | Bacterial Culture, Anaerobic | 1 | 87075 |  |  | When this test is ordered, the reflex tests may be performed and charged.
ANAID | [NAME] | Anaerobe Ident | Anaerobe Ident | 1 | 87076 | No | No
ISAN | [NAME] | Anaerobe Ident by Sequencing | Anaerobe Ident by Sequencing | 1 | 87153 | No | No
TISSR | [NAME] | Tissue Processing | Tissue Processing | 1 | 87176 | No | No
ANAH2 | Test | Antinuclear Antibodies (ANA), [NAME], Serum | Antinuclear Ab, HEp-2 Substrate, S | 1 | 86038 |  |  | If ANA HEp-2 substrate screen is positive, then ANA (multiple) will be performed at an additional charge.
ANAB | [NAME] | Antinuclear Antibody (Multiple), Serum | Antinuclear Antibody (Multiple), S | 1 | 86039 | No | No
ANAT | Test | Alpha-N-Acetylglucosaminidase, Fibroblasts | A-N-Acetylglucosaminidase, Fibro | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
ANIDE | Test | Organism Referred for Identification, Anaerobic Bacteria | Organism Ref for ID, Anaerobic Bact | 1 | 87076 |  |  | When this test is ordered, the reflex tests may be performed and charged.
ANAID | [NAME] | Anaerobe Ident | Anaerobe Ident | 1 | 87076 | No | No
ISAN | [NAME] | Anaerobe Ident by Sequencing | Anaerobe Ident by Sequencing | 1 | 87153 | No | No
ARPKD | Test | Autosomal Recessive Polycystic Kidney Disease (ARPKD), Full Gene Analysis | ARPKD Mutation Screen | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
ARPKM | Test | Autosomal Recessive Polycystic Kidney Disease (ARPKD), Known Mutation | ARPKD Known Mutation | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
ARSAK | Test | ARSA Gene, Known Mutation | ARSA Gene, Known Mutation | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.   For prenatal specimens only: If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
ARSAS | Test | ARSA Gene, Full Gene Analysis | ARSA Gene, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
ARSB | Test | Arylsulfatase B, Fibroblasts | Arylsulfatase B, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
ARST | Test | Arylsulfatase A, Fibroblasts | Arylsulfatase A, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
BARBU | Test | Barbiturate Confirmation, [NAME] | Barbiturate Confirmation, U | 1 | 82205 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
BDIAL | Test | Bleeding Diathesis Profile, Limited | Bleeding Diath Prof, Limited |  | PROFILE |  |  | Initial testing includes: prothrombin time (PT), activated partial thromboplastin time, thrombin time (bovine), fibrinogen, D-dimer, soluble fibrin monomer, coagulation factor VIII activity assay, [NAME] factor antigen, [NAME] factor activity, factor [NAME] screen, and special coagulation interpretation.
FIBC | Component | Fibrinogen, Plasma | Fibrinogen, P | 1 | 85384 | Yes | Yes
VWFX | Component | von Willebrand Factor Activity, Plasma | von Willebrand Factor Activity, P | 1 | 85397 | Yes | Yes
CCC | Component | Special Coagulation Interpretation | Special Coagulation Interpretation | 1 | 85390 | Yes | No
VWAG | Component | von Willebrand Factor [NAME], Plasma | von Willebrand Factor Ag, P | 1 | 85246 | Yes | Yes
TT | Component | Thrombin Time (Bovine), Plasma | Thrombin Time (Bovine), P | 1 | 85670 | Yes | Yes
DIRM | Component | D-Dimer, Plasma | D-Dimer, P | 1 | 85379 | Yes | Yes
SFM | Component | Soluble [NAME] | Soluble [NAME] | 1 | 85366 | Yes | No
PTC | Component | Prothrombin Time (PT), Plasma | Prothrombin Time (PT), P | 1 | 85610 | Yes | Yes
APTTB | Component | Activated Partial Thromboplastin Time (APTT), Plasma | Activated Partial Thrombopl Time, P | 1 | 85730 | Yes | Yes
FXIII | Component | Factor [NAME] (13), Screen | Factor XIII(13),Scrn | 1 | 85291 | Yes | No
F8A | Component | Coagulation Factor VIII Activity Assay, Plasma | Coag Factor VIII Activity Assay, P | 1 | 85240 | Yes | Yes
VWFM | [NAME] | von WillebrandFactor Multimer Analysis, Plasma | von Willebrand Factor Multimer, P | 1 | 85247 | No | Yes
STLA | [NAME] | Staclot Lupus Anticoagulant, Plasma | Staclot LA, P | 1 | 85598 | No | No
DRVTC | [NAME] | DRVVT Confirmation | DRVVT Confirmation | 1 | 85613 | No | No
PNP | [NAME] | Platelet Neutralization Procedure | Platelet Neutralization Procedure | 1 | 85597 | No | No
APTTM | [NAME] | APTT Mix 1:1 | APTT Mix 1:1 | 1 | 85732 | No | No
DRVTM | [NAME] | DRVVT Mix | DRVVT Mix | 1 | 85613 | No | No
PTMX | [NAME] | PT Mix 1:1 | PT Mix 1:1 | 1 | 85611 | No | No
F7_IS | [NAME] | Factor VII Inhibitor Screen | Factor [NAME] | 1 | 85335 | No | No
11_IS | [NAME] | Factor XI Inhibitor Screen | Factor [NAME] Scrn | 1 | 85335 | No | No
F5_IS | [NAME] | Factor V Inhibitor Screen | Factor V Inhib Scrn | 1 | 85335 | No | No
DRVT | [NAME] | [NAME] Viper Venom Time (DRVVT), Plasma | Dilute Russells Viper Venom Time, P | 1 | 85613 | No | No
F9_IS | [NAME] | Factor IX Inhibitor Screen | Factor IX Inhib Scrn | 1 | 85335 | No | No
F_11 | [NAME] | Coagulation Factor XI Activity Assay, Plasma | Coag Factor XI Assay, P | 1 | 85270 | No | Yes
F8IS | [NAME] | Coagulation Factor VIII Inhibitor Screen, Plasma | Coag Factor VIII Assay [NAME],P | 1 | 85335 | No | No
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
10_IS | [NAME] | Factor X Inhibitor Screen | Factor X Inhib Scrn | 1 | 85335 | No | No
RPTL | [NAME] | Reptilase Time, Plasma | Reptilase Time, P | 1 | 85635 | No | Yes
F_7 | [NAME] | Coagulation Factor VII Activity Assay, Plasma | Coag Factor VII Assay, P | 1 | 85230 | No | Yes
F_9 | [NAME] | Coagulation Factor IX Activity Assay, Plasma | Coag Factor IX Assay, P | 1 | 85250 | No | Yes
F_2 | [NAME] | Coagulation Factor II Activity Assay, Plasma | Coag Factor II Assay, P | 1 | 85210 | No | Yes
FACTV | [NAME] | Coagulation Factor V Activity Assay, Plasma | Coag Factor V Assay, P | 1 | 85220 | No | Yes
RIST | [NAME] | [NAME], Plasma | [NAME], P | 1 | 85245 | No | No
F_12 | [NAME] | Coagulation Factor XII Activity Assay, Plasma | Coag Factor XII Assay, P | 1 | 85280 | No | Yes
APSM | [NAME] | [NAME], Plasma | [NAME], P | 1 | 85410 | No | Yes
F_10 | [NAME] | Coagulation Factor X Activity Assay, Plasma | Coag Factor X Assay, P | 1 | 85260 | No | Yes
F2_IS | [NAME] | Factor II Inhibitor Screen | Factor II Inhib Scrn | 1 | 85335 | No | No
BENZU | Test | Benzodiazepine Confirmation, [NAME] | Benzodiazepine Confirmation, U | 1 | 80154 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
BGAT | Test | Beta-Galactosidase, Fibroblasts | Beta-Galactosidase, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
BGLR | Test | Beta-Glucuronidase, Fibroblasts | Beta-Glucuronidase, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
[NAME] | Test | Beta-Glucosidase, Fibroblasts | Beta-Glucosidase, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
BLM | Test | Bloom Syndrome, Mutation Analysis, 2281del6/ins7 | Bloom Syndrome, Mutation Analysis | 1 | 81209 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
BRAF | Test | BRAF Mutation Analysis (V600E), Tumor | BRAF Mutation Analysis(V600E),Tumor | 1 | 81210 |  |  | When this test is ordered, slide review will always be performed at an additional charge.
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
BRAFM | Test | BRAF Mutation Analysis (V600), Melanoma | BRAF Mutation AnalysisV600 Melanoma | 1 | 81210 |  |  | When this test is ordered, slide review will always be performed at an additional charge.
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
BRUGM | Test | [NAME], IgG & IgM, Serum | [NAME], IgG and IgM, S |  | PROFILE |  |  | If [NAME] antibody screen, IgG & IgM is positive or equivocal, then BRUTA/8112 Brucella Total Antibody Confirmation, Agglutination, Serum will be performed at an additional charge.
BRUGM | Component |  | [NAME], IgG, S | 1 | 86622 | No | No
BRUGM | Component |  | [NAME], IgM, S | 1 | 86622 | No | No
BRUTA | [NAME] | Brucella Total Antibody Confirmation, Agglutination, Serum | [NAME], Agglutination, S | 1 | 86622 | No | Yes
BTDKM | Test | Biotinidase Deficiency, [NAME], Known Mutation | [NAME], Known Mutation | 1 | 81403 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
BWSRS | Test | Beckwith-Wiedemann Syndrome (BWS)/Russell-Silver Syndrome (RSS) Molecular Analysis | BWS/RSS Molecular Analysis | 1 | 81401 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.   For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
C2 | Test | C2 Complement, Functional, with [NAME], Serum | C2 Complement,Functional,w/Reflex,S | 1 | 86161 |  |  | If the C2 result is <15 U/mL, then [NAME] and C4 will be performed at an additional charge.
[NAME] | [NAME] | [NAME], Serum | [NAME], S | 1 | 86160 | No | Yes
C4 | [NAME] | [NAME], Serum | [NAME], S | 1 | 86160 | No | Yes
CACTK | Test | Carnitine-Acylcarnitine Translocase Deficiency, Known Mutation | SLC25A20 Gene, Known Mutation | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
CACTS | Test | Carnitine-Acylcarnitine Translocase Deficiency, Full Gene Analysis | SLC25A20 Gene, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and changed separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
CANW | Test | Canavan Disease, Mutation Analysis, ASPA | Canavan Disease, Mutation Analysis | 1 | 81200 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
CBC | Test | CBC with Differential, Blood | CBC with Differential, B | 1 | 85025 |  |  | For Mayo patients:   A morphology evaluation is performed when the automated 5-part differential is invalid and/or when abnormal results are identified upon microscopic examination.
CE | [NAME] | Consultant Evaluation | Consultant Eval. |  |  | No | No
DIFFR | [NAME] | Morphology Eval (Special Smear) | Morphology Eval (special Smear) | 1 | 85007 | No | No
CBGT | Test | Galactosylceramide Beta-Galactosidase, Fibroblasts | [NAME],Fibro | 1 | 82658 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
CCRYP | Test | Cryptococcus Antigen Screen, Spinal Fluid | Cryptococcus Ag Screen, CSF | 1 | 87327 |  |  | If EIA results are reactive, latex agglutination testing (Cryptococcus Ag ) will be performed at an additional charge.
[NAME] | [NAME] | [NAME], [NAME] | Cryptococcus Ag, CSF | 1 | 86403 | No | No
CDAU | Test | Drug Abuse Survey with Confirmation, [NAME] | Confirmed Drug Abuse Survey, U | 1 | 80104 |  |  | Testing begins with screening assays. If alcohol (ethanol) screen is positive, then the gas chromatography-flame ionization detector confirmation with quantification will be performed at an additional charge. If amphetamines, barbiturates, benzodiazepines, cocaine and metabolites, opiates, phencyclidine, or tetrahydrocannabinol metabolite screen is positive, then the gas chromatography-mass spectrometry confirmation with quantification will be performed at an additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
AMPHU | [NAME] | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 | No | Yes
BARBU | [NAME] | Barbiturate Confirmation, [NAME] | Barbiturate Confirmation, U | 1 | 82205 | No | Yes
BENZU | [NAME] | Benzodiazepine Confirmation, [NAME] | Benzodiazepine Confirmation, U | 1 | 80154 | No | Yes
COKEU | [NAME] | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 | No | Yes
[NAME] | [NAME] | Ethanol, [NAME] | Ethanol, U | 1 | 82055 | No | No
OPATU | [NAME] | Opiates, [NAME] | Opiates, U | 1 | 83925 | No | Yes
PCPU | [NAME] | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 | No | Yes
THCU | [NAME] | Tetrahydrocannabinol (THC) Confirmation, [NAME] | [NAME], U | 1 | 80299 | No | Yes
CDAU1 | Test | Drug Abuse Survey with Confirmation, Evaluation 1, [NAME] | Confirmed Drug Abuse Survey 1, U | 1 | 80104 |  |  | Testing begins with screening tests for ethanol and drugs of abuse. Positives are confirmed and quantitated by definitive methods (gas chromatography-flame ionization detector for ethanol; gas chromatography-mass spectrometry for amphetamines, barbiturates, cocaine and metabolites, methadone, opiates, phencyclidine, and propoxyphene) at an additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
AMPHU | [NAME] | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 | No | Yes
BARBU | [NAME] | Barbiturate Confirmation, [NAME] | Barbiturate Confirmation, U | 1 | 82205 | No | Yes
COKEU | [NAME] | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 | No | Yes
[NAME] | [NAME] | Ethanol, [NAME] | Ethanol, U | 1 | 82055 | No | No
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
MTDNU | [NAME] | Methadone Confirmation, [NAME] | Methadone Confirmation, U | 1 | 83840 | No | Yes
OPATU | [NAME] | Opiates, [NAME] | Opiates, U | 1 | 83925 | No | Yes
PCPU | [NAME] | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 | No | Yes
CDAU2 | Test | Drug Abuse Survey with Confirmation, Evaluation 2, [NAME] | Confirmed Drug Abuse Survey 2, U | 1 | 80104 |  |  | Testing begins with immunoassay screen. Positives are confirmed and quantitated by gas chromatography-mass spectrometry at an additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
AMPHU | [NAME] | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 | No | Yes
BARBU | [NAME] | Barbiturate Confirmation, [NAME] | Barbiturate Confirmation, U | 1 | 82205 | No | Yes
COKEU | [NAME] | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 | No | Yes
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
MTDNU | [NAME] | Methadone Confirmation, [NAME] | Methadone Confirmation, U | 1 | 83840 | No | Yes
OPATU | [NAME] | Opiates, [NAME] | Opiates, U | 1 | 83925 | No | Yes
PCPU | [NAME] | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 | No | Yes
CDAU3 | Test | Drug Abuse Survey with Confirmation, Evaluation 3, [NAME] | Confirmed Drug Abuse Survey 3, U | 1 | 80104 |  |  | Gas chromatography-mass spectrometry confirmation with quantification of positives for amphetamines, barbiturates, benzodiazepines, cocaine and metabolites, opiates, phencyclidine, and [NAME] will be performed at an additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
AMPHU | [NAME] | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 | No | Yes
BARBU | [NAME] | Barbiturate Confirmation, [NAME] | Barbiturate Confirmation, U | 1 | 82205 | No | Yes
BENZU | [NAME] | Benzodiazepine Confirmation, [NAME] | Benzodiazepine Confirmation, U | 1 | 80154 | No | Yes
COKEU | [NAME] | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 | No | Yes
OPATU | [NAME] | Opiates, [NAME] | Opiates, U | 1 | 83925 | No | Yes
PCPU | [NAME] | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 | No | Yes
THCU | [NAME] | Tetrahydrocannabinol (THC) Confirmation, [NAME] | [NAME], U | 1 | 80299 | No | Yes
CDAU5 | Test | Drug Abuse Survey with Confirmation, Panel 5, [NAME] | Confirmed Drug Abuse Survey 5, U | 1 | 80104 |  |  | Testing begins with immunoassay screen. Positives are confirmed and quantitated by gas chromatography-mass spectrometry at an additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
AMPHU | [NAME] | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 | No | Yes
COKEU | [NAME] | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 | No | Yes
OPATU | [NAME] | Opiates, [NAME] | Opiates, U | 1 | 83925 | No | Yes
PCPU | [NAME] | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 | No | Yes
THCU | [NAME] | Tetrahydrocannabinol (THC) Confirmation, [NAME] | [NAME], U | 1 | 80299 | No | Yes
CDAU7 | Test | Drug Abuse Survey with Confirmation, Evaluation 12, [NAME] | Confirmed Drug Abuse Survey 12, U | 1 | 80104 |  |  | Testing begins with screening tests for alcohol and drugs of abuse. Positives are confirmed and quantitated by definitive methods (gas chromatography-flame ionization detector for ethanol; gas chromatography-mass spectrometry for amphetamines, barbiturates, benzodiazepines, cocaine and metabolites, methadone, opiates, phencyclidine, propoxyphene, and [NAME]) at an additional charge.
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
BENZU | [NAME] | Benzodiazepine Confirmation, [NAME] | Benzodiazepine Confirmation, U | 1 | 80154 | No | Yes
THCU | [NAME] | Tetrahydrocannabinol (THC) Confirmation, [NAME] | [NAME], U | 1 | 80299 | No | Yes
MTDNU | [NAME] | Methadone Confirmation, [NAME] | Methadone Confirmation, U | 1 | 83840 | No | Yes
[NAME] | [NAME] | Ethanol, [NAME] | Ethanol, U | 1 | 82055 | No | No
PCPU | [NAME] | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 | No | Yes
AMPHU | [NAME] | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 | No | Yes
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
OPATU | [NAME] | Opiates, [NAME] | Opiates, U | 1 | 83925 | No | Yes
BARBU | [NAME] | Barbiturate Confirmation, [NAME] | Barbiturate Confirmation, U | 1 | 82205 | No | Yes
COKEU | [NAME] | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 | No | Yes
CDCOM | Test | Celiac Disease Comprehensive Cascade | Celiac Disease Comprehensive Casc |  | PROFILE |  |  | If [NAME] is age-specified normal, then tissue transglutaminase (tTG) IgA will be performed at an additional charge.     If tTG IgA is equivocal, then endomysial antibodies IgA and deamidated gliadin antibody IgA will be performed at an additional charge.     If [NAME] is > or =1.0 mg/dL but lower than age-specified normal, then tTG IgA, tTG IgG, deamidated gliadin IgA, and deamidated gliadin IgG will be performed at an additional charge.     If IgA is below detection (<1.0 mg/[NAME]), then tTG IgG and deamidated gliadin IgG will be performed at an additional charge.
CDCOM | Component |  | HLA-DQ Typing | 1 | 86816 | No | No
IGA | Component | Immunoglobulin A (IgA), Serum | Immunoglobulin A (IgA), S | 1 | 82784 | Yes | Yes
CDCM1 | Component | Celiac Disease Interpretation | Celiac Disease Interpretation |  |  | Yes | No
CELI2 | Component | HLA-DQ Typing | HLA-DQ Typing | 1 | 86816 | Yes | Yes
EMA | [NAME] | Endomysial Antibodies (IgA), Serum | Endomysial Abs, S (IgA) | 1 | 86256 | No | Yes
TTGA | [NAME] | Tissue Transglutaminase (tTG) Antibody, IgA, Serum | Tissue Transglutaminase Ab, IgA, S | 1 | 83516 | No | Yes
TTGG | [NAME] | Tissue Transglutaminase (tTG) Antibody, IgG, Serum | Tissue Transglutaminase Ab, IgG, S | 1 | 83516 | No | Yes
DAGL | [NAME] | Gliadin (Deamidated) Antibody, IgA, Serum | Gliadin(Deamidated) Ab, IgA, S | 1 | 83516 | No | Yes
DGGL | [NAME] | Gliadin (Deamidated) Antibody, IgG, Serum | Gliadin(Deamidated) Ab, IgG, S | 1 | 83516 | No | Yes
CDGF | Test | [NAME] | [NAME] | 1 | 86816 |  |  | If HLA-DQ typing is positive or equivocal for DQ2 or DQ8, then IgA, tissue transglutaminase (tTG) IgA and IgG, and deamidated gliadin IgA and IgG will be performed at an additional charge.
CDGF1 | Component | Celiac Disease Interpretation | Celiac Disease Interpretation |  |  | Yes | No
CELI2 | Component | HLA-DQ Typing | HLA-DQ Typing |  |  | Yes | Yes
DAGL | [NAME] | Gliadin (Deamidated) Antibody, IgA, Serum | Gliadin(Deamidated) Ab, IgA, S | 1 | 83516 | No | Yes
DGGL | [NAME] | Gliadin (Deamidated) Antibody, IgG, Serum | Gliadin(Deamidated) Ab, IgG, S | 1 | 83516 | No | Yes
IGA | [NAME] | Immunoglobulin A (IgA), Serum | Immunoglobulin A (IgA), S | 1 | 82784 | No | Yes
TTGA | [NAME] | Tissue Transglutaminase (tTG) Antibody, IgA, Serum | Tissue Transglutaminase Ab, IgA, S | 1 | 83516 | No | Yes
TTGG | [NAME] | Tissue Transglutaminase (tTG) Antibody, IgG, Serum | Tissue Transglutaminase Ab, IgG, S | 1 | 83516 | No | Yes
CDKKM | Test | CDKN1C Gene, Known Mutation | CDKN1C Gene, Known Mutation | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
CDKMS | Test | CDKN1C Gene, Full Gene Analysis | CDKN1C Gene, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
CDSP | Test | Celiac Disease Serology Cascade | Celiac Disease Serology Cascade | 1 | 82784 |  |  | If [NAME] is age-specified normal, then tissue transglutaminase (tTG) IgA will be performed at an additional charge.   If tTG IgA is equivocal, then endomysial antibodies IgA and deamidated gliadin antibody IgA will be performed at an additional charge.   If [NAME] is > or =1.0 mg/dL but lower than age-specified normal, then tTG IgA, tTG IgG, deamidated gliadin IgA, and deamidated gliadin IgG will be performed at an additional charge.   If [NAME] is below detection (<1.0 mg/[NAME]), then tTG IgG and deamidated gliadin IgG will be performed at an additional charge.
IGA | Component | Immunoglobulin A (IgA), Serum | Immunoglobulin A (IgA), S | 1 | 82784 | Yes | Yes
CDSP1 | Component | Celiac Disease Interpretation | Celiac Disease Interpretation |  |  | Yes | No
DAGL | [NAME] | Gliadin (Deamidated) Antibody, IgA, Serum | Gliadin(Deamidated) Ab, IgA, S | 1 | 83516 | No | Yes
DGGL | [NAME] | Gliadin (Deamidated) Antibody, IgG, Serum | Gliadin(Deamidated) Ab, IgG, S | 1 | 83516 | No | Yes
TTGA | [NAME] | Tissue Transglutaminase (tTG) Antibody, IgA, Serum | Tissue Transglutaminase Ab, IgA, S | 1 | 83516 | No | Yes
EMA | [NAME] | Endomysial Antibodies (IgA), Serum | Endomysial Abs, S (IgA) | 1 | 86256 | No | Yes
TTGG | [NAME] | Tissue Transglutaminase (tTG) Antibody, IgG, Serum | Tissue Transglutaminase Ab, IgG, S | 1 | 83516 | No | Yes
CFPB | Test | Cystic Fibrosis Mutation Analysis, 106-Mutation Panel | Cystic Fibrosis Mutation Panel | 1 | 81220 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
CFTRK | Test | CFTR Gene, Known Mutation | CFTR Gene, Known Mutation | 1 | 81221 |  |  | For prenatal specimens only: If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture will be added and charged separately. If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
CHEP | Test | Chimerism-Recipient Engraftment (Post) | Chimerism-Recipient Engraft |  |  |  |  | Initial Chimerism Testing   Complete chimerism analysis requires 3 specimens. These specimens should be submitted when collected. An interpretive report will be provided once all specimens are received.
PCS1 | [NAME] | Post Cell Sort, 1 | Post Cell Sort, 1 |  |  | No | No
PCS2 | [NAME] | Post Cell Sort, 2 | Post Cell Sort, 2 |  |  | No | No
CHMT | [NAME] | Chimerism-Recipient Engraftment (Post) | Chimerism Analysis | 1 | 81267 | No | No
ADDO | [NAME] | Additional Donor | Additional Donor |  |  | No | No
CHOU | Test | Carbohydrate, [NAME] | Carbohydrate, U | 1 | 84377 |  |  | Testing begins with CHOU/9255 Carbohydrate, [NAME]. If qualitative results are normal, or abnormal but not indicative of galactose or glucose, testing is complete.     If qualitative results indicate the presence of galactose, GALU/8765 Galactose, Quantitative, [NAME] will be performed at an additional charge.      If qualitative results indicate the presence of glucose, RGLUR/89847 [NAME], Random, [NAME] will be performed at an additional charge.
GALU | [NAME] | Galactose, Quantitative, [NAME] | Galactose, QN, U | 1 | 82760 | No | Yes
RGLUR | [NAME] | Glucose, Random, [NAME] | Glucose, Random, U | 1 | 82945 | No | Yes
CHSBP | Test | Chronic Hepatitis Profile (Type B) | Chronic Hepatitis Profile (Type B) |  | PROFILE |  |  | If HBs antigen is reactive, then HBs antigen confirmation will be performed at an additional charge.
EAG | Component | [NAME], Serum | Hepatitis Be Ag, S | 1 | 87350 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HEAB | Component | [NAME], Serum | [NAME], S | 1 | 86707 | Yes | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
CHSUP | Test | Chronic Hepatitis Profile (Type Unknown) | Chronic Hepatitis Prof (Unknown) |  | PROFILE |  |  | If hepatitis B surface antigen (HBsAg) is reactive, then HBsAg confirmation will be performed at an additional charge.
HBAB | Component | Hepatitis B Surface Antibody, Qualitative/Quantitative, Serum | [NAME], S | 1 | 86706 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HBC | Component | Hepatitis B Core Total Antibodies, Serum | HBc Total Ab, S | 1 | 86704 | Yes | Yes
HCV | Component | Hepatitis C Antibody Screen, Serum | HCV Ab Screen, S | 1 | 86803 | Yes | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
CKELR | Test | [NAME], Serum | [NAME], S | 1 | 82550 |  |  | Testing begins with total creatine kinase analysis (CK). If the total CK activity is <100 U/L testing is complete. CK isoenzyme electrophoresis (CKE) testing will not be performed. If the total CK activity is > or =100 U/L, CK isoenzyme electrophoresis (CKE) will be performed at an additional charge.
CK | Component | [NAME] (CK), Serum | [NAME] (CK), S | 1 | 82550 | Yes | Yes
CKER | Component | CK Isoenzyme Elec, [NAME] Only | CK Isoenzyme Elec, [NAME] Only |  |  | Yes | No
CKE | [NAME] | CK Isoenzyme Electrophoresis, Serum | CK Isoenzyme Electrophoresis, S | 1 | 82552 | No | No
CLLM | Test | CLL Monitoring, MRD Detection, Blood | CLL Monitoring, MRD Detection, B |  | PROFILE |  |  | When this test is ordered, flow cytometry interpretation, 2 to 8 markers will always be performed at an additional charge.
CLLM | Component |  | Flow Cytometry, first marker | 1 | 88184 | No | No
CLLM | Component |  | Each additional marker | 5 | 88185 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | Yes | No
CLYME | Test | Lyme Disease Serology, Spinal Fluid | Lyme Disease Serology, CSF | 1 | 86618 |  |  | If Lyme disease serology is positive, then immunoblot testing will be performed at an additional charge.
CLYWB | [NAME] | Lyme Disease Antibody, Immunoblot, Spinal Fluid | Lyme Disease Ab, Immunoblot, CSF | 2 | 86617 | No | Yes
COKEU | Test | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
CORAB | Test | Hepatitis B Core Total Antibodies, with [NAME] to Hepatitis B Core Antibody, IgM, Serum | HBc [NAME], w/Reflex, S | 1 | 86704 |  |  | If hepatitis B core total antibodies is positive, then hepatitis B core antibody IgM is performed at an additional charge.
HBIM | [NAME] | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | No | Yes
CORAB | Test | Hepatitis B Core Total Antibodies, with [NAME] to Hepatitis B Core Antibody, IgM, Serum | HBc [NAME], w/Reflex, S | 1 | 86704 |  |  | If hepatitis B core total antibodies is positive, then hepatitis B core antibody IgM is performed at an additional charge.
HBIM | [NAME] | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | No | Yes
CPOXK | Test | CPOX Gene, Known Mutation | CPOX Gene, Known Mutation | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
CPOXS | Test | CPOX Gene, Full Gene Analysis | CPOX Gene, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
CPTKM | Test | Carnitine Palmitoyltransferase II Deficiency, Known Mutation | CPT2 Gene, Known Mutation | 1 | 81403 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
CPTMS | Test | Carnitine Palmitoyltransferase II Deficiency, Full Gene Analysis | CPT2 Gene, Full Gene Analysis | 1 | 81404 |  |  | If skin biopsy is received, fibroblast culture will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
CRDPU | Test | [NAME], [NAME] | [NAME], U |  |  |  |  | CRDPU/88697 Creatine Disorders Panel, [NAME] is a single test that carries the results for the panel. When the test is resulted, the following procedures are billed:   23466 [NAME], ([NAME] Only), [NAME]     23467 Creatinine, ([NAME] Only), [NAME]     23468 Guanidinoacetate, ([NAME] Only), [NAME]
23468 | [NAME] | Guanidinoacetate, ([NAME] Only), [NAME] | Guanidinoacetate, ([NAME] Only), U | 1 | 83789 | Yes | No
23467 | [NAME] | Creatinine, ([NAME] Only), [NAME] | Creatinine, ([NAME] Only), U | 1 | 82570 | Yes | No
23466 | [NAME] | [NAME], ([NAME] Only), [NAME] | [NAME], ([NAME] Only), U | 1 | 82540 | Yes | No
CRGSP | Test | Cryoglobulin and Cryofibrinogen Panel, Serum and Plasma | Cryo Panel, S and P |  | PROFILE |  |  | If cryoglobulin has a result other than negative, then immunofixation will be performed at an additional charge. Positive cryoglobulins of > or =0.1 mL of precipitate will be typed once.
CRY_P | Component | Cryofibrinogen, Plasma | Cryofibrinogen, P | 1 | 82585 | Yes | No
CRY_S | Component | Cryoglobulin, Serum | Cryoglobulin, S | 1 | 82595 | Yes | Yes
IMFXC | [NAME] | Immunofixation Cryoglobulin | Immunofixation Cryoglobulin | 1 | 86334 | No | No
CRY_S | Test | Cryoglobulin, Serum | Cryoglobulin, S | 1 | 82595 |  |  | If cryoglobulin has a result other than negative, then iImmunofixation will be performed at an additional charge. Positive cryoglobulins of > or =0.1 mL of precipitate will be typed once.
IMFXC | [NAME] | Immunofixation Cryoglobulin | Immunofixation Cryoglobulin | 1 | 86334 | No | No
CTDC | Test | Connective Tissue Diseases Cascade, Serum | Connective Tissue Disease Cascade,S |  | PROFILE |  |  | If antinuclear antibodies are > or =3.0 U, then antibodies to double-stranded DNA (ds-DNA), extractable nuclear antigen evaluation, ribosome P, and centromere are performed at an additional charge.
ANA2 | Component | Antinuclear Antibodies (ANA), Serum | Antinuclear Ab, S | 1 | 86038 | Yes | Yes
IM_01 | Component | Interpretation | Interpretation |  |  | Yes | No
CCP | Component | Cyclic Citrullinated Peptide Antibodies, IgG, Serum | Cyclic Citrullinated Peptide Ab, S | 1 | 86200 | Yes | Yes
ENAE | [NAME] | Antibody to Extractable Nuclear Antigen Evaluation, Serum | Ab to Extractable Nuclear Ag Eval,S |  | PROFILE | No | Yes
RIB | [NAME] | Ribosome P Antibodies, IgG, Serum | Ribosome P Ab, IgG, S | 1 | 83520 | No | Yes
CASMT | [NAME] | [NAME] | [NAME] |  |  | No | No
CMA | [NAME] | Centromere Antibodies, IgG, Serum | [NAME], IgG, S | 1 | 83520 | No | Yes
ADNA | [NAME] | DNA Double-Stranded (dsDNA) Antibodies, IgG, Serum | DNA Double-Stranded Ab, IgG, S | 1 | 86225 | No | Yes
DAAMP | Test | Drug of Abuse, Amphetamine Screen with GC-MS Confirmation, [NAME] | Drug of Abuse, Amphetamine, U | 1 | 80101 |  |  | If the amphetamines screen is >499 ng/mL then amphetamines confirmation is performed at an additional charge.
DAUAM | [NAME] | Drug of Abuse, Amphetamines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 2 | 82145 | No | Yes
DABAR | Test | Drug of Abuse, Barbiturate Screen with GC-MS Confirmation, [NAME] | Drug of Abuse, Barbiturate, U | 1 | 80101 |  |  | If the barbituate screen is > or =200 ng/mL then barbiturate confirmation is performed at an additional charge.
MSBR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, Barbiturate Conf, U | 1 | 82205 | No | Yes
DABZO | Test | Drug of Abuse, Benzodiazepine Screen with GC-MS Confirmation, [NAME] | Drug of Abuse, Benzodiazepine, U | 1 | 80101 |  |  | If the benzodiazepine screen is > or =200 ng/mL, then benzodiazepine confirmation is performed at an additional charge.
DAUBZ | [NAME] | Drug of Abuse, Benzodiazepines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80154 | No | Yes
DASM4 | Test | Drugs of Abuse Screen, Meconium 4 | Drugs of Abuse Screen, Meconium 4 | 1 | 80104 |  |  | Testing begins with immunoassay screen. Positives are confirmed and quantitated by liquid-chromatography/tandem-mass spectrometry (LC-MS/MS) at an additional charge.
AMPHM | [NAME] | Amphetamine-Type Stimulants, Confirmation, Meconium | Amphetamines, Confirmation, M | 2 | 82145 | No | Yes
COKEM | [NAME] | Cocaine and Metabolites Confirmation, Meconium | Cocaine and [NAME], Confirm, M | 1 | 82520 | No | Yes
OPATM | [NAME] | Opiate Confirmation, Meconium | Opiate Confirmation, M | 1 | 83925 | No | Yes
THCM | [NAME] | 11-nor-Delta-9-Tetrahydrocannabinol-9-Carboxylic Acid (Carboxy-THC), Meconium | Carboxy-THC Confirmation, M | 1 | 80299 | No | Yes
DASM5 | Test | Drugs of Abuse Screen, Meconium 5 | Drugs of Abuse Screen, Meconium 5 | 1 | 80104 |  |  | Testing begins with immunoassay screen. Positives are confirmed and quantitated by liquid-chromatography/tandem-mass spectrometry (LC-MS/MS) at an additional charge.
THCM | [NAME] | 11-nor-Delta-9-Tetrahydrocannabinol-9-Carboxylic Acid (Carboxy-THC), Meconium | Carboxy-THC Confirmation, M | 1 | 80299 | No | Yes
AMPHM | [NAME] | Amphetamine-Type Stimulants, Confirmation, Meconium | Amphetamines, Confirmation, M | 2 | 82145 | No | Yes
PCPMC | [NAME] | Phencyclidine Confirmation, Meconium | PCP Confirmation, Meconium | 1 | 83992 | No | Yes
OPATM | [NAME] | Opiate Confirmation, Meconium | Opiate Confirmation, M | 1 | 83925 | No | Yes
COKEM | [NAME] | Cocaine and Metabolites Confirmation, Meconium | Cocaine and [NAME], Confirm, M | 1 | 82520 | No | Yes
DAU | Test | Drug of Abuse Screen, DAU10, [NAME] | Drugs of Abuse, Clin, DAU10, U |  | PROFILE |  |  | If the cocaine screen is >149 ng/mL then cocaine confirmation is performed at an additional charge.   If the THC screen is >49 ng/mL then THC confirmation is performed at an additional charge.   If the opiate screen is >299 ng/mL then opiate confirmation is performed at an additional charge.   If the barbiturate screen is >199 ng/mL then barbiturate confirmation is performed at an additional charge.   If the benzodiazepine screen is >199 ng/mL then benzodiazepine confirmation is performed at an additional charge.   If the phencyclidine screen is >24 ng/mL then phencyclidine confirmation is performed at an additional charge.   If the amphetamines screen is >499 ng/mL then amphetamines confirmation is performed at an additional charge.   If the methadone screen is >299 ng/mL then methadone confirmation is performed at an additional charge.   If the propoxyphene screen is >299 ng/mL then propoxyphene confirmation is performed at an additional charge.
MSCO | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 82520 | No | Yes
MSPCP | [NAME] | Drug of Abuse, Phencyclidine GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME] | 1 | 83992 | No | Yes
MSOP | [NAME] | Drugs of Abuse, Opiates Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 83925 | No | No
MSMT | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 83840 | No | Yes
DAUAM | [NAME] | Drug of Abuse, Amphetamines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 2 | 82145 | No | Yes
MSTHC | [NAME] | Drug of Abuse, Tetrahydrocannabinol GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80299 | No | Yes
MSBR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, Barbiturate Conf, U | 1 | 82205 | No | Yes
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
DAUBZ | [NAME] | Drug of Abuse, Benzodiazepines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80154 | No | Yes
DAU7 | Test | Drugs of Abuse Screen, DAU7, [NAME] | Drug of Abuse, Clin, DAU7, U | 1 | 80104 |  |  | If the cocaine screen is >149 ng/mL then cocaine confirmation is performed at an additional charge.   If the THC screen is >49 ng/mL then THC confirmation is performed at an additional charge.   If the opiate screen is >299 ng/mL then opiate confirmation is performed at an additional charge.   If the barbiturate screen is >199 ng/mL then barbiturate confirmation is performed at an additional charge.   If the benzodiazepine screen is >199 ng/mL then benzodiazepine confirmation is performed at an additional charge.   If the phencyclidine screen is >24 ng/mL then phencyclidine confirmation is performed at an additional charge.   If the amphetamines screen is >499 ng/mL then amphetamines confirmation is performed at an additional charge.
MSBR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, Barbiturate Conf, U | 1 | 82205 | No | Yes
MSCO | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 82520 | No | Yes
DAUAM | [NAME] | Drug of Abuse, Amphetamines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 2 | 82145 | No | Yes
DAUBZ | [NAME] | Drug of Abuse, Benzodiazepines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80154 | No | Yes
MSPCP | [NAME] | Drug of Abuse, Phencyclidine GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME] | 1 | 83992 | No | Yes
MSOP | [NAME] | Drugs of Abuse, Opiates Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 83925 | No | No
MSTHC | [NAME] | Drug of Abuse, Tetrahydrocannabinol GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80299 | No | Yes
DAU8 | Test | Drugs of Abuse Screen, DAU8, [NAME] | Drugs of Abuse, Clin, DAU8, U | 7 | 80101 |  |  | If the cocaine screen is >149 ng/mL then cocaine confirmation is performed at an additional charge.   If the THC screen is >49 ng/mL then THC confirmation is performed at an additional charge.   If the opiate screen is >299 ng/mL then opiate confirmation is performed at an additional charge.   If the barbiturate screen is >199 ng/mL then barbiturate confirmation is performed at an additional charge.   If the benzodiazepine screen is >199 ng/mL then benzodiazepine confirmation is performed at an additional charge.   If the phencyclidine screen is >24 ng/mL then phencyclidine confirmation is performed at an additional charge.   If the amphetamines screen is >499 ng/mL then amphetamines confirmation is performed at an additional charge.
MSTHC | [NAME] | Drug of Abuse, Tetrahydrocannabinol GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80299 | No | Yes
MSCO | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 82520 | No | Yes
MSOP | [NAME] | Drugs of Abuse, Opiates Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 83925 | No | No
MSPCP | [NAME] | Drug of Abuse, Phencyclidine GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME] | 1 | 83992 | No | Yes
DAUAM | [NAME] | Drug of Abuse, Amphetamines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 2 | 82145 | No | Yes
DAUBZ | [NAME] | Drug of Abuse, Benzodiazepines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80154 | No | Yes
MSBR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, Barbiturate Conf, U | 1 | 82205 | No | Yes
DAU9 | Test | Drugs of Abuse Screen, DAU9, [NAME] | Drug of Abuse, Clin, DAU9, U | 1 | 80104 |  |  | If the cocaine screen is >149 ng/mL then cocaine confirmation is performed at an additional charge.   If the THC screen is >49 ng/mL then THC confirmation is performed at an additional charge.   If the opiate screen is >299 ng/mL then opiate confirmation is performed at an additional charge.   If the barbiturate screen is >199 ng/mL then barbiturate confirmation is performed at an additional charge.   If the benzodiazepine screen is >199 ng/mL then benzodiazepine confirmation is performed at an additional charge.   If the phencyclidine screen is >24 ng/mL then phencyclidine confirmation is performed at an additional charge.   If the amphetamines screen is >499 ng/mL then amphetamines confirmation is performed at an additional charge.   If the methadone screen is >299 ng/mL then methadone confirmation is performed at an additional charge.   If the propoxyphene screen is >299 ng/mL then propoxyphene confirmation is performed at an additional charge.
MSPCP | [NAME] | Drug of Abuse, Phencyclidine GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME] | 1 | 83992 | No | Yes
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
MSMT | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 83840 | No | Yes
MSCO | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 82520 | No | Yes
MSOP | [NAME] | Drugs of Abuse, Opiates Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 83925 | No | No
DAUAM | [NAME] | Drug of Abuse, Amphetamines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 2 | 82145 | No | Yes
MSBR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, Barbiturate Conf, U | 1 | 82205 | No | Yes
DAUBZ | [NAME] | Drug of Abuse, Benzodiazepines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80154 | No | Yes
MSTHC | [NAME] | Drug of Abuse, Tetrahydrocannabinol GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80299 | No | Yes
DAUCO | Test | Drug of Abuse, Cocaine Screen with GC-MS Confirmation, [NAME] | Drug of Abuse, Cocaine, U | 1 | 80101 |  |  | If the cocaine screen is >149 ng/mL then cocaine confirmation is performed at an additional charge.
MSCO | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 82520 | No | Yes
[NAME] | Test | Drug of Abuse, Methadone Screen with GC-MS Confirmation, [NAME] | Drug of Abuse, Methadone, U | 1 | 80101 |  |  | If the methadone screen is > or =300 ng/mL then methadone confirmation is performed at an additional charge.
MSMT | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 83840 | No | Yes
DPCP | Test | Drug of Abuse, Phencyclidine Screen With GC-MS Confirmation, [NAME] | Drug of Abuse, Phencyclidine, U | 1 | 80101 |  |  | If the phencyclidine screen is 25 ng/mL or greater, then phencyclidine confirmation is performed at an additional charge.
MSPCP | [NAME] | Drug of Abuse, Phencyclidine GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME] | 1 | 83992 | No | Yes
DPRP | Test | Drug of Abuse, [NAME] with GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80101 |  |  | If the propoxyphene screen is >299 ng/mL, then propoxyphene confirmation is performed at an additional charge.
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
DTHC | Test | Drug of Abuse, Tetrahydrocannabinol Screen with GC-MS Confirmation, [NAME] | Drug of Abuse, THC, U | 1 | 80101 |  |  | If the tetrahydrocannabinol screen is > or =50 ng/mL, then THC confirmation is performed at an additional charge.
MSTHC | [NAME] | Drug of Abuse, Tetrahydrocannabinol GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80299 | No | Yes
EEEVP | Test | Red Blood Cell (RBC) Enzyme Evaluation | RBC Enzyme Evaluation |  | PROFILE |  |  | This is a consultative evaluation in which the case will be evaluated at Mayo Medical Laboratories, the appropriate tests performed at an additional charge, and the results interpreted.   Note: RBCE/23544 Reflexed RBC Enzymes, Blood includes: adenosine deaminase, adenylate kinase, phosphofructokinase, phosphoglycerate kinase, triosephosphate isomerase, and pyrimidine 5'nucleotidase.
HEXK | Component | Hexokinase, Blood | Hexokinase, B | 1 | 82657 | Yes | No
EEEV | Component | Red Blood Cell (RBC) Enzyme Interpretation | Erythrocyte Enzyme Interpretation | 1 | 0 | Yes | No
PK | Component | [NAME], [NAME] | [NAME], RBC | 1 | 84220 | Yes | Yes
GPI | Component | [NAME], [NAME] | [NAME], B | 1 | 84087 | Yes | Yes
G6PD | Component | Glucose-6-Phosphate Dehydrogenase (G-6-PD), Quantitative, Erythrocytes | G-6-PD, QN, RBC | 1 | 82955 | Yes | Yes
GLTI | [NAME] | Glutathione, Blood | Glutathione, B | 1 | 82978 | No | No
RBCE | [NAME] | Reflexed RBC Enzymes, Blood | Reflexed RBC Enzymes |  | PROFILE | No | No
EGFR | Test | [NAME], 29 Mutation Panel, Tumor | [NAME], Tumor | 1 | 81235 |  |  | When this test is ordered, slide review will always be performed at an additional charge.
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
EGFRX | Test | [NAME], EGFR with [NAME], Tumor | [NAME], EGFR with [NAME] | 1 | 81235 |  |  | When this test is ordered, [NAME], 29 Mutation Panel, Tumor, will always be performed. All specimens without an EGFR mutation will be automatically reflexed for ALK (2p23) FISH testing.   When this test is ordered, SLRVW/61860 Slide Review will always be performed at an additional charge.
FLCA | [NAME] | [NAME], ALK (2p23) Rearrangement, FISH, Tissue | [NAME], ALK (2p23), FISH, Ts |  | PROFILE | No | Yes
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
ENFD | Test | Epidermal Nerve Fiber Density Consult | Epidermal Nerve Fiber Density |  |  |  |  | When this test is ordered, 1 of the 3 ENFD consult tests will be performed and charged for each biopsied site. Each additional stain will be charged separately.   Note: Special stains performed outside Mayo Medical Laboratories and included with the case may be repeated and charged at the reviewing neuropathologist's discretion. In addition, testing requested by referring physician (immunostains, molecular studies, etc) may not be performed if deemed unnecessary by the Mayo neuropathologist. For all requested consultations, auxiliary testing is ordered at the discretion of the Mayo neuropathologist.
ENFDC | [NAME] | Epidermal Nerve Fiber Density Consult, Tissue | [NAME], Tissue | 1 | 88323 | No | No
EROSB | [NAME] | Epidermal Nerve Fiber Density, Review of Outside Slides/Block | ENFD, Review Outside Slides/Block | 1 | 88325 | No | No
MORAN | [NAME] | [NAME] | [NAME] | 1 | 88356 | Yes | No
PGP95 | [NAME] | PGP 9.5 Immunostain | PGP 9.5 Immunostain | 1 | 88342 | No | No
CRED | [NAME] | Congo Red, Nrv ST | Congo Red, Nrv ST | 1 | 88313 | No | No
EOSPS | [NAME] | Epidermal Nerve Fiber Density, Outside Slides-PGP Stained | ENFD, Outside Slides-PGP Stained | 1 | 88321 | No | No
EPU | Test | Electrophoresis, Protein, [NAME] | Electrophoresis, Protein, U |  | PROFILE |  |  | If a discrete electrophoresis band is identified, the laboratory will evaluate the urine protein electrophoresis and, if necessary, perform immunofixation at an additional charge.
PEU | Component | Electrophoresis, Protein, [NAME] | Protein Electrophoresis, U | 1 | 84166 | Yes | No
PTU | Component | Protein, Total, [NAME] | Protein, Total, U | 1 | 84156 | Yes | Yes
IFXU | [NAME] | Immunofixation, [NAME] | Immunofixation, U | 1 | 86335 | No | No
F10IS | Test | Coagulation Factor X Inhibitor Screen, Plasma | Coag Factor X Inhibitor Scrn, P |  | PROFILE |  |  | If appropriate, a Bethesda titer will be performed at an additional charge to quantify the inhibitor.
10_IS | Component | Factor X Inhibitor Screen | Factor X Inhib Scrn | 1 | 85335 | Yes | No
F_10 | Component | Coagulation Factor X Activity Assay, Plasma | Coag Factor X Assay, P | 1 | 85260 | Yes | Yes
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
F11IS | Test | Coagulation Factor XI Inhibitor Screen, Plasma | Coag Factor XI Inhibitor Scrn, P |  | PROFILE |  |  | If appropriate, a Bethesda titer will be performed at an additional charge to quantify the inhibitor.
11_IS | Component | Factor XI Inhibitor Screen | Factor [NAME] Scrn | 1 | 85335 | Yes | No
F_11 | Component | Coagulation Factor XI Activity Assay, Plasma | Coag Factor XI Assay, P | 1 | 85270 | Yes | Yes
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
F2IS | Test | Coagulation Factor II Inhibitor Screen, Plasma | Coag Factor II Inhibitor Scrn, P |  | PROFILE |  |  | If appropriate, a Bethesda titer will be performed at an additional charge to quantify the inhibitor.
F2_IS | Component | Factor II Inhibitor Screen | Factor II Inhib Scrn | 1 | 85335 | Yes | No
F_2 | Component | Coagulation Factor II Activity Assay, Plasma | Coag Factor II Assay, P | 1 | 85210 | Yes | Yes
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
F2ISO | Test | F2-Isoprostanes, [NAME] | F2-Isoprostanes, U | 1 | 83789 |  |  | When F2-Isoprostanes testing is performed, urine creatinine will always be performed at no additional charge.
AACT | [NAME] | Creatinine, [NAME] | Creatinine, U |  |  | Yes | No
F5IS | Test | Coagulation Factor V Inhibitor Screen, Plasma | Coag Factor V Inhibitor Scrn, P |  | PROFILE |  |  | If appropriate, a Bethesda titer will be performed at an additional charge to quantify the inhibitor.
FACTV | Component | Coagulation Factor V Activity Assay, Plasma | Coag Factor V Assay, P | 1 | 85220 | Yes | Yes
F5_IS | Component | Factor V Inhibitor Screen | Factor V Inhib Scrn | 1 | 85335 | Yes | No
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
F7IS | Test | Coagulation Factor VII Inhibitor Screen, Plasma | Coag Factor VII Inhibitor Scrn, P |  | PROFILE |  |  | If appropriate, a Bethesda titer will be performed at an additional charge to quantify the inhibitor.
F7_IS | Component | Factor VII Inhibitor Screen | Factor [NAME] | 1 | 85335 | Yes | No
F_7 | Component | Coagulation Factor VII Activity Assay, Plasma | Coag Factor VII Assay, P | 1 | 85230 | Yes | Yes
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
F8INH | Test | Factor VIII Inhibitor Evaluation | Factor 8 Inhib Prof | 1 | 85240 |  |  | Testing begins with coagulation factor VIII activity assay with dilutions to evaluate assay inhibition; if the factor VIII activity assay is decreased, an inhibitor screen will be performed to look for specific factor VIII inhibition. If specific inhibition is apparent, the titer of the inhibitor will be determined.
F8A | Component | Coagulation Factor VIII Activity Assay, Plasma | Coag Factor VIII Activity Assay, P | 1 | 85240 | Yes | Yes
F8IS | [NAME] | Coagulation Factor VIII Inhibitor Screen, Plasma | Coag Factor VIII Assay [NAME],P | 1 | 85335 | No | No
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
CCCR | [NAME] | Special Coagulation Interpretation | Special Coagulation Interpretation | 1 | 85390 | No | No
F9INH | Test | Factor IX Inhibitor Evaluation | Factor IX Inhib Profile | 1 | 85250 |  |  | Testing begins with coagulation factor IX activity assay with dilutions to evaluate assay inhibition; if the factor IX activity assay is decreased, an inhibitor will be performed to look for specific factor IX inhibition. If specific inhibition is apparent, it will be titered.
F_9 | Component | Coagulation Factor IX Activity Assay, Plasma | Coag Factor IX Assay, P | 1 | 85250 | Yes | Yes
CCCR | [NAME] | Special Coagulation Interpretation | Special Coagulation Interpretation | 1 | 85390 | No | No
F9_IS | [NAME] | Factor IX Inhibitor Screen | Factor IX Inhib Scrn | 1 | 85335 | No | No
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
FABKM | Test | [NAME], Known Mutation | [NAME] | 1 | 81403 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
FAML | Test | Acute [NAME] (AML), FISH | AML, FISH |  | PROFILE |  |  | See Acute Promyelocytic Leukemia: Guideline to Diagnosis and Follow-up in Special Instructions.
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
FANCA | Test | Fanconi Anemia C Mutation Analysis, IVS4(+4)A->T and 322delG | [NAME], Mutation Analysis | 1 | 81242 |  |  | For prenatal specimens only: If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture will be added and charged separately. If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
FAO | Test | Fatty Acid Oxidation Probe Assay, Fibroblast Culture | Fatty Acid Ox Probe Assay, Fibro | 1 | 82017 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
FBALL | Test | B-Cell Acute Lymphoblastic Leukemia (ALL), FISH | ALL (B-Cell), FISH |  | PROFILE |  |  | This panel includes testing for the following anomalies via the probes listed. The entire panel is recommended for pediatric patients.
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
FBLP | Test | B-Cell Lymphoma, FISH, Blood or Bone Marrow | B-Cell Lymphoma, FISH, B/BM |  | PROFILE |  |  | Indicate which subtype of B-cell lymphoma is suspected as well as which anomalies need to be investigated from the following profile.
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
FBORE | Test | Bordetella pertussis Antibodies, IgG and IgM by ELISA with Reflex to Immunoblot | B. pertussis Abs, IgG, IgM w/Reflex | 2 | 86615 |  |  | If Bordetella pertussis Antibody, IgG by ELISA is 2.5 U/mL or greater, then B. pertussis [NAME], IgG Immunoblot testing will be performed at an additional charge.   If Bordetella pertussis Antibody IgM by ELISA is 1.2 U/mL or greater, then B. pertussis Ab, IgM Immunoblot testing will be performed at an additional charge.
FBAMI | [NAME] | Bordetella pertussis Antibody, IgM by Immunoblot | B. pertussis Ab, IgM Immunoblot | 1 | 86615 | No | No
FBAGI | [NAME] | Bordetella pertussis Antibody, IgG by Immunoblot | B. pertussis [NAME], IgG Immunoblot | 1 | 86615 | No | No
FBPTS | Test | Bordetella pertussis Antibodies, IgA, IgG and IgM by ELISA with Reflex to Immunoblot | B. pertussis [NAME], M, A w/Reflex | 3 | 86615 |  |  | If Bordetella pertussis Antibody, IgA by ELISA is 1.2 U/mL or greater, then B. pertussis Ab, IgA Immunoblot testing will be performed at an additional charge.   If Bordetella pertussis Antibody, IgG by ELISA is 2.5 U/mL or greater, then B. pertussis [NAME], IgG Immunoblot testing will be performed at an additional charge.   If Bordetella pertussis Antibody, IgM by ELISA is 1.2 U/mL or greater, then B. pertussis Ab, IgM Immunoblot testing will be performed at an additional charge.
FBAGI | [NAME] | Bordetella pertussis Antibody, IgG by Immunoblot | B. pertussis [NAME], IgG Immunoblot | 1 | 86615 | No | No
FBAMI | [NAME] | Bordetella pertussis Antibody, IgM by Immunoblot | B. pertussis Ab, IgM Immunoblot | 1 | 86615 | No | No
FBAAI | [NAME] | Bordetella pertussis Antibody, IgA by Immunoblot | B. pertussis Ab, IgA Immunoblot | 1 | 86615 | No | No
FCGHP | Test | [NAME] (aCGH) Parental Testing, FISH | aCGH Parental Testing, FISH |  | PROFILE |  |  | When this test is ordered, 1 to 4 FISH probes will be added at an additional charge.
FCGHP | Component |  | DNA probe, each | 2 | 88271 | No | No
FCGHP | Component |  | Chromosomal in situ hybridization | 1 | 88273 | No | No
FCGHP | Component |  | Interpretation and Report | 1 | 88291 | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
FCLL | Test | Chronic Lymphocytic Leukemia (CLL), FISH | CLL, FISH |  | PROFILE |  |  | FISH testing is recommended in place of chromosome analysis for this disorder. This panel includes testing for the following anomalies via the probes listed:
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
FCSP | Test | Chromosome Anomalies, [NAME] with Chromosome-Specific FISH [NAME] | Chromosome Anomalies, [NAME], FISH |  | PROFILE |  |  | When this test is ordered, 2 FISH probes are included. If further probes are needed, they will be added at an additional charge.
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
FD | Test | Familial Dysautonomia, Mutation Analysis, IVS20(+6T->C) and R696P | Familial Dysautonomia, Mutation | 1 | 81260 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
FDS9R | Test | Drug Screen 9 Panel, Serum or Plasma-Immunoassay Screen with Reflex to Mass Spectrometry Confirmation/Quantitation | Drug Screen 9 Pnl, with [NAME] | 9 | 80101 |  |  | If screen is positive, specimens are automatically confirmed by GC/MS and/or LC/MS/MS at an additional charge.
FAMPC | [NAME] | Amphetamines, Confirmation | Amphetamines, Confirmation | 1 | 82145 | No | No
FBABC | [NAME] | Barbiturates, Confirmation | Barbiturates, Confirmation | 1 | 82205 | No | No
FBENC | [NAME] | Benzodiazepines, Confirmation | Benzodiazepines, Confirmation | 1 | 80154 | No | No
FCANC | [NAME] | Cannabinoids, Confirmation | Cannabinoids, Confirmation | 1 | 82542 | No | No
FCOMC | [NAME] | Cocaine and [NAME] | Cocaine and [NAME], Confirm | 1 | 82520 | No | No
[NAME] | [NAME] | Methadone and Metabolite Confirm | Methadone and Metabolite Confirm | 1 | 83840 | No | No
FOPMC | [NAME] | Opiate and Metabolites Confirm | Opiate and Metabolites Confirm | 1 | 83925 | No | No
FPHNC | [NAME] | Phencyclidine, Confirmation | Phencyclidine, Confirmation | 1 | 83992 | No | No
FPPMC | [NAME] | Propoxyphene/Metab, Confirmation | Propoxyphene/Metab, Confirmation | 1 | 83925 | No | No
FEAGR | Test | [NAME] (IgG), EIA with Reflex to Western Blot | [NAME] [NAME] to WB | 1 | 86682 |  |  | If [NAME], EIA is positive, then Echinococcus IgG Western Blot will be performed at an additional charge.
FEGWB | [NAME] | [NAME] (IgG), Western Blot | [NAME], WB | 1 | 86682 | No | No
FENAB | Test | Encephalitis Antibody Panel (CSF) | Encephalitis Antibody Panel (CSF) |  | PROFILE |  |  | If HSV 1 IgM Screen is Positive, then HSV 1 IgM Titer (FMTR1) will be performed at an additional charge.    If HSV 2 IgM Screen is Positive, then HSV 2 IgM Titer (FMTR2) will be performed at an additional charge.
FHSGC | Component | HSV 1/2 (IgG) Type-Specific Ab, CSF | HSV 1/2 (IgG) Type-Specific Ab, CSF |  |  | Yes | No
FENAB | Component |  | MUMPS ANTIBODY | 2 | 86735 | No | No
FENAB | Component |  | VARICELLA-ZOSTER ANTIBODY | 2 | 86787 | No | No
FHSMC | Component | Herpes Simplex Virus 1/2 IgM Ab, CSF | Herpes Simplex Virus 1/2 IgM Ab,CSF |  |  | Yes | No
FLCAC | Component | LCM Virus Ab, IFA (CSF) | LCM Virus Ab, IFA CSF |  |  | Yes | No
FMGMC | Component | Measles (Rubeola) G/M Ab, IFA CSF | Measles (Rubeola) G/M Ab, IFA CSF |  |  | Yes | No
FWNAB | Component | West Nile Virus Antibodies (IgG, IgM), CSF | West Nile Virus Ab (IgG, IgM), CSF |  |  | Yes | No
[NAME] | Component | Mumps Antibody Panel, IFA (CSF) | Mumps Antibody Panel, IFA (CSF) |  |  | Yes | No
FENAB | Component |  | HERPES SIMPLEX TEST | 1 | 86695 | No | No
FENAB | Component |  | RUBEOLA ANTIBODY | 2 | 86765 | No | No
FVZTC | Component | Varicella-Zoster, Total/IgM Ab, CSF | Varicella-Zoster, Total/IgM Ab, CSF |  |  | Yes | No
FENAB | Component |  | WEST NILE VIRUS AB IGM | 1 | 86788 | No | No
FENAB | Component |  | HERPES SIMPLEX TYPE 2 | 1 | 86696 | No | No
FENAB | Component |  | LYMPH CHORIOMENINGITIS AB | 2 | 86727 | No | No
FENAB | Component |  | WEST NILE VIRUS ANTIBODY | 1 | 86789 | No | No
FENAB | Component |  | HERPES SIMPLEX TYPE 2 | 1 | 86696 | No | No
FENAB | Component |  | HERPES SIMPLEX TEST | 1 | 86695 | No | No
FMTR1 | [NAME] | HSV 1 IgM Titer | HSV 1 IgM Titer |  | PROFILE | No | No
FMTR2 | [NAME] | HSV 2 IgM Titer | HSV 2 IgM Titer | 1 | 86696 | No | No
FENTU | Test | [NAME], [NAME] | [NAME] and Metabolite, U | 1 | 80299 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
FFAPL | Test | Febrile Antibodies Panel | Febrile Antibodies Panel |  | PROFILE |  |  | If RMSF IgG is Detected, then FRMFG RMSF IgG Titer will be performed at an additional charge.   If RMSF IgM is Detected, then FRMFM RMSF IgM Titer will be performed at an additional charge.   If [NAME] IgG is Detected, then FRTG R. Typhi IgG Titer will be performed at an additional charge.   If R. Typhi IgM is Detected, then FRTM R. Typhi IgM Titer will be performed at an additional charge.   If Brucella IgM is > or =1.10, then FBRAG Brucella Agglutination will be performed at an additional charge.
FFAPL | Component |  | BRUCELLA ANTIBODY | 2 | 86622 | No | No
FFAPL | Component |  | RICKETTSIA ANTIBODY | 4 | 86757 | No | No
FFAPL | Component |  | SALMONELLA ANTIBODY | 5 | 86768 | No | No
FBRAG | [NAME] | Brucella Agglutination | Brucella Agglutination | 1 | 86622 | No | No
FRMFG | [NAME] | Rickettsia (RMSF) [NAME] | RMSF IgG Titer | 1 | 86757 | No | No
FRMFM | [NAME] | Rickettsia (RMSF) IgM Titer | RMSF IgM Titer | 1 | 86757 | No | No
FRTG | [NAME] | R. Typhi IgG Titer | R. Typhi IgG Titer | 1 | 86757 | No | No
FRTM | [NAME] | R. Typhi IgM Titer | R. Typhi IgM Titer | 1 | 86757 | No | No
FFTPG | Test | Treponema pallidum Antibody (FTA-ABS), Serum, IgG by IFA with [NAME] to Treponema pallidum Antibody by TP-PA | T. pallidum [NAME] (FTA-ABS), IgG | 1 | 86780 |  |  | When [NAME] pallidum [NAME] (FTA-ABS), IgG is reported as Inconclusive, "Treponema pallidum [NAME] by TP-PA" will be performed at an additional charge.
FFTP | [NAME] | Treponema pallidum [NAME] by TP-PA | Treponema pallidum [NAME] by TP-PA | 1 | 86780 | No | No
FHAN | Test | Hantavirus Antibodies (IgG, IgM) with Reflex to Confirmation | [NAME], IgM w/Rfl | 2 | 86790 |  |  | If [NAME] is >=2.00 and Hantavirus IgM is >=2.00 FSING #57201 Sin Nombre Virus IgG Confirmation will be performed at an additional charge.
FSING | [NAME] | Sin Nombre Virus IgG Confirmation, IBL | Sin Nombre Virus IgG Confirmation | 1 | 86790 | No | No
FSINM | [NAME] | Sin Nombre Virus IgM Confirmation, ELISA | Sin Nombre Virus IgM Confirmation | 1 | 86790 | No | No
FHSAB | Test | Herpes Simplex Virus 1/2 Antibody (IgM), IFA with [NAME] to [NAME], Serum | HSV 1/2 IgM Ab IFA Reflex to [NAME] |  | PROFILE
FHSAB | Component |  | HERPES SIMPLEX TEST | 1 | 86695 | No | No
FHSAB | Component |  | HERPES SIMPLEX TYPE 2 | 1 | 86696 | No | No
FHSII | [NAME] | HSV 2 IgM Titer | HSV 2 IgM Titer | 1 | 86696 | No | No
FHSI | [NAME] | HSV 1 IgM Titer | HSV 1 IgM Titer | 1 | 86695 | No | No
FHUAB | Test | [NAME] with [NAME] to [NAME] and Western Blot | [NAME] with Reflex | 1 | 86255 |  |  | If FHUAB is Positive, then [NAME] ([NAME], Western Blot, Serum) will be performed at an additional charge.   If [NAME] is Positive, then FHUAT ([NAME], Serum) will be performed at an additional charge.
FHUAT | [NAME] | [NAME], Serum | [NAME], Serum | 1 | 86256 | No | No
FHUWB | [NAME] | [NAME], Serum | [NAME], Western Blot, Serum | 1 | 84181 | No | No
FIBR | Test | Fibroblast Culture | Fibroblast Culture | 1 | 88233 |  |  | When this test is ordered, cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 30 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIMRG | Test | Imatinib Mesylate Responsive Genes, Locus Anomalies, FISH | Imatinib [NAME], FISH |  | PROFILE |  |  | Panel includes testing for the following anomalies via the probes listed:
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
FLUPV | Test | Lupus Anticoagulant Evaluation w/Reflexes | Lupus Anticoagulant Eval w/Reflexes |  | PROFILE |  |  | If the PTT-LA is >40, then the Hexagonal Phase Confirmation (FHEXC) will be performed at an additional charge.   If the Hexagonal Phase Confirm is positive or weakly positive, a Thrombin Clotting Time (FCLOT) will be performed at an additional charge.    If the DRVVT Screen is >45 then the DRVVT Confirmation (FDVTC) will be performed at an additional charge.   If the DRVVT Confirmation is positive, then the DRVVT 1:1 Mix (FDVTX) will be performed at an additional charge.
FLUPV | Component |  | Lupus Anticoagulant | 1 | 85730 | No | No
FLUPV | Component |  | DRVVT Screen | 1 | 85613 | No | No
FCLOT | [NAME] | Thrombin Clotting Time | Thrombin Clotting Time | 1 | 85670 | No | No
FDVTC | [NAME] | DRVVT Confirm | DRVVT Confirm | 1 | 85597 | No | No
FDVTX | [NAME] | DRVVT 1:1 Mix | DRVVT 1:1 Mix | 1 | 85613 | No | No
FHEXC | [NAME] | Hexagonal Phase Confirm | Hexagonal Phase Confirm | 1 | 85597 | No | No
FMCPL | Test | [NAME], CSF | Meningoencephalitis Comp Panel, CSF |  | PROFILE |  |  | If HSV 1 IgM Screen is Positive, then HSV 1 IgM Titer (FMTR1) will be performed at an additional charge.    If HSV 2 IgM Screen is Positive, then HSV 2 IgM Titer (FMTR2) will be performed at an additional charge.
FWNIL | Component | West Nile Virus Antibodies (IgG, IgM), CSF | West Nile Virus Ab (IgG, IgM), CSF |  |  | Yes | No
FCMGA | Component | [NAME], ELISA CSF | [NAME], ELISA CSF |  |  | Yes | No
FCBAC | Component | [NAME] (1-6) Antibodies, CSF | [NAME] (1-6) Antibodies, CSF |  |  | Yes | No
[NAME] | Component | Coxsackie A Antibodies, CSF | Coxsackie A Antibodies, CSF |  |  | Yes | No
FVZVA | Component | Varicella-Zoster Virus Antibody, CSF | Varicella-Zoster Virus Antibody, CSF |  |  | Yes | No
FHSAC | Component | HSV 1/2 IgG Type-Specific Ab, CSF | HSV 1/2 IgG Type-Specific Ab, CSF |  |  | Yes | No
FMABC | Component | Mumps Antibody Panel, IFA CSF | Mumps Antibody Panel, IFA CSF |  |  | Yes | No
FMGMA | Component | Measles (Rubeola) G/M Ab, IFA CSF | Measles (Rubeola) G/M Ab, IFA CSF |  |  | Yes | No
FMCPL | Component |  | WEST NILE VIRUS ANTIBODY | 1 | 86789 | No | No
FMCPL | Component |  | ENCEPHALITIS ANTIBODY | 2 | 86651 | No | No
FMCPL | Component |  | HERPES SIMPLEX TYPE 2 | 1 | 86696 | No | No
FMCPL | Component |  | ENTEROVIRUS ANTIBODY | 6 | 86658 | No | No
FMCPL | Component |  | WEST NILE VIRUS AB IGM | 1 | 86788 | No | No
FSTLE | Component | St. Louis Enceph Virus Ab, IFA CSF | St. Louis Enceph Virus Ab, IFA CSF |  |  | Yes | No
FLCHV | Component | Lymphocytic [NAME], CSF | Lymphocytic [NAME], CSF |  |  | Yes | No
FCMVM | Component | Cytomegalovirus IgM Ab, ELISA CSF | Cytomegalovirus IgM Ab, ELISA CSF |  |  | Yes | No
FADAC | Component | [NAME], CSF | [NAME], CSF |  |  | Yes | No
FWEQC | Component | [NAME], IFA CSF | [NAME], IFA CSF |  |  | Yes | No
FEASF | Component | Echovirus Antibodies, CSF | Echovirus Antibodies, CSF |  |  | Yes | No
FMCPL | Component |  | CMV ANTIBODY | 1 | 86644 | No | No
FMCPL | Component |  | ENCEPHALITIS ANTIBODY | 2 | 86654 | No | No
FMCPL | Component |  | ENCEPHALITIS ANTIBODY | 2 | 86653 | No | No
FEEQC | Component | [NAME], IFA CSF | [NAME], IFA CSF |  |  | Yes | No
FMCPL | Component |  | LYMPH CHORIOMENINGITIS AB | 2 | 86727 | No | No
FMCPL | Component |  | INFLUENZA VIRUS ANTIBODY | 2 | 86710 | No | No
FMCPL | Component |  | MUMPS ANTIBODY | 2 | 86735 | No | No
FMCPL | Component |  | VARICELLA-ZOSTER ANTIBODY | 1 | 86787 | No | No
FMCPL | Component |  | RUBEOLA ANTIBODY | 2 | 86765 | No | No
FCEVC | Component | Calif Enceph Virus Ab Pnl, IFA CSF | Calif Enceph Virus Ab Pnl, IFA CSF |  |  | Yes | No
FMCPL | Component |  | [NAME] ANTIBODY | 1 | 86603 | No | No
FMCPL | Component |  | ENCEPHALITIS ANTIBODY | 2 | 86652 | No | No
FMCPL | Component |  | HERPES SIMPLEX TEST | 1 | 86695 | No | No
FMCPL | Component |  | HERPES SIMPLEX TYPE 2 | 1 | 86696 | No | No
FMCPL | Component |  | ENTEROVIRUS ANTIBODY | 6 | 86658 | No | No
FMCPL | Component |  | ENTEROVIRUS ANTIBODY | 5 | 86658 | No | No
FMCPL | Component |  | CMV ANTIBODY IGM | 1 | 86645 | No | No
FMCPL | Component |  | HERPES SIMPLEX TEST | 1 | 86695 | No | No
FHERM | Component | HSV 1/2 IgM Ab IFA Reflex to [NAME] | HSV 1/2 IgM Ab IFA Reflex to [NAME] |  |  | Yes | No
FITAB | Component | Influenza Virus A and B Ab, CSF | Influenza Virus A and B Ab, CSF |  |  | Yes | No
FMTR2 | [NAME] | HSV 2 IgM Titer | HSV 2 IgM Titer | 1 | 86696 | No | No
FMTR1 | [NAME] | HSV 1 IgM Titer | HSV 1 IgM Titer |  | PROFILE | No | No
FMDS | Test | Myelodysplastic Syndrome (MDS), FISH | MDS, FISH |  | PROFILE |  |  | Chromosome analysis is recommended as first-tier testing for this disorder; FISH should be used if chromosomes are not successful.
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
FMEPL | Test | Meningoencephalitis (Encephalitis) Panel, CSF | Meningoencephalitis Panel CSF |  | PROFILE |  |  | If positive HSV 1 IgM Screen, reflex to titer (FMTR1) will be performed at an additional charge.   If positive HSV 2 IgM Screen, reflex to titer (FMTR2) will be performed at an additional charge.
FEEEV | Component | [NAME], IFA CSF | [NAME], IFA CSF |  |  | Yes | No
FMEPL | Component |  | LYMPH CHORIOMENINGITIS AB | 2 | 86727 | No | No
FWEQE | Component | [NAME], IFA CSF | [NAME], IFA CSF |  |  | Yes | No
FHSVA | Component | HSV 1/2 IgM Ab IFA Reflex to [NAME] | HSV 1/2 IgM Ab IFA Reflex to [NAME] |  |  | Yes | No
FCEVP | Component | Calif Enceph Virus Ab Pnl, IFA CSF | California Encephalitis Ab Panel, CSF |  |  | Yes | No
FMEPL | Component |  | ENCEPHALITIS ANTIBODY | 2 | 86651 | No | No
FMEPL | Component |  | ENCEPHALITIS ANTIBODY | 2 | 86654 | No | No
FHSV | Component | HSV 1/2 IgG Type-Specific Ab, CSF | HSV 1/2 IgG Type-Specific Ab, CSF |  |  | Yes | No
FLCVC | Component | LCM Virus Ab, IFA CSF | LCM Virus Ab, IFA CSF |  |  | Yes | No
[NAME] | Component | West Nile Virus Antibodies (IgG, IgM), CSF | West Nile Virus Ab (IgG, IgM), CSF |  |  | Yes | No
FSLEV | Component | St. Louis Encephalitis Ab, IFA CSF | St Louis Encephalitis Ab, IFA (CSF) |  |  | Yes | No
FMEPL | Component |  | ENCEPHALITIS ANTIBODY | 2 | 86653 | No | No
FMAPC | Component | Mumps Antibody Panel, IFA CSF | Mumps Antibody Panel, IFA CSF |  |  | Yes | No
FMEPL | Component |  | ENCEPHALITIS ANTIBODY | 2 | 86652 | No | No
FMEPL | Component |  | WEST NILE VIRUS AB IGM | 1 | 86788 | No | No
FMEPL | Component |  | HERPES SIMPLEX TEST | 1 | 86695 | No | No
FMEPL | Component |  | WEST NILE VIRUS ANTIBODY | 1 | 86789 | No | No
FMEPL | Component |  | HERPES SIMPLEX TEST | 1 | 86695 | No | No
FMEPL | Component |  | MUMPS ANTIBODY | 2 | 86735 | No | No
FMEPL | Component |  | HERPES SIMPLEX TYPE 2 | 1 | 86696 | No | No
FMEPL | Component |  | HERPES SIMPLEX TYPE 2 | 1 | 86696 | No | No
FMTR2 | [NAME] | HSV 2 IgM Titer | HSV 2 IgM Titer | 1 | 86696 | No | No
FMTR1 | [NAME] | HSV 1 IgM Titer | HSV 1 IgM Titer |  | PROFILE | No | No
FMFC | Test | Myeloma, FISH, Fixed Cells | Myeloma, FISH, Fixed Cells |  | PROFILE |  |  | The number of probes ordered will determine the price of the testing. When this test is ordered, a charge for 2 FISH probes and interpretation is included. If additional probes or the entire panel are ordered, additional probe charges will be added.
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
FMGA | Test | [NAME]. [NAME] (MAG) Antibody w/Reflex to MAG-SGPG & MAG, EIA | MAG w/Reflex MAG-SGPG and MAG, EIA | 1 | 84181 |  |  | If FMGA is Positive, then FMGS (MAG EIA Reflex) is performed at an additional charge.
FMGS | [NAME] | MAG EIA Reflex | MAG EIA Reflex |  | PROFILE | No | No
FNARI | Test | [NAME] with [NAME] to [NAME] and Western Blot | [NAME] Screen with Reflex | 1 | 86255 |  |  | If [NAME] is Positive, then FRIWB ([NAME], Western Blot) will be performed at an additional charge.   If FRIWB is Positive, then FNRIT ([NAME], [NAME]) will be performed at an additional charge.
FNRIT | [NAME] | [NAME], [NAME] | [NAME], [NAME] | 1 | 86256 | No | No
FRIWB | [NAME] | [NAME], Western Blot | [NAME], Western Blot | 1 | 84181 | No | No
FRDP | Test | Rickettsial Disease Panel | Rickettsial Disease Panel |  | PROFILE |  |  | If R. Typhi IgG is Detected - FRTG Rickettsia (Typhus Fever) [NAME] will be performed at an additional charge.   If R. Typhi IgM is Detected - FRTM Rickettsia (Typhus Fever) IgM Titer will be performed at an additional charge.   If RMSF IgG is Detected - FRMFG Rickettsia (RMSF) [NAME] will be performed at an additional charge.   If RMSF IgM is Detected - FRMFM Rickettsia (RMSF) IgM Titer will be performed at an additional charge.   If Q Fever IgG Phase I (FQGI) is Positive – FQFG1 Q Fever IgG Phase I Titer will be performed at an additional charge.    If Q Fever IgM Phase I (FQMI) is Positive – FQFG2 Q Fever IgM Phase I Titer will be performed at an additional charge.    If Q Fever IgG Phase II (FQG2S) is Positive – FQFM1 Q Fever IgG Phase II Titer will be performed at an additional charge.   If Q Fever IgM Phase II (FQM2S) is Positive – FQFM2 Q Fever IgM Phase II Titer will be performed at an additional charge.
FQM2S | Component | Q Fever IgM Phase II Screen | Q Fever IgM Phase II Screen | 1 | 86638 | Yes | No
FRMGM | Component | RMSF IgG/IgM Reflex to Titers | RMSF IgG/IgM Reflex to Titers |  |  | Yes | No
FQGI | Component | Q Fever IgG Phase I Screen | Q Fever IgG Phase I Screen | 1 | 86638 | Yes | No
FQMI | Component | Q Fever IgM Phase I Screen | Q Fever IgM Phase I Screen | 1 | 86638 | Yes | No
FQG2S | Component | Q Fever IgG Phase II Screen | Q Fever IgG Phase II Screen | 1 | 86638 | Yes | No
FRDP | Component |  | RICKETTSIA ANTIBODY | 2 | 86757 | No | No
FRTGM | Component | [NAME]/IgM Reflex to Titers | [NAME]/IgM Reflex to Titers |  |  | Yes | No
FRDP | Component |  | RICKETTSIA ANTIBODY | 2 | 86757 | No | No
FRMFM | [NAME] | Rickettsia (RMSF) IgM Titer | RMSF IgM Titer | 1 | 86757 | No | No
FQFG1 | [NAME] | Q Fever IgG Phase I Titer | Q Fever IgG Phase I Titer | 1 | 86638 | No | No
FRMFG | [NAME] | Rickettsia (RMSF) [NAME] | RMSF IgG Titer | 1 | 86757 | No | No
FRTM | [NAME] | R. Typhi IgM Titer | R. Typhi IgM Titer | 1 | 86757 | No | No
FRTG | [NAME] | R. Typhi IgG Titer | R. Typhi IgG Titer | 1 | 86757 | No | No
FQFG2 | [NAME] | Q Fever IgG Phase II Titer | Q Fever IgG Phase II Titer | 1 | 86638 | No | No
FQFM2 | [NAME] | Q Fever IgM Phase II Titer | Q Fever IgM Phase II Titer | 1 | 86638 | No | No
FQFM1 | [NAME] | Q Fever IgM Phase I Titer | Q Fever IgM Phase I Titer | 1 | 86638 | No | No
FRTAL | Test | T-Cell Acute Lymphoblastic Leukemia (T-ALL), FISH | ALL (T-Cell), FISH |  | PROFILE |  |  | This panel includes analysis for the disease-associated abnormalities using the 8 probe sets listed below.
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
FRTLP | Test | T-Cell Lymphoma, FISH, Blood or Bone Marrow | T-Cell Lymphoma, FISH, B/BM |  | PROFILE |  |  | This panel includes testing for the following anomalies via the probes listed:
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
FSC | Test | Fungal Antibody Survey, Spinal Fluid | [NAME], CSF |  | PROFILE |  |  | If Cryptococcus antigen screen result is reactive (by EIA), then latex agglutination testing (CCRYR/28072 [NAME], [NAME]) will be performed at an additional charge.
CCRYP | Component | Cryptococcus Antigen Screen, Spinal Fluid | Cryptococcus Ag Screen, CSF | 1 | 87327 | Yes | Yes
CHIST | Component | [NAME], Spinal Fluid | [NAME], CSF | 3 | 86698 | Yes | Yes
CBLAS | Component | Blastomyces Antibody by EIA, [NAME] | Blastomyces Ab, EIA, CSF | 1 | 86612 | Yes | Yes
CCOC | Component | [NAME], Spinal Fluid | Cocci CF and ID, CSF | 3 | 86635 | Yes | Yes
FSC | Component |  | [NAME], CSF | 3 | 86698 | No | No
FSC | Component |  | Cocci CF & ID, CSF | 3 | 86635 | No | No
[NAME] | [NAME] | [NAME], [NAME] | Cryptococcus Ag, CSF | 1 | 86403 | No | Yes
FSS | Test | [NAME], Serum | [NAME], S |  | PROFILE |  |  | If Histoplasma capsulatum antibody screen result is equivocal or positive (by enzyme-linked immunosorbent assay), then complement fixation/immunodiffusion testing (SHSTO/26692 [NAME], Serum) will be performed at an additional charge.
HISTO | Component | Histoplasma capsulatum [NAME], Serum | [NAME], S | 1 | 86698 | Yes | Yes
SCRYP | Component | Cryptococcus Antigen Screen, Serum | Cryptococcus Ag Screen, S | 1 | 87327 | Yes | Yes
SBLAS | Component | Blastomyces Antibody by EIA, Serum | Blastomyces Ab, EIA, S | 1 | 86612 | Yes | Yes
FSS | Component |  | [NAME], S | 3 | 86635 | No | No
SCOC | Component | [NAME], Serum | [NAME], S | 3 | 86635 | Yes | Yes
SCRYR | [NAME] | [NAME], Serum | Cryptococcus Ag, S | 1 | 86403 | No | Yes
SHSTO | [NAME] | [NAME], Serum | [NAME], S | 3 | 86698 | No | Yes
FSTSC | Test | [NAME] with [NAME] to [NAME] | Streptozyme Screen w/[NAME] | 1 | 86403 |  |  | If the Streptozyme Screen is "Positive" then the Streptozyme Titer will be performed at an additional charge (CPT code 86406).
FSTTI | [NAME] | [NAME] | [NAME] | 1 | 86406 | No | No
FUCT | Test | Alpha-Fucosidase, Fibroblasts | Alpha-Fucosidase, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
FX13M | Test | Factor [NAME], Qualitative, with [NAME] to Factor [NAME] 1:1 Mix | Factor [NAME], Qual, w/[NAME] 1:1 Mix | 1 | 85291 |  |  | If Factor XIII 1:1 has a result of Lysis, then Factor XIII, 1:1 Mix will be performed at an additional charge.
F13BO | [NAME] | Factor XIII 1:1, [NAME] Only | Factor XIII 1:1, [NAME] Only | 1 | 85291 | No | No
FXPB | Test | Fragile X Syndrome, Molecular Analysis | Fragile X Syndrome, [NAME]. Analysis | 1 | 81243 |  |  | When this test is ordered, fragile X follow-up analysis testing will be performed and charged dependent upon on the size of the CAG repeat found by PCR analysis.   For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
FXFU | [NAME] | Fragile X, Follow up Analysis | Fragile X, Follow Up Analysis | 1 | 81244 | No | No
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
G6ST | Test | N-Acetylgalactosamine-6-Sulfate Sulfatase, Fibroblasts | N-Acetylgalactosamine 6 Slft, Fibro | 1 | 82658 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
GAAKM | Test | Pompe Disease, Known Mutation | Pompe Disease, Known Mutation | 1 | 81403 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
GAAMS | Test | Pompe Disease, Full Gene Sequencing | Pompe Disease, Full Gene Sequencing | 1 | 81406 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
GALCK | Test | Krabbe Disease, Known Mutation | Krabbe Disease, Known Mutation | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
GALCS | Test | Krabbe Disease, Full Gene Analysis and Large (30 kb) Deletion, PCR | Krabbe Disease, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
GALTK | Test | Galactosemia Gene Analysis, Known Mutation | Galactosemia Known Mutation | 1 | 81403 |  |  | For prenatal specimens only: If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
GALTP | Test | Galactose-1-Phosphate Uridyltransferase Biochemical Phenotyping, [NAME] | Gal-1-Phos Urdyltrns Phenotype,RBC | 1 | 82664 |  |  | A quantitative galactose-1-phosphate uridyltransferase (GALT) level (GALT/8333 Galactose-1-Phosphate Uridyltransferase [GALT], Blood) is used in addition to the isoelectric focusing for accurate interpretation. If recent GALT test results are not provided, GALT will be automatically performed at an additional charge. However, if previous GALT results are provided, GALT testing will be cancelled and not charged.
GALT | [NAME] | Galactose-1-Phosphate Uridyltransferase (GALT), Blood | Gal-1-P Uridyltransferase, RBC | 1 | 82775 | Yes | Yes
GAUW | Test | Gaucher Disease, Mutation Analysis, GBA | Gaucher Disease, Mutation Analysis | 1 | 81251 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
GBAKM | Test | Gaucher Disease, Known Mutation | Gaucher Disease, Known Mutation | 1 | 81403 |  |  | If skin biopsy is received, fibroblast culture will be added and charged separately.   For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
GBAMS | Test | Gaucher Disease, Full Gene Analysis | Gaucher Disease, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
GCT | Test | [NAME], Blood | [NAME], B | 1 | 82775 |  |  | Testing begins with galactose-1-phosphate uridyltransferase (GALT) enzyme analysis. If GALT is > or =18.5 U/g of hemoglobin, testing is complete. No molecular test will be performed. If GALT is <18.5 U/g of hemoglobin, GAL6/84366 Galactosemia Gene Analysis (6-Mutation Panel) will be performed at an additional charge.
GAL6 | [NAME] | Galactosemia Gene Analysis (6-Mutation Panel) | Galactosemia Gene Analysis | 1 | 81401 | No | Yes
GFDKM | Test | [NAME], Known Mutation | [NAME], Known Mutation | 1 | 81479
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
GFDMS | Test | [NAME], Full Gene Analysis | [NAME], Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
[NAME] | Test | HIV-1 Genotypic Drug Resistance Mutation Analysis, with Reflex to Phenotypic Drug Resistance Prediction, Plasma | HIV-1 Geno Reflex to Pheno Predict | 1 | 87901 |  |  | If HIV type 1 genotypic drug resistance mutation analysis detects drug resistance mutations, then VPHIV/88781 HIV-1 Phenotypic Drug Resistance Prediction (Add-On) will be performed at an additional charge.
VPHIV | [NAME] | HIV-1 Phenotypic Drug Resistance Prediction (Add-On) | HIV-1 Phenotypic Resist Prediction | 1 | 87900 | No | No
GRHKM | Test | GRHPR Gene, Known Mutation | GRHPR Gene, Known Mutation | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal sample that is received, maternal cell contamination studies maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
HAEVP | Test | Hemolytic Anemia Evaluation | Hemolytic Anemia Evaluation |  | PROFILE |  |  | This is a consultative evaluation in which the case will be evaluated at Mayo Medical Laboratories, the appropriate tests performed at an additional charge, and the results interpreted.   Note: RBCE/23544 Reflexed RBC Enzymes, Blood includes: adenosine deaminase, adenylate kinase, phosphofructokinase, phosphoglycerate kinase, triosephosphate isomerase, and pyrimidine 5' nucleotidase.
PBSM | Component | Morphology Review | Morphology Review | 1 | 85060 | Yes | No
G6PD | Component | Glucose-6-Phosphate Dehydrogenase (G-6-PD), Quantitative, Erythrocytes | G-6-PD, QN, RBC | 1 | 82955 | Yes | Yes
FRAGO | Component | Osmotic Fragility | Osmotic Fragility |  |  | Yes | No
HEXK | Component | Hexokinase, Blood | Hexokinase, B | 1 | 82657 | Yes | No
PK | Component | [NAME], [NAME] | [NAME], RBC | 1 | 84220 | Yes | Yes
HAEVP | Component |  | Osmotic Fragility, RBC | 1 | 85557 | No | No
HBEL | Component | [NAME], Blood | [NAME], B | 1 | 83020 | Yes | No
UNHB | Component | Hemoglobin, Unstable, Blood | Hemoglobin, Unstable, B | 1 | 83068 | Yes | Yes
HAEV | Component | Hemolytic Anemia Interpretation | Hemolytic Anemia Interpretation |  |  | Yes | Yes
SCTRL | Component | Sex of Control Vial | Sex of Control Vial |  |  | Yes | No
GPI | Component | [NAME], [NAME] | [NAME], B | 1 | 84087 | Yes | Yes
A2F | Component | [NAME] and F, Blood | [NAME] and F | 1 | 83021 | Yes | Yes
IEF | [NAME] | IEF Confirms | IEF Confirms | 1 | 82664 | No | No
MASS | [NAME] | [NAME] by Mass Spectrometry | [NAME] by [NAME], B | 1 | 83789 | No | No
RBCE | [NAME] | Reflexed RBC Enzymes, Blood | Reflexed RBC Enzymes |  | PROFILE | No | No
SDEX | [NAME] | [NAME], Screen, Blood | [NAME], Scrn, B | 1 | 85660 | No | Yes
HGBMO | [NAME] | [NAME], Molecular | HGB Electrophoresis, Molecular |  | PROFILE | No | No
GLTI | [NAME] | Glutathione, Blood | Glutathione, B | 1 | 82978 | No | No
BND3 | [NAME] | Band 3 Fluorescence Staining | Band 3 [NAME], RBC | 1 | 88184 | No | No
HPFH | [NAME] | [NAME], Red Cell Distribution, Blood | [NAME], Red Cell Distrib, B | 1 | 88184 | No | Yes
HAPB | Test | Hemophilia A, Molecular Analysis for Inversion, Diagnosis and Carrier Detection | Hemophilia A Mol Anal for Inversion | 1 | 81403 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
HAVAB | Test | Hepatitis A Total Antibodies, with [NAME] to Hepatitis A IgM Antibody, Serum | Hepatitis A Total Ab, w/Reflex, S | 1 | 86708 |  |  | If hepatitis A total antibodies is positive, then hepatitis A IgM antibody is performed at an additional charge.
HAVM | [NAME] | Hepatitis A IgM Antibody, Serum | Hepatitis A IgM Ab, S | 1 | 86709 | No | Yes
HAVAB | Test | Hepatitis A Total Antibodies, with [NAME] to Hepatitis A IgM Antibody, Serum | Hepatitis A Total Ab, w/Reflex, S | 1 | 86708 |  |  | If hepatitis A total antibodies is positive, then hepatitis A IgM antibody is performed at an additional charge.
HAVM | [NAME] | Hepatitis A IgM Antibody, Serum | Hepatitis A IgM Ab, S | 1 | 86709 | No | Yes
HBAG | Test | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 |  |  | If hepatitis B surface antigen (HBsAg) screen is reactive with S/CO ratio in the range of 1.00 to 50.0, then HBsAg confirmation will be performed at an additional charge.
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HBAG | Test | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 |  |  | If hepatitis B surface antigen (HBsAg) screen is reactive with S/CO ratio in the range of 1.00 to 50.0, then HBsAg confirmation will be performed at an additional charge.
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HBAGP | Test | Hepatitis B Surface Antigen Prenatal, Serum | HBs Antigen Prenatal, S | 1 | 87340 |  |  | If hepatitis B surface antigen (HBsAg) is reactive, then HBsAg confirmation will be performed at an additional charge.
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HBAGP | Test | Hepatitis B Surface Antigen Prenatal, Serum | HBs Antigen Prenatal, S | 1 | 87340 |  |  | If hepatitis B surface antigen (HBsAg) is reactive, then HBsAg confirmation will be performed at an additional charge.
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HBELC | Test | Hemoglobin Electrophoresis Cascade, Blood | HGB Electrophoresis Cascade |  | PROFILE |  |  | Hemoglobin electrophoresis cascade will always include [NAME]) and F and hemoglobin electrophoresis.
A2F | Component | [NAME] and F, Blood | [NAME] and F | 1 | 83021 | Yes | Yes
HBEL | Component | [NAME], Blood | [NAME], B | 1 | 83020 | Yes | No
UNHB | [NAME] | Hemoglobin, Unstable, Blood | Hemoglobin, Unstable, B | 1 | 83068 | No | Yes
MASS | [NAME] | [NAME] by Mass Spectrometry | [NAME] by [NAME], B | 1 | 83789 | No | No
SDEX | [NAME] | [NAME], Screen, Blood | [NAME], Scrn, B | 1 | 85660 | No | Yes
IEF | [NAME] | IEF Confirms | IEF Confirms | 1 | 82664 | No | No
HGBMO | [NAME] | [NAME], Molecular | HGB Electrophoresis, Molecular |  | PROFILE | No | No
HPFH | [NAME] | [NAME], Red Cell Distribution, Blood | [NAME], Red Cell Distrib, B | 1 | 88184 | No | Yes
HBGCD | Test | [NAME] (HBsAg) for Cadaveric or Hemolyzed Specimens, Serum | HBsAg Cadaver/Hemolyzed, S | 1 | 87340 |  |  | All reactive HBsAg EIA results are confirmed by HBsAg neutralization at an additional charge.
BNTCD | [NAME] | Hepatitis B Surface Antigen Confirmation for Cadaveric or Hemolyzed Specimens, Serum | HBsAg Confirm Cadav/Hemol, S | 1 | 87341 | No | No
HBIS | Test | Hepatitis B Immune Status Profile, Serum | Hepatitis B Immune Status Prof, S |  | PROFILE |  |  | Confirmatory testing will be performed at an extra charge on all reactive hepatitis B surface antigen prenatal specimens as well as all other reactive specimens that have a signal-to-cutoff ratio (S/CO) of < or =50.0. Specimens with an S/CO of >50.0 that are not prenatal specimens do not require confirmation.
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HBAB | Component | Hepatitis B Surface Antibody, Qualitative/Quantitative, Serum | [NAME], S | 1 | 86706 | Yes | Yes
CORAB | Component | Hepatitis B Core Total Antibodies, with [NAME] to Hepatitis B Core Antibody, IgM, Serum | HBc [NAME], w/Reflex, S | 1 | 86704 | Yes | Yes
EAG | Component | [NAME], Serum | Hepatitis Be Ag, S | 1 | 87350 | Yes | Yes
HEAB | Component | [NAME], Serum | [NAME], S | 1 | 86707 | Yes | Yes
HBIM | [NAME] | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | No | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HCCAD | Test | Hepatitis C Virus Antibody Screen for Cadaveric or Hemolyzed Specimens, Serum | HCV Ab Cadaver/Hemolyzed Screen, S | 1 | 86803 |  |  | If hepatitis C virus (HCV) antibody screen is reactive with a single-to-cutoff ratio of > or =1.0, then HCV antibody confirmation by RIBA will be performed at an additional charge. The RIBA is not FDA-approved for testing cadaveric or hemolyzed specimens. A disclaimer will be added to all RIBA tests performed on cadaveric (or hemolyzed) specimens.
RIBA | [NAME] | Hepatitis C Virus Antibody Confirmation by Recombinant Immunoblot Assay (RIBA), Serum | HCV Ab Confirmation by RIBA, S | 1 | 86804 | No | Yes
HCH | Test | [NAME], [NAME], Bone Marrow or /Peripheral Blood | Heme Chromosome Hold, B/BM | 1 | 81479 |  |  | This test is designed to hold the specimen but delay chromosome preparation and analysis while preliminary morphologic assessment is in process.
BM | [NAME] | Chromosome Analysis, [NAME], Bone Marrow | Chromosomes, Hematolog, Bone Marrow |  | PROFILE | No | Yes
HBL | [NAME] | Chromosome Analysis, [NAME], Blood | Chromosomes, [NAME], Blood |  | PROFILE | No | Yes
HCPCR | Test | Hepatitis C Antibody Screen with Reflex to HCV RNA by PCR, Serum | HCV [NAME] w/Reflex to HCV PCR, S | 1 | 86803 |  |  | If hepatitis C virus (HCV) antibody screen by chemiluminescence immunoassay is reactive, then HCV RNA by RT-PCR will be performed at an additional charge.
HCVQU | [NAME] | Hepatitis C Virus (HCV) RNA Detection and Quantification by Real-Time Reverse Transcription-PCR (RT-PCR), Serum | HCV RNA Detect/Quant, S | 1 | 87522 | No | Yes
HCPCR | Test | Hepatitis C Antibody Screen with Reflex to HCV RNA by PCR, Serum | HCV [NAME] w/Reflex to HCV PCR, S | 1 | 86803 |  |  | If hepatitis C virus (HCV) antibody screen by chemiluminescence immunoassay is reactive, then HCV RNA by RT-PCR will be performed at an additional charge.
HCVQU | [NAME] | Hepatitis C Virus (HCV) RNA Detection and Quantification by Real-Time Reverse Transcription-PCR (RT-PCR), Serum | HCV RNA Detect/Quant, S | 1 | 87522 | No | Yes
HCVPS | Test | Hepatitis C Antibody Screen Patient Source, Serum | HCV Ab Screen Patient Source, S | 1 | 86803 |  |  | If hepatitis C virus (HCV) antibody screen is reactive, then HCV RNA by reverse transcriptase-polymerase chain reaction (RT-PCR) will be performed at an additional charge.
PHCPS | [NAME] | Hepatitis C Virus (HCV) RNA [NAME], Serum | HCV RNA Pt Source, S | 1 | 87521 | No | Yes
HEMP | Test | Hereditary Erythrocytosis Mutations | Hereditary Erythrocytosis Mut, B | 1 | 81479 |  |  | This evaluation is recommended for patients presenting with lifelong erythrocytosis, usually with a positive family history of similar symptoms. Polycythemia vera should be excluded prior to testing as it is much more common than hereditary erythrocytosis, and can be present even in young patients. A JAK2 V617F or JAK2 exon 12 mutation should not be present. Additionally, p50 testing should be performed and a normal result confirmed before ordering this test. For a complete evaluation including p50 testing, hemoglobin electrophoresis testing, and hereditary erythrocytosis mutation analysis in an algorithmic fashion, order REVP/84160 Erythrocytosis Evaluation. Please note that this test (HEMP/61337) is a reflex test for REVP and should not be ordered if REVP is ordered.
PHD2 | Component | [NAME] Domain-2 (PHD2/EGLN1) [NAME] | PHD2 Gene, Mutation Analysis, B |  |  | Yes | No
EPOR | Component | Erythropoietin Receptor (EPOR) Gene, Exon 8 Sequencing | [NAME], Mutation Analysis, B |  |  | Yes | No
HIF2A | Component | Hypoxia-inducible Factor [NAME] (EPAS1/HIF2A) Gene, Exon 12 Sequencing | HIF2A Gene, Mutation Analysis, B |  |  | Yes | No
MINT | Component | Molecular Interpretation | Molecular Interpretation |  |  | Yes | No
VHLSP | [NAME] | [NAME] (VHL) Gene, Full Gene Analysis | VHL Full Gene Analysis | 1 | 81404 | No | Yes
HEPB | Test | Hepatitis B Profile, Serum | Hepatitis B Profile, P/S |  | PROFILE |  |  | Confirmatory testing will be performed at an extra charge on all reactive Hepatitis B Surface Antigen prenatal specimens as well as all other reactive specimens that have a signal-to-cutoff ratio (S/CO) of < or =50.0.
HBAB | Component | Hepatitis B Surface Antibody, Qualitative/Quantitative, Serum | [NAME], S | 1 | 86706 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
CORAB | Component | Hepatitis B Core Total Antibodies, with [NAME] to Hepatitis B Core Antibody, IgM, Serum | HBc [NAME], w/Reflex, S | 1 | 86704 | Yes | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HBIM | [NAME] | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | No | Yes
HEPP | Test | Hepatitis Profile, Serum | Hepatitis Profile, S |  | PROFILE |  |  | Confirmatory testing will be performed at an extra charge on all reactive Hepatitis B Surface Antigen prenatal specimens as well as all other reactive specimens that have a signal-to-cutoff ratio ( S/CO) of < or =50.0. Specimens with an S/CO of >50.0 that are not prenatal specimens do not require confirmation.
HAVAB | Component | Hepatitis A Total Antibodies, with [NAME] to Hepatitis A IgM Antibody, Serum | Hepatitis A Total Ab, w/Reflex, S | 1 | 86708 | Yes | Yes
HBAB | Component | Hepatitis B Surface Antibody, Qualitative/Quantitative, Serum | [NAME], S | 1 | 86706 | Yes | Yes
CORAB | Component | Hepatitis B Core Total Antibodies, with [NAME] to Hepatitis B Core Antibody, IgM, Serum | HBc [NAME], w/Reflex, S | 1 | 86704 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HAVM | [NAME] | Hepatitis A IgM Antibody, Serum | Hepatitis A IgM Ab, S | 1 | 86709 | No | Yes
HBIM | [NAME] | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | No | Yes
HEPS | Test | Hepatitis Screening Panel, Serum | Hepatitis Screening Panel, S |  | PROFILE |  |  | Confirmatory testing will be performed at an extra charge on all reactive hepatitis B surface antigen prenatal specimens as well as all other reactive specimens that have a signal-to-cutoff ratio (S/CO) of < or =50.0.    Specimens with an S/CO of >50.0 that are not prenatal specimens do not require confirmation.
HAVAB | Component | Hepatitis A Total Antibodies, with [NAME] to Hepatitis A IgM Antibody, Serum | Hepatitis A Total Ab, w/Reflex, S | 1 | 86708 | Yes | Yes
CORAB | Component | Hepatitis B Core Total Antibodies, with [NAME] to Hepatitis B Core Antibody, IgM, Serum | HBc [NAME], w/Reflex, S | 1 | 86704 | Yes | Yes
HBAB | Component | Hepatitis B Surface Antibody, Qualitative/Quantitative, Serum | [NAME], S | 1 | 86706 | Yes | Yes
HCV | Component | Hepatitis C Antibody Screen, Serum | HCV Ab Screen, S | 1 | 86803 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HAVM | [NAME] | Hepatitis A IgM Antibody, Serum | Hepatitis A IgM Ab, S | 1 | 86709 | No | Yes
HBIM | [NAME] | Hepatitis B Core Antibody, IgM, Serum | HBc IgM Ab, S | 1 | 86705 | No | Yes
HEXKM | Test | Tay-Sachs Disease, HEXA Gene, Known Mutation | HEXA Gene, Known Mutation | 1 | 81403 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
HFH | Test | [NAME], Fluorescence In Situ Hybridization (FISH) Hold, Bone Marrow or Peripheral Blood | Heme FISH Hold, B/BM | 1 | 81479 |  |  | This test is designed to hold the sample but delay FISH testing while preliminary morphologic assessment or flow cytometry testing is in process. When ordering this test, a FISH test must be indicated when prompted. Based on the morphologic assessment, the FISH test originally indicated may be changed. If a different test or specific probes are needed, the client can call the laboratory and modify the requested probes (see cancellation policy below).
13FP | [NAME] | Thirteen Additional FISH Probes | Thirteen Additional FISH Probes |  | PROFILE | No | No
14FP | [NAME] | Fourteen Additional FISH Probes | Fourteen Additional FISH Probes |  | PROFILE | No | No
15FP | [NAME] | Fifteen Additional FISH Probes | Fifteen Additional FISH Probes |  | PROFILE | No | No
16FP | [NAME] | Sixteen Additional FISH Probes | Sixteen Additional FISH Probes |  | PROFILE | No | No
17FP | [NAME] | Seventeen Additional FISH Probes | Seventeen Additional FISH Probes |  | PROFILE | No | No
18FP | [NAME] | Eighteen Additional FISH Probes | Eighteen Additional FISH Probes |  | PROFILE | No | No
19FP | [NAME] | Nineteen Additional FISH Probes | Nineteen Additional FISH Probes |  | PROFILE | No | No
20FP | [NAME] | Twenty Additional FISH Probes | Twenty Additional FISH Probes |  | PROFILE | No | No
21FP | [NAME] | Twenty One Additional FISH Probes | Twenty One Additional FISH Probes |  | PROFILE | No | No
22FP | [NAME] | Twenty Two Additional FISH Probes | Twenty Two Additional FISH Probes |  | PROFILE | No | No
23FP | [NAME] | Twenty Three Additional FISH Probes | Twenty Three Additional FISH Probes |  | PROFILE | No | No
24FP | [NAME] | Twenty Four Additional FISH Probes | Twenty Four Additional FISH Probes |  | PROFILE | No | No
25FP | [NAME] | Twenty Five Additional FISH Probes | Twenty Five Additional FISH Probes |  | PROFILE | No | No
26FP | [NAME] | Twenty Six Additional FISH Probes | Twenty Six Additional FISH Probes |  | PROFILE | No | No
27FP | [NAME] | Twenty Seven Additional FISH Probes | Twenty Seven Additional FISH Probes |  | PROFILE | No | No
28FP | [NAME] | Twenty Eight Additional FISH Probes | Twenty Eight Additional FISH Probes |  | PROFILE | No | No
29FP | [NAME] | Twenty Nine Additional FISH Probes | Twenty Nine Additional FISH Probes |  | PROFILE | No | No
30FP | [NAME] | Thirty Additional FISH Probes | Thirty Additional FISH Probes |  | PROFILE | No | No
ADD10 | [NAME] | Ten Additional FISH Probes | Ten Additional FISH Probes |  | PROFILE | No | No
ADD11 | [NAME] | Eleven Additional FISH Probes | Eleven Additional FISH Probes |  | PROFILE | No | No
ADD12 | [NAME] | Twelve Additional FISH Probes | Twelve Additional FISH Probes |  | PROFILE | No | No
ADD1F | [NAME] | One Additional FISH Probe | One Additional FISH Probe |  | PROFILE | No | No
ADD2F | [NAME] | Two Additional FISH Probes | Two Additional FISH Probes |  | PROFILE | No | No
ADD3F | [NAME] | Three Additional FISH Probes | Three Additional FISH Probes |  | PROFILE | No | No
ADD4F | [NAME] | Four Additional FISH Probes | Four Additional FISH Probes |  | PROFILE | No | No
ADD5F | [NAME] | Five Additional FISH Probes | Five Additional FISH Probes |  | PROFILE | No | No
ADD6F | [NAME] | Six Additional FISH Probes | Six Additional FISH Probes |  | PROFILE | No | No
ADD7F | [NAME] | Seven Additional FISH Probes | Seven Additional FISH Probes |  | PROFILE | No | No
ADD8F | [NAME] | Eight Additional FISH Probes | Eight Additional FISH Probes |  | PROFILE | No | No
ADD9F | [NAME] | Nine Additional FISH Probes | Nine Additional FISH Probes |  | PROFILE | No | No
F512 | [NAME] | PDGFRB/TEL Translocation (5;12) for Chronic Myelomonocytic Leukemia, FISH | PDGFRB/TEL, FISH |  | PROFILE | No | Yes
FAML | [NAME] | Acute [NAME] (AML), FISH | AML, FISH |  | PROFILE | No | Yes
FBALL | [NAME] | B-Cell Acute Lymphoblastic Leukemia (ALL), FISH | ALL (B-Cell), FISH |  | PROFILE | No | Yes
FBLP | [NAME] | B-Cell Lymphoma, FISH, Blood or Bone Marrow | B-Cell Lymphoma, FISH, B/BM |  | PROFILE | No | Yes
FBMT | [NAME] | XX/XY in Opposite Sex Bone Marrow Transplantation, FISH | XX/XY in Opposite Sex BMT, FISH |  | PROFILE | No | Yes
FCHIC | [NAME] | CHIC2, 4q12 Deletion (FIP1L1 and PDGFRA Fusion), FISH | CHIC2, 4q12 Deletion, FISH |  | PROFILE | No | Yes
FCLL | [NAME] | Chronic Lymphocytic Leukemia (CLL), FISH | CLL, FISH |  | PROFILE | No | Yes
FCSP | [NAME] | Chromosome Anomalies, [NAME] with Chromosome-Specific FISH [NAME] | Chromosome Anomalies, [NAME], FISH |  | PROFILE | No | Yes
FGFR1 | [NAME] | FGFR1, 8p11.2 Rearrangement, FISH | FGFR1 8p11.2, FISH |  | PROFILE | No | Yes
FIMRG | [NAME] | Imatinib Mesylate Responsive Genes, Locus Anomalies, FISH | Imatinib [NAME], FISH |  | PROFILE | No | Yes
FMDS | [NAME] | Myelodysplastic Syndrome (MDS), FISH | MDS, FISH |  | PROFILE | No | Yes
FMFC | [NAME] | Myeloma, FISH, Fixed Cells | Myeloma, FISH, Fixed Cells |  | PROFILE | No | Yes
FMNB | [NAME] | Neuroblastoma, 2p24 (MYCN) Amplification, FISH, Blood or Bone Marrow | MYCN, 2p24, FISH, B/BM |  | PROFILE | No | Yes
FRTAL | [NAME] | T-Cell Acute Lymphoblastic Leukemia (T-ALL), FISH | ALL (T-Cell), FISH |  | PROFILE | No | Yes
FRTLP | [NAME] | T-Cell Lymphoma, FISH, Blood or Bone Marrow | T-Cell Lymphoma, FISH, B/BM |  | PROFILE | No | Yes
MBCR | [NAME] | BCR/ABL, Translocation 9;22, FISH (D-FISH) | BCR/ABL, FISH |  | PROFILE | No | Yes
HIQGP | Test | HIV-1 Quantification with Reflex to Genotypic Drug Resistance Analysis and Phenotypic Resistance Prediction, Plasma | HIV-1 Quant Reflex to Geno/Pheno, P | 1 | 87536 |  |  | If HIV-1 RNA quantification is > or =1,000, then HIV type 1 genotypic drug resistance mutation analysis will be performed at an additional charge.   If HIV type 1 genotypic drug resistance mutation analysis detects drug resistance mutations, then VPHIV/88781 HIV-1 Phenotypic Drug Resistance Prediction (Add-On) will be performed at an additional charge.
VPHIV | [NAME] | HIV-1 Phenotypic Drug Resistance Prediction (Add-On) | HIV-1 Phenotypic Resist Prediction | 1 | 87900 | No | No
[NAME] | [NAME] | HIV-1 Genotypic Drug Resistance Mutation Analysis, with Reflex to Phenotypic Drug Resistance Prediction, Plasma | HIV-1 Geno Reflex to Pheno Predict | 1 | 87901 | No | Yes
HISTO | Test | Histoplasma capsulatum [NAME], Serum | [NAME], S | 1 | 86698 |  |  | If result is equivocal or positive, SHSTO/26692 [NAME], Serum will be ordered at an additional charge.
SHSTO | [NAME] | [NAME], Serum | [NAME], S | 3 | 86698 | No | Yes
HIV2 | Test | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 |  |  | If HIV-2 antibody by EIA is repeatedly reactive, then HIV-2 antibody confirmation for confirmatory/supplemental testing will be added at an additional charge.
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
HIV2M | Test | HIV-2 Antibody Screen, Serum | HIV-2 Ab Screen, S | 1 | G0432 |  |  | If HIV-2 antibody by EIA is repeatedly reactive, then HIV-2 antibody confirmation for confirmatory/supplemental testing will be added at an additional charge.
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
HIVE | Test | HIV-1/-2 [NAME], Serum | HIV-1/-2 [NAME], S | 1 | 86703 |  |  | This test begins with HIV-1/-2 antibody screen by the chemiluminescence immunoassay method. If HIV-1/-2 antibody screen chemiluminescence immunoassay result is reactive, then HIV-1/-2 antibody confirmatory evaluation is performed at an additional charge. HIV-1/-2 antibody confirmatory evaluation is a reflex test that includes HIV-1 Western blot assay and, when appropriate and at an additional charge, HIV-2 antibody screen by EIA, HIV-1 antibody confirmation by immunofluorescence assay, and HIV-2 antibody confirmation by line immunoassay.
WBAR | [NAME] | HIV-1/-2 Antibody Confirmatory Evaluation, Serum | HIV-1/-2 Ab Confirm Eval, S | 1 | 86689 | No | Yes
HIV2 | [NAME] | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 | No | Yes
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
HIVFA | [NAME] | HIV-1 Antibody Confirmation by Immunofluorescence, Serum | HIV-1 Ab Confirm by IFA, S | 1 | 86689 | No | Yes
HIVE | Test | HIV-1/-2 [NAME], Serum | HIV-1/-2 [NAME], S | 1 | 86703 |  |  | This test begins with HIV-1/-2 antibody screen by the chemiluminescence immunoassay method. If HIV-1/-2 antibody screen chemiluminescence immunoassay result is reactive, then HIV-1/-2 antibody confirmatory evaluation is performed at an additional charge. HIV-1/-2 antibody confirmatory evaluation is a reflex test that includes HIV-1 Western blot assay and, when appropriate and at an additional charge, HIV-2 antibody screen by EIA, HIV-1 antibody confirmation by immunofluorescence assay, and HIV-2 antibody confirmation by line immunoassay.
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
HIVFA | [NAME] | HIV-1 Antibody Confirmation by Immunofluorescence, Serum | HIV-1 Ab Confirm by IFA, S | 1 | 86689 | No | Yes
WBAR | [NAME] | HIV-1/-2 Antibody Confirmatory Evaluation, Serum | HIV-1/-2 Ab Confirm Eval, S | 1 | 86689 | No | Yes
HIV2 | [NAME] | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 | No | Yes
HIVQR | Test | HIV-1 RNA Quantification with [NAME] to HIV-1 Genotypic Drug Resistance Mutation Analysis, Plasma | HIV-1 Quant with [NAME] to Genotype, P | 1 | 87536 |  |  | If HIV-1 RNA titer is > or =1,000 copies/mL, then HIV-1 genotypic drug resistance mutations will be determined at an additional charge.
GHIV | [NAME] | HIV-1 Genotypic Drug Resistance Mutation Analysis, Plasma | HIV-1 Genotypic Drug Resistance, P | 1 | 87901 | No | Yes
HLLFH | Test | [NAME], Leukemia/Lymphoma; Flow Hold Varies | Heme Leukemia/Lymphoma; Flow Hold V |  |  |  |  | This test is designed to delay the start of leukemia/lymphoma immunophenotyping until the preliminary assessment is completed. [NAME] are held in lab until noon (12 p.m. CST) 2 days after the collection date. For testing to be cancelled, the client must call Mayo Medical Laboratories at [PHONE]. The testing process will be initiated and fully charged if no notification is received within this time period. To expedite the beginning testing, please call Mayo Medical Laboratories at [PHONE].
88467 | [NAME] | Flow Cytometry Interpretation, 16 or More Markers | Flow Cytometry Interp,16 or greater | 1 | 88189 | No | No
88466 | [NAME] | Flow Cytometry Interpretation, 9 to 15 Markers | Flow Cytometry Interp, 9-15 Markers | 1 | 88188 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | No | No
81047 | [NAME] | Flow Cytometry, Cell Surface, Additional | Flow Cytometry, Cell Surface, [NAME] | 1 | 88185 | No | No
80997 | [NAME] | Flow Cytometry, Cell Surface, First | Flow Cytometry, Cell Surface, First | 1 | 88184 | No | No
HMBSK | Test | [NAME], Known Mutation | [NAME], Known Mutation | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
HMBSS | Test | [NAME], Full Gene Analysis | [NAME], Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
HNPCC | Test | Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Screen | HNPCC Screen | 1 | 81301 |  |  | When this test is ordered, SLRVW/61852 slide review, MLH1, [NAME], MSH6, and PMS2 stains will always be performed at an additional charge.
TUMSI | Component | Microsatellite Instability (MSI), Tumor | Microsatellite Instability, Tumor | 1 | 81301 | Yes | Yes
IHCO | Component | [NAME] (MMR) Protein Immunohistochemistry Only, Tumor | MMR Protein, IHC Only, Tumor |  |  | Yes | Yes
MSH6B | [NAME] | MSH-6, Immunostain | MSH-6, Immunostain | 1 | 88342 | Yes | No
PMS2B | [NAME] | PMS-2, Immunostain | PMS-2, Immunostain | 1 | 88342 | Yes | No
MLH1B | [NAME] | MLH-1, Immunostain | MLH-1, Immunostain | 1 | 88342 | Yes | No
MSH2B | [NAME] | MSH-2, Immunostain | MSH-2, Immunostain | 1 | 88342 | Yes | No
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
HSEP | Test | Hereditary Spherocytosis Evaluation | Hereditary Spherocytosis Evaluation | 1 | 85557 |  |  | If the osmotic fragility test is abnormal, then the band 3 fluorescence staining will be performed at an additional charge.
FRAGO | Component | Osmotic Fragility | Osmotic Fragility |  |  | Yes | No
HSEV | Component | Spherocytosis Interpretation | Spherocytosis Interpretation |  |  | Yes | No
SCTRL | Component | Sex of Control Vial | Sex of Control Vial |  |  | Yes | No
BND3 | [NAME] | Band 3 Fluorescence Staining | Band 3 [NAME], RBC | 1 | 88184 | No | No
HSV | Test | Herpes Simplex Virus (HSV) Type 1- and Type 2-Specific Antibodies, Serum | HSV Types 1 and 2 Ab, S |  | PROFILE |  |  | If herpes simplex virus (HSV) antibody screen is reactive, then HSV antibody by immunofluorescence assay will be performed at an additional charge.
HS1G | Component | Herpes Simplex Virus (HSV) Type 1 Specific Antibodies, Serum | HSV Type 1 Ab, IgG, S | 1 | 86695 | Yes | No
MHSV | Component | Herpes Simplex Virus (HSV) Antibody Screen, IgM, by EIA, Serum | HSV Ab Screen, IgM, S by EIA | 1 | 86694 | Yes | Yes
HS2G | Component | Herpes Simplex Virus (HSV) Type 2 Specific Antibodies, Serum | HSV Type 2 Ab, IgG, S | 1 | 86696 | Yes | No
HSMR | [NAME] | Herpes Simplex Virus (HSV) Antibody, IgM, by Immunofluorescence Assay (IFA), Serum | HSV Ab, IgM, S by IFA | 1 | 86694 | No | No
HTLVI | Test | Human T-Cell Lymphotropic Virus Types I and II (HTLV-I/-II) Antibody Screen with Confirmation, Serum | HTLV-I/-II Ab Screen, S | 1 | 86687 |  |  | If HTLV-I/-II antibody by EIA is reactive, HTLV-I/-II antibody confirmation by line immunoassay will be performed at an additional charge.
HTLVL | [NAME] | Human T-Cell Lymphotropic Virus Types I and II (HTLV-I/-II) Antibody Confirmation, Serum | HTLV-I/-II Ab Confirmation, S | 1 | 86689 | No | Yes
HURLK | Test | Hurler Syndrome, Known Mutation | Hurler Syndrome, Known Mutation | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
HURLS | Test | Hurler Syndrome, Full Gene Analysis | Hurler Syndrome, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
HV1CD | Test | HIV-1 and HIV-2 Antibodies for Cadaveric or Hemolyzed Specimens, Serum | HIV-1/-2 Cadaver/Hemolyzed, S | 1 | 86703 |  |  | This test begins with HIV-1/-2 antibody EIA. If HIV-1/-2 antibody EIA is reactive, then HIV-1/-2 antibody confirmatory evaluation is performed at an additional charge.   HIV-1/-2 antibody confirmatory evaluation is a reflex test that includes HIV-1 Western blot (WB) assay and, when appropriate and at an additional charge, HIV-2 EIA, HIV-1 immunofluorescence, and HIV-2 antibody confirmation.
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
WBAR | [NAME] | HIV-1/-2 Antibody Confirmatory Evaluation, Serum | HIV-1/-2 Ab Confirm Eval, S | 1 | 86689 | No | Yes
HIV2 | [NAME] | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 | No | Yes
HIVFA | [NAME] | HIV-1 Antibody Confirmation by Immunofluorescence, Serum | HIV-1 Ab Confirm by IFA, S | 1 | 86689 | No | Yes
HV1CM | Test | HIV-1 and HIV-2 Antibody Screen for Hemolyzed Specimens, Serum | HIV-1/-2 Ab Screen Hemolyzed, S | 1 | G0432 |  |  | This test begins with HIV-1/-2 antibody EIA. If HIV-1/-2 antibody EIA is reactive, then HIV-1/-2 antibody confirmatory evaluation is performed at an additional charge. HIV-1/-2 antibody confirmatory evaluation is a reflex test that includes HIV-1 Western blot (WB) assay and, when appropriate and at an additional charge, HIV-2 EIA, HIV-1 immunofluorescence, and HIV-2 antibody confirmation.
HIV2 | [NAME] | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 | No | Yes
WBAR | [NAME] | HIV-1/-2 Antibody Confirmatory Evaluation, Serum | HIV-1/-2 Ab Confirm Eval, S | 1 | 86689 | No | Yes
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
HIVFA | [NAME] | HIV-1 Antibody Confirmation by Immunofluorescence, Serum | HIV-1 Ab Confirm by IFA, S | 1 | 86689 | No | Yes
IABCS | Test | B-Cell Phenotyping Profile for Immunodeficiency and Immune Competence Assessment, Blood | Immune Assessment B Cell Subsets, B |  | PROFILE |  |  | If immune assessment B-cell subsets is abnormal, CVID confirmation flow panel will be performed at an additional charge.
IABCS | Component |  | T-cells total count | 1 | 86359 | No | No
IABCS | Component |  | Natural killer cells | 1 | 86357 | No | No
TBBS | Component | T- and B-Cell Quantitation by Flow Cytometry | T- and B-Cell QN by Flow Cytometry |  | PROFILE | No | Yes
IABC | Component | B-Cell Phenotyping Screen for Immunodeficiency and Immune Competence Assessment, Blood | Immune Assessment B Cell Subsets, B |  |  | Yes | No
IABCS | Component |  | Absolute CD4/CD8 Count | 1 | 86360 | No | No
IABCS | Component |  | B cells, total count | 1 | 86355 | No | No
IABCS | Component |  | Each additional marker | 7 | 88185 | No | No
IABCS | Component |  | Flow Cytometry first mark | 1 | 88184 | No | No
CVID | [NAME] | Common Variable Immunodeficiency Confirmation Flow Panel | CVID Confirmation Flow Panel |  | PROFILE | No | Yes
IDNS | Test | Iduronate Sulfatase, Fibroblasts | Iduronate Sulfatase, Fibroblasts | 1 | 82658 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
IDOAU | Test | Drug Abuse Survey, [NAME] | Drug Abuse Survey, U | 1 | 80104 |  |  | This survey is a screen only. Positives are not confirmed by an alternative method. Screens for the following drug classes:, amphetamines, barbiturates, benzodiazepines, cocaine, ethanol, opiates, phencyclidine, and [NAME]. Results are qualitative only. An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
IDST | Test | Alpha-L-Iduronidase, Fibroblasts | Alpha-L-Iduronidase, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
IHCO | Test | [NAME] (MMR) Protein Immunohistochemistry Only, Tumor | MMR Protein, IHC Only, Tumor |  |  |  |  | When this test is ordered, MLH1, [NAME], MSH6, and PMS2 stains will always be performed at an additional charge.
MLH1B | [NAME] | MLH-1, Immunostain | MLH-1, Immunostain | 1 | 88342 | Yes | No
MSH2B | [NAME] | MSH-2, Immunostain | MSH-2, Immunostain | 1 | 88342 | Yes | No
MSH6B | [NAME] | MSH-6, Immunostain | MSH-6, Immunostain | 1 | 88342 | Yes | No
PMS2B | [NAME] | PMS-2, Immunostain | PMS-2, Immunostain | 1 | 88342 | Yes | No
KETAU | Test | Ketamine and Metabolite Confirmation, [NAME] | [NAME], U | 1 | 80299 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
KRAS7 | Test | KRAS Mutation Analysis, 7 Mutation Panel, Colorectal | KRAS Mutation Analysis, Colorectal | 1 | 81275 |  |  | When this test is ordered, Slide Review will always be performed at an additional charge.
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
KRASA | Test | KRAS Mutation Analysis, 7 Mutation Panel, Other (Non-Colorectal) | KRAS Mutation Analysis, Other | 1 | 81275 |  |  | When this test is ordered, Slide Review will always be performed at an additional charge.
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
LBCR | Test | [NAME], Amniotic Fluid | [NAME], AF | 1 | 83664 |  |  | If lamellar body count is indeterminate (between 15,000-50,000/mcL), then FLP/8929 Fetal Lung Profile, [NAME] (includes lecithin/sphingomyelin ratio and phosphatidylglycerol) is performed, at an additional charge, to aid in the risk assessment for respiratory distress syndrome.
LBC | Component | [NAME], Amniotic Fluid | [NAME], AF | 1 | 83664 | Yes | Yes
FLP | [NAME] | [NAME], Amniotic Fluid | [NAME], AF |  | PROFILE | No | Yes
LCMS | Test | Leukemia/Lymphoma Immunophenotyping by Flow Cytometry | Leukemia/Lymphoma, Phenotype |  |  |  |  | When a blood, bone marrow, or fluid test is ordered, a screening panel and a professional interpretation will always be charged. The screening panel will be charged based on number of markers tested (80997 for first marker, 81047 for each additional marker). The interpretation will be based on markers tested in increments of 2 to 8, 9 to 15, or 16 and greater. In addition, reflex testing may occur to fully characterize a disease state or clarify any abnormalities from the screening test. Reflex tests will be performed at an additional charge for each marker tested (80997 if applicable, 81047 if applicable).
80997 | [NAME] | Flow Cytometry, Cell Surface, First | Flow Cytometry, Cell Surface, First | 1 | 88184 | Yes | No
81047 | [NAME] | Flow Cytometry, Cell Surface, Additional | Flow Cytometry, Cell Surface, [NAME] | 1 | 88185 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | No | No
88466 | [NAME] | Flow Cytometry Interpretation, 9 to 15 Markers | Flow Cytometry Interp, 9-15 Markers | 1 | 88188 | No | No
88467 | [NAME] | Flow Cytometry Interpretation, 16 or More Markers | Flow Cytometry Interp,16 or greater | 1 | 88189 | No | No
VBETA | [NAME] | T-Cell Clonality by Flow Cytometry of TCR V-Beta | TCR V-BETA |  | PROFILE | No | No
LLPT | Test | Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue | Leukemia Lymphoma Phenotype, Tissue |  |  |  |  | When this test is ordered, a screening panel and a professional interpretation will always be charged. The screening panel will be charged based on number of makers tested (80997 for first marker, 81047 for each additional marker). The interpretation will be set based on markers tested in increments of 9 to 15, or 16 and greater. In addition, reflex testing may occur to fully characterize a disease state or clarify any abnormalities from the screening test. Reflex tests will be performed at an additional charge for each marker tested (80997 if applicable, 81047 if applicable).
80997 | [NAME] | Flow Cytometry, Cell Surface, First | Flow Cytometry, Cell Surface, First | 1 | 88184 | No | No
81047 | [NAME] | Flow Cytometry, Cell Surface, Additional | Flow Cytometry, Cell Surface, [NAME] | 1 | 88185 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | No | No
88466 | [NAME] | Flow Cytometry Interpretation, 9 to 15 Markers | Flow Cytometry Interp, 9-15 Markers | 1 | 88188 | No | No
88467 | [NAME] | Flow Cytometry Interpretation, 16 or More Markers | Flow Cytometry Interp,16 or greater | 1 | 88189 | No | No
LSDU | Test | Lysergic Acid Diethylamide (LSD) Confirmation, [NAME] | LSD Confirmation, U | 1 | 80299 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
LUPPR | Test | Lupus Anticoagulant Profile | [NAME] |  | PROFILE |  |  | Initial testing includes: prothrombin time (PT), activated partial thromboplastin time (APTT), and dilute [NAME]'s viper venom time (DRVVT).     If the PT, APTT, and DRVVT are normal, a computer-generated interpretive comment indicating no evidence of a lupus anticoagulant will be provided.     If PT is > or =14 seconds, PT mix will be performed.     If APTT is >36 seconds, APTT mix will be performed.     If APTT mix is >36 seconds with no evidence of heparin in sample, platelet neutralization procedure (PNP) will be performed.     If DRVVT ratio is > or =1.2, DRVVT mix will be performed.     If DRVVT mix ratio is > or =1.2, DRVVT confirm will be performed.     If PT, APTT, or DRVVT are prolonged, thrombin time (TT) will be performed.     If TT is >23 seconds, reptilase will be performed.      If appropriate, coagulation factor assays, [NAME], D-dimer, [NAME], and soluble fibrin monomer will be performed to clarify a significant abnormality in the screening clotting times.      If factor VIII result is <55%, the factor VIII inhibitor screen may be performed along with the Bethesda titering assay, if indicated.   If any test results are abnormal, all results will be reviewed by a coagulation consultant and a Special Coagulation Consultant Interpretation will be provided.
PTC | Component | Prothrombin Time (PT), Plasma | Prothrombin Time (PT), P | 1 | 85610 | Yes | Yes
APTTB | Component | Activated Partial Thromboplastin Time (APTT), Plasma | Activated Partial Thrombopl Time, P | 1 | 85730 | Yes | Yes
DRVT | Component | [NAME] Viper Venom Time (DRVVT), Plasma | Dilute Russells Viper Venom Time, P | 1 | 85613 | Yes | No
CCC1 | Component | Interpretation | Interpretation |  |  | Yes | No
STLA | [NAME] | Staclot Lupus Anticoagulant, Plasma | Staclot LA, P | 1 | 85598 | No | No
DRVTC | [NAME] | DRVVT Confirmation | DRVVT Confirmation | 1 | 85613 | No | No
CCC2 | [NAME] | Special Coagulation Interpretation | Special Coagulation Interpretation | 1 | 85390 | No | No
F_2 | [NAME] | Coagulation Factor II Activity Assay, Plasma | Coag Factor II Assay, P | 1 | 85210 | No | Yes
TT | [NAME] | Thrombin Time (Bovine), Plasma | Thrombin Time (Bovine), P | 1 | 85670 | No | Yes
APTTM | [NAME] | APTT Mix 1:1 | APTT Mix 1:1 | 1 | 85732 | No | No
FACTV | [NAME] | Coagulation Factor V Activity Assay, Plasma | Coag Factor V Assay, P | 1 | 85220 | No | Yes
SFM | [NAME] | Soluble [NAME] | Soluble [NAME] | 1 | 85366 | No | No
RPTL | [NAME] | Reptilase Time, Plasma | Reptilase Time, P | 1 | 85635 | No | Yes
FIBC | [NAME] | Fibrinogen, Plasma | Fibrinogen, P | 1 | 85384 | No | Yes
F8A | [NAME] | Coagulation Factor VIII Activity Assay, Plasma | Coag Factor VIII Activity Assay, P | 1 | 85240 | No | Yes
PNP | [NAME] | Platelet Neutralization Procedure | Platelet Neutralization Procedure | 1 | 85597 | No | No
F_12 | [NAME] | Coagulation Factor XII Activity Assay, Plasma | Coag Factor XII Assay, P | 1 | 85280 | No | Yes
F_9 | [NAME] | Coagulation Factor IX Activity Assay, Plasma | Coag Factor IX Assay, P | 1 | 85250 | No | Yes
DIRM | [NAME] | D-Dimer, Plasma | D-Dimer, P | 1 | 85379 | No | Yes
F_10 | [NAME] | Coagulation Factor X Activity Assay, Plasma | Coag Factor X Assay, P | 1 | 85260 | No | Yes
F_11 | [NAME] | Coagulation Factor XI Activity Assay, Plasma | Coag Factor XI Assay, P | 1 | 85270 | No | Yes
F_7 | [NAME] | Coagulation Factor VII Activity Assay, Plasma | Coag Factor VII Assay, P | 1 | 85230 | No | Yes
DRVTM | [NAME] | DRVVT Mix | DRVVT Mix | 1 | 85613 | No | No
F8IS | [NAME] | Coagulation Factor VIII Inhibitor Screen, Plasma | Coag Factor VIII Assay [NAME],P | 1 | 85335 | No | No
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
PTMX | [NAME] | PT Mix 1:1 | PT Mix 1:1 | 1 | 85611 | No | No
LYME | Test | Lyme Disease Serology, Serum | Lyme Disease Serology, S | 1 | 86618 |  |  | If Lyme disease serology is positive, then Lyme disease antibody confirmation (by Western blot) will be performed at an additional charge.
LYWB | [NAME] | Lyme Disease Antibody, Immunoblot, Serum | Lyme Disease Ab, Immunoblot, S | 2 | 86617 | No | Yes
LYME | Test | Lyme Disease Serology, Serum | Lyme Disease Serology, S | 1 | 86618 |  |  | If Lyme disease serology is positive, then Lyme disease antibody confirmation (by Western blot) will be performed at an additional charge.
LYWB | [NAME] | Lyme Disease Antibody, Immunoblot, Serum | Lyme Disease Ab, Immunoblot, S | 2 | 86617 | No | Yes
MAHKM | Test | Methylmalonic Aciduria and [NAME], cblC Type, Known Mutation | [NAME], Known Mutation | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
MAHMS | Test | Methylmalonic Aciduria and [NAME], cblC Type, Full Gene Analysis | [NAME], Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MANT | Test | Alpha-Mannosidase, Fibroblasts | Alpha-Mannosidase, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
MCADS | Test | Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Mutation Screen | MCAD Mutation Screen | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCDKM | Test | MLYCD Gene, Known Mutation | MLYCD Gene, Known Mutation | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
MCDMS | Test | MLYCD Gene, Full Gene Analysis | MLYCD Gene, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCIV | Test | Mucolipidosis IV, Mutation Analysis, IVS3(-2)A->G and del6.4kb | Mucolipidosis IV, Mutation Analysis | 1 | 81290 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
ME2KM | Test | MECP2 Gene, Known Mutation | MECP2 Gene, Known Mutation | 1 | 81303 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
[NAME] | Test | Methaqualone, [NAME] | Methaqualone, U | 1 | 80299 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
MEVP | Test | Methemoglobinemia Evaluation | Methemoglobinemia Evaluation |  | PROFILE |  |  | This is a consultative evaluation in which the case will be evaluated at Mayo Medical Laboratories, the appropriate tests performed at an additional charge, and the results interpreted.
MEV | Component | Methemoglobinemia Interpretation | Methemoglobinemia Interpretation |  |  | Yes | No
SULF | Component | [NAME], Blood | [NAME], B | 1 | 83060 | Yes | Yes
[NAME] | Component | [NAME], Blood | [NAME], B | 1 | 83050 | Yes | Yes
A2F | Component | [NAME] and F, Blood | [NAME] and F | 1 | 83021 | Yes | Yes
METR | Component | [NAME], Blood | [NAME], B | 1 | 82657 | Yes | Yes
HBEL | Component | [NAME], Blood | [NAME], B | 1 | 83020 | Yes | No
MASS | [NAME] | [NAME] by Mass Spectrometry | [NAME] by [NAME], B | 1 | 83789 | No | No
SDEX | [NAME] | [NAME], Screen, Blood | [NAME], Scrn, B | 1 | 85660 | No | Yes
HPFH | [NAME] | [NAME], Red Cell Distribution, Blood | [NAME], Red Cell Distrib, B | 1 | 88184 | No | Yes
UNHB | [NAME] | Hemoglobin, Unstable, Blood | Hemoglobin, Unstable, B | 1 | 83068 | No | Yes
HGBMO | [NAME] | [NAME], Molecular | HGB Electrophoresis, Molecular |  | PROFILE | No | No
IEF | [NAME] | IEF Confirms | IEF Confirms | 1 | 82664 | No | No
[NAME] | Test | [NAME] (MG) Evaluation, [NAME] | MG Evaluation, [NAME] |  | PROFILE |  |  | If [NAME] antibodies are > or =90% and striational antibodies are > or =1:60, AChR ganglionic neuronal autoantibody, glutamic acid decarboxylase autoantibody, neuronal voltage-gated potassium channel (VGKC) autoantibody, and CRMP-5-IgG Western blot will be performed at an additional charge.
ARBI | Component | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) Binding Ab | 1 | 83519 | Yes | Yes
ARMO | Component | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) [NAME] | 1 | 83519 | Yes | No
STR | Component | Striational (Striated Muscle) Antibodies, Serum | Striational (Striated Muscle) Ab, S | 1 | 83520 | Yes | Yes
VGKC | [NAME] | Neuronal Voltage-Gated Potassium Channel (VGKC) Autoantibody, Serum | Neuronal (V-G) K+ Channel Ab, S | 1 | 83519 | No | No
CRMWS | [NAME] | [NAME] Protein-5-IgG (CRMP-5-IgG) Western Blot, Serum | CRMP-5-IgG Western Blot, S | 1 | 84182 | No | No
GD65S | [NAME] | Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Serum | GAD65 Ab Assay, S | 1 | 86341 | No | Yes
GANG | [NAME] | Ganglionic Acetylcholine Receptor (Alpha3) Autoantibody, Serum | [NAME], S | 1 | 83519 | No | No
MGLES | Test | [NAME] (MG)/Lambert-Eaton Syndrome (LES) Evaluation | MG/LES Evaluation |  | PROFILE |  |  | If [NAME] antibodies are > or =90% and striational antibodies are > or =1:60, AChR ganglionic neuronal antibody and CRMP-5-IgG Western blot will be performed at an additional charge.
CCPQ | Component | P/Q-Type Calcium Channel Antibody, Serum | P/Q-Type Calcium Channel Ab | 1 | 83519 | Yes | No
CCN | Component | N-Type Calcium Channel Antibody, Serum | N-Type Calcium Channel Ab | 1 | 83519 | Yes | No
STR | Component | Striational (Striated Muscle) Antibodies, Serum | Striational (Striated Muscle) Ab, S | 1 | 83520 | Yes | Yes
ARBI | Component | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) Binding Ab | 1 | 83519 | Yes | Yes
ARMO | Component | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) [NAME] | 1 | 83519 | Yes | No
GANG | [NAME] | Ganglionic Acetylcholine Receptor (Alpha3) Autoantibody, Serum | [NAME], S | 1 | 83519 | No | No
CRMWS | [NAME] | [NAME] Protein-5-IgG (CRMP-5-IgG) Western Blot, Serum | CRMP-5-IgG Western Blot, S | 1 | 84182 | No | No
MHDKM | Test | Methylmalonic Aciduria and Homocystinuria, cblD Type, Known Mutation | MMADHC Gene, Known Mutation | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
MHDMS | Test | Methylmalonic Aciduria and Homocystinuria, cblD Type, Full Gene Analysis | MMADHC Gene, Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MHSV | Test | Herpes Simplex Virus (HSV) Antibody Screen, IgM, by EIA, Serum | HSV Ab Screen, IgM, S by EIA | 1 | 86694 |  |  | If herpes simplex virus (HSV) antibody screen, IgM by EIA is reactive, then HSV antibody, IgM by immunofluorescence assay will be performed at an additional charge.
HSMR | [NAME] | Herpes Simplex Virus (HSV) Antibody, IgM, by Immunofluorescence Assay (IFA), Serum | HSV Ab, IgM, S by IFA | 1 | 86694 | No | No
MLBRF | Test | MLH1 Hypermethylation and BRAF Mutation Analyses, Tumor | MLH1 Hypermethylation/BRAF Mutation |  | PROFILE |  |  | When this test is ordered, slide review will always be performed at an additional charge.
MLBRF | Component |  | UNLISTED MOLECULAR PATHOLOGY | 1 | 81479 | No | No
BRAFP | Component | BRAF Mutation | BRAF Mutation Analysis (V600E) |  |  | Yes | Yes
MLHHM | Component | MLH1 Hypermethylation | MLH1 Hypermethylation |  |  | Yes | Yes
MBPIN | Component | MLH1 Hypermethylation/BRAF (V600E) Mutation Interpretation | MLH1 Hyp/BRAF (V600E) Mut Interp |  |  | Yes | No
MLBRF | Component |  | BRAF GENE | 1 | 81210 | No | No
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
MLH1H | Test | MLH1 Hypermethylation Analysis, Tumor | MLH1 [NAME], Tumor | 1 | 81479 |  |  | When this test is ordered, slide review will always be performed at an additional charge.
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
MMLNS | Test | Antimicrobial Susceptibility, Nocardia species | Susceptibility, Nocardia species | 1 | 87186 |  |  | When this test is ordered, Susceptibility Nocardia species will be performed and charged.
SSNS | [NAME] | Susceptibility Nocardia species | Susceptibility Nocardia species | 1 | 87186 | Yes | No
MMLRG | Test | Antimicrobial Susceptibility, Acid-Fast Bacilli, Rapidly Growing | Susceptibility, AFB, Rapid Grower | 1 | 87186 |  |  | When this test is ordered, Susceptibility Rapid Grower will be performed and charged.
SRG | [NAME] | Susceptibility Rapid Grower | Susceptibility Rapid Grower | 1 | 87186 | Yes | No
[NAME] | Test | Antimicrobial Susceptibility, [NAME], MIC | Susceptibility, Anaerobic, MIC | 3 | 87181 |  |  | When this test is ordered, then Anaerobe Suscep Battery will be performed and charged.   Based on susceptibility criteria, the Beta Lactamase and/or Anaerobe Suscep per agent may be performed at an additional charge.
BLA | [NAME] | Beta Lactamase ([NAME] Only) | Beta Lactamase | 1 | 87185 | No | No
SANA | [NAME] | Anaerobe Suscep per Agent ([NAME] Only) | Anaerobe Suscep per agent | 1 | 87181 | No | No
BATTA | [NAME] | Anaerobe [NAME] (Bill Only) | Anaerobe Suscep Battery | 3 | 87181 | Yes | No
MMLSG | Test | Antimicrobial Susceptibility, Acid-Fast Bacilli, Slowly Growing | Susceptibility, AFB, Slow Grower | 1 | 87186 |  |  | When this test is ordered, the reflex test will be performed and charged.
RSLG | [NAME] | Susceptibility [NAME] | Susceptibility [NAME] | 1 | 87186 | Yes | No
MMLYP | Test | Antimicrobial Susceptibility Panel, Yeast | Susceptibility Panel, Yeast | 1 | 87186 |  |  | When this test is ordered, Susceptibility Yeast Panel will be performed and charged.
SYP | [NAME] | Susceptibility Yeast Panel | Susceptibility Yeast Panel | 1 | 87186 | Yes | No
MSIO | Test | Microsatellite Instability (MSI), Tumor | Microsatellite Instability, Tumor | 1 | 81301 |  |  | When this test is ordered, slide review for molecular genetics will always be performed at an additional charge.
TUMSI | Component | Microsatellite Instability (MSI), Tumor | Microsatellite Instability, Tumor | 1 | 81301 | Yes | No
SLRVW | [NAME] | Slide Review | Slide Review | 1 | 88381 | Yes | No
MTBV2 | Test | Antimicrobial Susceptibility, Mycobacterium tuberculosis Complex, Broth Method | Susceptibility, [NAME], Broth | 4 | 87188
STV | [NAME] | Susceptibility, [NAME], Broth | Susceptibility, [NAME], Broth | 4 | 87188 | Yes | No
MTDNU | Test | Methadone Confirmation, [NAME] | Methadone Confirmation, U | 1 | 83840 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
MYCPN | Test | Mycoplasma pneumoniae Antibodies, IgG and IgM, Serum | M. [NAME], IgG and IgM, S |  | PROFILE |  |  | If [NAME] pneumoniae antibodies, IgM is positive or equivocal, then Mycoplasma pneumoniae antibodies, IgM by indirect immunofluorescence assay (IFA) will be performed at an additional charge.
MYCG | Component | Mycoplasma pneumoniae Antibodies, IgG, Serum | M. [NAME], IgG, S | 1 | 86738 | Yes | No
MYCM | Component | Mycoplasma pneumoniae Antibodies, IgM, Serum | M. pneumoniae Ab, IgM, S | 1 | 86738 | Yes | No
MMYCO | [NAME] | Mycoplasma pneumoniae Antibodies, IgM, Serum by Indirect Immunofluorescence Assay (IFA) | M. pneumoniae Ab, IgM, S by IFA | 1 | 86738 | No | No
NAGR | Test | Hexosaminidase A and Total, Leukocytes/Molecular Reflex | Hexosaminidase A and Tot, WBC/Mole | 2 | 83080 |  |  | If hexosaminidase A is <63%, then TSD/82588 Tay-Sachs Disease, Mutation Analysis, HEXA will be added and performed at an additional charge.
TSD | [NAME] | Tay-Sachs Disease, Mutation Analysis, HEXA | Tay-Sachs, Mutation Analysis | 1 | 81255 | No | Yes
NEURF | Test | Neuraminidase, Fibroblasts | Neuraminidase, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
NIEM | Test | Niemann-Pick Type C Detection, Fibroblasts | Niemann-Pick Type C, Fibro | 1 | 82658 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
NMOER | Test | Neuromyelitis Optica (NMO) Evaluation with [NAME], Serum | NMO Evaluation w/Reflex, S | 1 | 83520 |  |  | If NMO/APQ4 ELISA results are indeterminate (> or =1.6 and < or =4.9 U/mL), NMO-IgG will be performed at an additional charge.
PAINT | Component | Interpretive Comments | Interpretive Comments |  |  | Yes | No
AQP4E | Component | Neuromyelitis Optica (NMO)/Aquaporin-4-IgG ELISA, Serum | NMO/AQP4-IgG ELISA, S |  |  | Yes | No
NMOS | [NAME] | Neuromyelitis Optica (NMO) Autoantibody, IgG, Serum | NMO-IgG, Serum | 1 | 86255 | No | No
NPAIN | Test | Pain Clinic Drug Screen, [NAME] | Pain Clinic Drug Screen, U |  | PROFILE |  |  | Screening immunoassay is performed to detect the above drugs of abuse, followed by confirmation and quantification of screen-positive specimens as follows, with the exception of opiate confirmation, which is performed as part of the profile.   If the cocaine screen is >149 ng/mL then cocaine confirmation is performed at an additional charge.   If the THC screen is >49 ng/mL then THC confirmation is performed at an additional charge.   If the barbiturate screen is >199 ng/mL then barbiturate confirmation is performed at an additional charge.   If the benzodiazepine screen is >199 ng/mL then benzodiazepine confirmation is performed at an additional charge.   If the phencyclidine screen is >24 ng/mL then phencyclidine confirmation is performed at an additional charge.   If the amphetamines screen is >499 ng/mL then amphetamines confirmation is performed at an additional charge.   If the methadone screen is >299 ng/mL then methadone confirmation is performed at an additional charge.   If the propoxyphene screen is >299 ng/mL then propoxyphene confirmation is performed at an additional charge.
NPAIN | Component |  | Drugs of Abuse,Cl,DAU10,U | 1 | 80104 | No | No
NPAIN | Component |  | Alcohol (ethanol): any spec escpt breath | 1 | 82055 | No | No
DAU | Component | Drug of Abuse Screen, DAU10, [NAME] | Drugs of Abuse, Clin, DAU10, U |  | PROFILE | Yes | Yes
MSOP | Component | Drugs of Abuse, Opiates Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 83925 | Yes | No
MSTHC | [NAME] | Drug of Abuse, Tetrahydrocannabinol GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80299 | No | Yes
MSPCP | [NAME] | Drug of Abuse, Phencyclidine GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME] | 1 | 83992 | No | Yes
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
MSBR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, Barbiturate Conf, U | 1 | 82205 | No | Yes
MSMT | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 83840 | No | Yes
DAUBZ | [NAME] | Drug of Abuse, Benzodiazepines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 1 | 80154 | No | Yes
DAUAM | [NAME] | Drug of Abuse, Amphetamines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | 2 | 82145 | No | Yes
MSCO | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 1 | 82520 | No | Yes
NPCKM | Test | Niemann-Pick Type C Disease, Known Mutation | NPC Known Mutation | 1 | 81479 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
NPCMS | Test | Niemann-Pick Type C, Full Gene Analysis | NPC Mutation Screen | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
NPD | Test | Niemann-Pick Disease, Types A and B, Mutation Analysis | Niemann-Pick Disease, Types A and B | 1 | 81330 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal sample that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
NPDKM | Test | Niemann-Pick Disease, Types A and B, Known Mutation | Niemann-Pick A-B, Known Mutation | 1 | 81403 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.   For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
NPDMS | Test | Niemann-Pick Disease, Types A and B, Full Gene Analysis | Niemann-Pick A-B Full Gene Analysis | 1 | 81479
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
OPATU | Test | Opiates, [NAME] | Opiates, U | 1 | 83925 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
PAIN | Test | Pain Clinic Survey 10, [NAME] | Pain Clinic Survey 10, U |  | PROFILE |  |  | If immunoassay screen is positive, then gas chromatography-mass spectrometry (GC-MS) confirmation is performed. GC-MS confirmation with quantification of positives for amphetamines, barbiturates, benzodiazepines, cocaine and metabolites, methadone, phencyclidine, propoxyphene, and [NAME] will be performed at an additional charge.
OPATU | Component | Opiates, [NAME] | Opiates, U | 1 | 83925 | Yes | Yes
PAIN | Component |  | Pain Clinic Survey 10 | 1 | 80104 | No | No
PN_10 | Component | Pain Clinic Survey 10 | Pain Clinic Survey 10 | 1 | 80104 | Yes | No
MTDNU | [NAME] | Methadone Confirmation, [NAME] | Methadone Confirmation, U | 1 | 83840 | No | Yes
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
THCU | [NAME] | Tetrahydrocannabinol (THC) Confirmation, [NAME] | [NAME], U | 1 | 80299 | No | Yes
AMPHU | [NAME] | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 | No | Yes
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
PCPU | [NAME] | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 | No | Yes
BARBU | [NAME] | Barbiturate Confirmation, [NAME] | Barbiturate Confirmation, U | 1 | 82205 | No | Yes
BENZU | [NAME] | Benzodiazepine Confirmation, [NAME] | Benzodiazepine Confirmation, U | 1 | 80154 | No | Yes
COKEU | [NAME] | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 | No | Yes
PARID | Test | Parasite Identification | Parasite Identification | 1 | 0 |  |  | When this test is ordered, 1 of the 2 reflex tests will be performed and charged.
[NAME] | [NAME] | Parasite Identification | Parasite Identification | 1 | 87169 | No | No
BUG | [NAME] | [NAME] | [NAME] | 1 | 87168 | No | No
PAVAL | Test | Paraneoplastic Autoantibody Evaluation, Serum | Paraneoplastic Autoantibody Eval, S |  | PROFILE |  |  | If IFA (ANN1S/83381, ANN2S/83382, ANN3S/83137, PCABP/83383, PCAB2/83138, PCATR/83076, [NAME], [NAME], AGN1S/89080) patterns are indeterminate, paraneoplastic autoantibody Western blot is performed at an additional charge.   If client requests or if IFA patterns suggest CRMP-5-IgG, CRMP-5-IgG Western blot is performed at an additional charge.   If IFA pattern is suggestive of neuromyelitis optica (NMO), NMO-IgG is performed at an additional charge.   If IFA patterns suggest amphiphysin antibody, amphiphysin Western blot is performed at an additional charge.   If IFA patterns suggest GAD65 antibody, GAD65 antibody radioimmunoassay is performed at an additional charge.   If ACh receptor binding antibody is >0.02 or if striational antibodies are > or =1:60, ACh receptor modulating antibodies and CRMP-5-IgG Western blot are performed at an additional charge.
PCABP | Component | Purkinje Cell Cytoplasmic Antibody, Type 1 (PCA-1), Serum | Purkinje Cell Cytoplasmic Ab Type 1 | 1 | 86256 | Yes | No
STR | Component | Striational (Striated Muscle) Antibodies, Serum | Striational (Striated Muscle) Ab, S | 1 | 83520 | Yes | Yes
VGKC | Component | Neuronal Voltage-Gated Potassium Channel (VGKC) Autoantibody, Serum | Neuronal (V-G) K+ Channel Ab, S | 1 | 83519 | Yes | No
GANG | Component | Ganglionic Acetylcholine Receptor (Alpha3) Autoantibody, Serum | [NAME], S | 1 | 83519 | Yes | No
PCATR | Component | Purkinje Cell Cytoplasmic Antibody, Type Tr (PCA-Tr), Serum | Purkinje Cell Cytoplasmic Ab Type Tr | 1 | 86256 | Yes | No
PCAB2 | Component | Purkinje Cell Cytoplasmic Antibody, Type 2 (PCA-2), Serum | Purkinje Cell Cytoplasmic Ab Type 2 | 1 | 86256 | Yes | No
AMPHS | Component | Amphiphysin Antibody Assay, Serum | [NAME], S | 1 | 86256 | Yes | No
CRMS | Component | [NAME] Protein-5 Neuronal (CRMP-5-IgG), Serum | CRMP-5-IgG, S | 1 | 86256 | Yes | No
ANN3S | Component | Antineuronal Nuclear Antibody-Type 3 (ANNA-3), Serum | Anti-Neuronal Nuclear Ab, Type 3 | 1 | 86256 | Yes | No
ARBI | Component | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) Binding Ab | 1 | 83519 | Yes | Yes
ANN2S | Component | Antineuronal Nuclear Antibody-Type 2 (ANNA-2), Serum | Anti-Neuronal Nuclear Ab, Type 2 | 1 | 86256 | Yes | No
AGN1S | Component | Anti-Glial/Neuronal Nuclear Antibody-Type 1 (AGNA-1), Serum | Anti-Glial Nuclear Ab, Type 1 | 1 | 86256 | Yes | No
CCN | Component | N-Type Calcium Channel Antibody, Serum | N-Type Calcium Channel Ab | 1 | 83519 | Yes | No
CCPQ | Component | P/Q-Type Calcium Channel Antibody, Serum | P/Q-Type Calcium Channel Ab | 1 | 83519 | Yes | No
PAINT | Component | Interpretive Comments | Interpretive Comments |  |  | Yes | No
ANN1S | Component | Antineuronal Nuclear Antibody-Type 1 (ANNA-1), Serum | Anti-Neuronal Nuclear Ab, Type 1 | 1 | 86256 | Yes | No
NMOS | [NAME] | Neuromyelitis Optica (NMO) Autoantibody, IgG, Serum | NMO-IgG, Serum | 1 | 86255 | No | No
CRMWS | [NAME] | [NAME] Protein-5-IgG (CRMP-5-IgG) Western Blot, Serum | CRMP-5-IgG Western Blot, S | 1 | 84182 | No | No
ABLOT | [NAME] | Amphiphysin Antibody Western Blot, Serum | Amphiphysin Western Blot, S | 1 | 84182 | No | No
GD65S | [NAME] | Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Serum | GAD65 Ab Assay, S | 1 | 86341 | No | Yes
WBN | [NAME] | [NAME], Western Blot Confirmation, Serum | Paraneoplastic Autoantibody WBlot,S | 1 | 84182 | No | No
ARMO | [NAME] | Acetylcholine Receptor ([NAME]) [NAME], Serum | ACh Receptor ([NAME]) [NAME] | 1 | 83519 | No | No
PCDS | Test | Pain Clinic Drug Screen, [NAME] | Pain Clinic Drug Screen, U |  | PROFILE |  |  | Testing begins with screening tests for alcohol and drugs of abuse. Positives are confirmed and quantitated by definitive methods (gas chromatography-flame ionization detector for ethanol; gas chromatography-mass spectrometry for amphetamines, barbiturates, benzodiazepines, cocaine and metabolites, methadone, opiates, phencyclidine, propoxyphene, and [NAME]) at an additional charge.
OPATU | Component | Opiates, [NAME] | Opiates, U | 1 | 83925 | Yes | Yes
PDSU | Component | Drug Screen, Prescription/OTC, [NAME] | Drug Screen, Prescription/OTC, U | 1 | 80100 | Yes | Yes
PCDS | Component |  | Conf Drug Abuse Sur 12,U | 1 | 80104 | No | No
CDAU7 | Component | Drug Abuse Survey with Confirmation, Evaluation 12, [NAME] | Confirmed Drug Abuse Survey 12, U | 1 | 80104 | Yes | Yes
[NAME] | [NAME] | Ethanol, [NAME] | Ethanol, U | 1 | 82055 | No | No
PCPU | [NAME] | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 | No | Yes
BARBU | [NAME] | Barbiturate Confirmation, [NAME] | Barbiturate Confirmation, U | 1 | 82205 | No | Yes
BENZU | [NAME] | Benzodiazepine Confirmation, [NAME] | Benzodiazepine Confirmation, U | 1 | 80154 | No | Yes
THCU | [NAME] | Tetrahydrocannabinol (THC) Confirmation, [NAME] | [NAME], U | 1 | 80299 | No | Yes
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
MTDNU | [NAME] | Methadone Confirmation, [NAME] | Methadone Confirmation, U | 1 | 83840 | No | Yes
COKEU | [NAME] | Cocaine Confirmation, [NAME] | Cocaine Confirmation, U | 1 | 82520 | No | Yes
AMPHU | [NAME] | Amphetamines, [NAME] | Amphetamines, U | 2 | 82145 | No | Yes
MSPR | [NAME] | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | 2 | 80299 | No | Yes
PCLLM | Test | CLL Monitoring, MRD Detection FLIP, see #60490 | CLL Monitoring, MRD Detection, BM |  | PROFILE |  |  | When this test is ordered, flow cytometry interpretation, 2 to 8 markers will always be performed at an additional charge.
PCLLM | Component |  | FLOWCYTOMETRY/ TC 1 MARKER | 1 | 88184 | No | No
PCLLM | Component |  | FLOWCYTOMETRY/TC ADD-ON | 5 | 88185 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | Yes | No
PCPRO | Test | [NAME], Bone Marrow | [NAME], Marrow |  | PROFILE |  |  | See Laboratory Screening Tests for Suspected Multiple Myeloma in Special Instructions.
PCPRO | Component |  | CELL MARKER STUDY | 1 | 88182 | No | No
PCPRO | Component |  | FLOWCYTOMETRY/ TC 1 MARKER | 1 | 88184 | No | No
PCPRO | Component |  | FLOWCYTOMETRY/TC ADD-ON | 5 | 88185 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | Yes | No
PCPU | Test | Phencyclidine Confirmation, [NAME] | Phencyclidine Confirmation, U | 1 | 83992 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
PDHC | Test | Pyruvate Dehydrogenase Complex (PDHC), Fibroblasts | Pyruvate Dehydrogenase Comp, Fibro | 1 | 82658 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
PEE | Test | Porphyrins Evaluation, [NAME] | Porphyrins Evaluation, WB | 1 | 84311 |  |  | Testing begins with total RBC porphyrins. If the result is <80 mcg/[NAME], it is normal and testing is complete. If the total RBC porphyrin value is >80 mcg/dL, fractionation assays will be performed at an additional charge to identify the porphyrin involved. The protoporphyrin fractionation yields free protoporphyrin and zinc-complexed protoporphyrin. Depending on this result, porphyrins fractionation may be added, which fractionates and individually quantitates RBC porphyrins (uroporphyrin, coproporphyrin, and protoporphyrin).
PPFR | [NAME] | Protoporphyrins, Fractionation, [NAME] | Protoporphyrins, Fractionation | 1 | 84202 | No | Yes
PFR | [NAME] | Porphyrins, Fractionation, [NAME] | Porphyrins, Fractionation | 1 | 82492 | No | No
PEL | Test | Electrophoresis, Protein, Serum | Electrophoresis, Protein, S |  | PROFILE |  |  | If a discrete electrophoresis band is identified, the laboratory will evaluate the serum protein electrophoresis and, if necessary, perform immunofixation at an additional charge.
ELP | Component | Protein Electrophoresis | Protein Electrophoresis | 1 | 84165 | Yes | No
TPE | Component | Total Protein | Total Protein | 1 | 84155 | Yes | Yes
IMFX | [NAME] | Immunofixation, Serum | Immunofixation | 1 | 86334 | No | No
PEWE | Test | Porphyrins Evaluation, Washed Erythrocytes | [NAME], RBC | 1 | 84311 |  |  | Testing begins with total RBC porphyrins. If the result is <80 mcg/[NAME], it is normal and testing is complete. If the total RBC porphyrin value is >80 mcg/dL, fractionation assays will be performed at an additional charge to identify the porphyrin involved. The PPFR/28116 Protoporphyrin, Fractionation, [NAME] fractionates RBC protoporphyrin into free protoporphyrin and zinc-complexed protoporphyrin. Depending on this result, the PFR/28117 Porphyrins, Fractionation, [NAME] may be added which fractionates and individually quantitates RBC porphyrins (uroporphyrin, coproporphyrin, and protoporphyrin).
PFR | [NAME] | Porphyrins, Fractionation, [NAME] | Porphyrins, Fractionation | 1 | 82492 | No | No
PPFR | [NAME] | Protoporphyrins, Fractionation, [NAME] | Protoporphyrins, Fractionation | 1 | 84202 | No | Yes
PHESP | Test | Previous Hepatitis Exposure Profile | Previous Hepatitis Exposure Profile |  | PROFILE |  |  | If hepatitis B surface antigen (HBsAg) is reactive, then HBsAg confirmation will be performed at an additional charge.
HCV | Component | Hepatitis C Antibody Screen, Serum | HCV Ab Screen, S | 1 | 86803 | Yes | Yes
HBAG | Component | Hepatitis B Surface Antigen, Serum | HBs Antigen, S | 1 | 87340 | Yes | Yes
HBAB | Component | Hepatitis B Surface Antibody, Qualitative/Quantitative, Serum | [NAME], S | 1 | 86706 | Yes | Yes
HBC | Component | Hepatitis B Core Total Antibodies, Serum | HBc Total Ab, S | 1 | 86704 | Yes | Yes
HAV | Component | Hepatitis A Total Antibodies, Serum | Hepatitis A Total Ab, S | 1 | 86708 | Yes | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
PHSP | Test | Prenatal Hepatitis Evaluation | Prenatal Hepatitis Evaluation | 1 | 87340 |  |  | If hepatitis B surface antigen (HBsAg) prenatal is reactive, then HBsAg confirmation will be performed at an additional charge. If HBsAg confirmation is positive, then hepatitis Be antigen and hepatitis Be antibody tests will be performed at an additional charge.
HBAGP | Component | Hepatitis B Surface Antigen Prenatal, Serum | HBs Antigen Prenatal, S | 1 | 87340 | Yes | Yes
EAG | [NAME] | [NAME], Serum | Hepatitis Be Ag, S | 1 | 87350 | No | Yes
HBGNT | [NAME] | Hepatitis B Surface Antigen Confirmation, Serum | HBs Antigen Confirmation, S | 1 | 87341 | No | No
HEAB | [NAME] | [NAME], Serum | [NAME], S | 1 | 86707 | No | Yes
PLINK | Test | PNH, PI-Linked Antigen, Blood | PNH, PI-Linked AG, B |  | PROFILE
PLINK | Component |  | FLOWCYTOMETRY/ TC 1 MARKER | 2 | 88184 | No | No
PLINK | Component |  | FLOWCYTOMETRY/TC ADD-ON | 7 | 88185 | No | No
88466 | [NAME] | Flow Cytometry Interpretation, 9 to 15 Markers | Flow Cytometry Interp, 9-15 Markers | 1 | 88188 | No | No
PLSD | Test | Lysosomal and Peroxisomal Storage Disorders Screen, Blood Spot | Lysosomal/Peroxisomal D/O Scrn, BS | 1 | 83789 |  |  | If C26 lysophosphatidylcholine is >0.30, then lysophosphatidylcholines will be performed at an additional charge.
LPCBS | [NAME] | Lysophosphatidylcholines by Liquid Chromatography Tandem Mass Spectrometry ([NAME]), Blood Spot | LysoPC by LC MS/MS ([NAME]), BS | 1 | 83789 | No | No
PMMIF | Test | Phosphomannomutase (PMM) and [NAME] (PMI), Fibroblasts | PMM-PMI, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
PNEOE | Test | Paraneoplastic Autoantibody Evaluation, Spinal Fluid | [NAME],CSF |  | PROFILE |  |  | If indirect immunofluorescence assay (IFA) (ANN1C/3852, ANN2C/7472, ANN3C/21633, PCA1C/3988, PCA2C/21632, PCTRC/21631, AMPHC/5906, CRMC/21650, [NAME]) is indeterminate, paraneoplastic autoantibody Western blot is performed at an additional charge.   If IFA pattern is suggestive of neuromyelitis optica (NMO), then NMO-IgG is performed at an additional charge.   If client requests or if IFA patterns suggest CRMP-5-IgG, CRMP-5-IgG Western blot is performed at an additional charge.   If IFA patterns suggest GAD65 antibody, GAD65 antibody radioimmunoprecipitation assay is performed at an additional charge.   If IFA patterns suggest amphiphysin antibody, amphiphysin Western blot is performed at an additional charge.
AMPHC | Component | Amphiphysin Antibody Assay, Spinal Fluid | [NAME], CSF | 1 | 86256 | Yes | No
CRMC | Component | [NAME] Protein-5 Neuronal (CRMP-5-IgG), [NAME] | CRMP-5-IgG, CSF | 1 | 86256 | Yes | No
ANN3C | Component | Antineuronal Nuclear Antibody-Type 3 (ANNA-3), [NAME] | Anti-Neuronal Nuclear Ab, Type 3 | 1 | 86256 | Yes | No
PCTRC | Component | Purkinje Cell Cytoplasmic Antibody, Type Tr (PCA-Tr), [NAME] | Purkinje Cell Cytoplasmc Ab Type Tr | 1 | 86256 | Yes | No
PCA2C | Component | Purkinje Cell Cytoplasmic Antibody, Type 2 (PCA-2), [NAME] | Purkinje Cell Cytoplasmic Ab Type 2 | 1 | 86256 | Yes | No
PCA1C | Component | Purkinje Cell Cytoplasmic Antibody, Type 1 (PCA-1), [NAME] | Purkinje Cell Cytoplasmic Ab Type 1 | 1 | 86256 | Yes | No
AGN1C | Component | Anti-Glial/Neuronal Nuclear Antibody-Type 1 (AGNA-1), [NAME] | Anti-Glial Nuclear Ab, Type 1 | 1 | 86256 | Yes | No
ANN1C | Component | Antineuronal Nuclear Antibody-Type 1 (ANNA-1), [NAME] | Anti-Neuronal Nuclear Ab, Type 1 | 1 | 86256 | Yes | No
ANN2C | Component | Antineuronal Nuclear Antibody-Type 2 (ANNA-2), [NAME] | Anti-Neuronal Nuclear Ab, Type 2 | 1 | 86256 | Yes | No
ABLTC | [NAME] | Amphiphysin Antibody Western Blot, [NAME] | Amphiphysin Western Blot, CSF | 1 | 84182 | No | No
NMOC | [NAME] | Neuromyelitis Optica (NMO) Autoantibody, IgG, Spinal Fluid | NMO-IgG, CSF | 1 | 86255 | No | Yes
GD65C | [NAME] | Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid | GAD65 Ab Assay, CSF | 1 | 86341 | No | Yes
WBNC | [NAME] | [NAME], Western Blot Confirmation, Spinal Fluid | [NAME],CSF | 1 | 84182 | No | No
CRMWC | [NAME] | [NAME] Protein-5-IgG (CRMP-5-IgG) Western Blot, [NAME] | CRMP-5-IgG Western Blot, CSF | 1 | 84182 | No | No
POC | Test | Chromosome Analysis, Autopsy, Products of Conception, or Stillbirth | Chromosome, Autopsy/Concep/Stillbirth |  | PROFILE |  |  | If the chromosome study fails to produce dividing cells, this test will be resulted at no charge, and FPOCR/29924 Aneuploidy Detection, Products of Conception (POC) Reflex, FISH will be performed.
POC | Component |  | Chromosome Culture,Tissue | 1 | 88233 | No | No
POC | Component |  | Cytogenetic Interp/Report | 1 | 88291 | No | No
POC | Component |  | Unlisted Cytogenetic Study | 1 | 88299 | No | No
FPOCR | [NAME] | [NAME], Products of Conception (POC) Reflex, FISH | [NAME], POC, FISH |  | PROFILE | No | No
PPOXK | Test | [NAME], Known Mutation | [NAME], Known Mutation | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
PPOXS | Test | [NAME], Full Gene Analysis | [NAME], Full Gene Analysis | 1 | 81479 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
PROCT | Test | Prolonged Clot Time Profile | Prolonged Clot Time Prof |  | PROFILE |  |  | Initial testing includes: prothrombin time (PT), activated partial thromboplastin time (APTT), dilute Russells viper venom time (DRVVT), thrombin time (bovine), fibrinogen, D-dimer, soluble fibrin monomer, and special coagulation interpretation. If PT is > or =14 seconds, PT mix will be performed. If APTT is >36 seconds, APTT mix will be performed. If APTT mix is >36 seconds with no evidence of heparin in samples, platelet neutralization procedure will be performed. If DRVVT ratio is > or =1.2, DRVVT mix will be performed. If DRVVT mix ratio is > or =1.2, DRVVT confirmation will be performed. If thrombin time is >23 seconds, reptilase time will be performed.     If PT, APTT, or DRVVT is prolonged, coagulation factor assays may be performed.
CCC | Component | Special Coagulation Interpretation | Special Coagulation Interpretation | 1 | 85390 | Yes | No
FIBC | Component | Fibrinogen, Plasma | Fibrinogen, P | 1 | 85384 | Yes | Yes
DIRM | Component | D-Dimer, Plasma | D-Dimer, P | 1 | 85379 | Yes | Yes
DRVT | Component | [NAME] Viper Venom Time (DRVVT), Plasma | Dilute Russells Viper Venom Time, P | 1 | 85613 | Yes | No
APTTB | Component | Activated Partial Thromboplastin Time (APTT), Plasma | Activated Partial Thrombopl Time, P | 1 | 85730 | Yes | Yes
TT | Component | Thrombin Time (Bovine), Plasma | Thrombin Time (Bovine), P | 1 | 85670 | Yes | Yes
SFM | Component | Soluble [NAME] | Soluble [NAME] | 1 | 85366 | Yes | No
PTC | Component | Prothrombin Time (PT), Plasma | Prothrombin Time (PT), P | 1 | 85610 | Yes | Yes
PNP | [NAME] | Platelet Neutralization Procedure | Platelet Neutralization Procedure | 1 | 85597 | No | No
PTMX | [NAME] | PT Mix 1:1 | PT Mix 1:1 | 1 | 85611 | No | No
STLA | [NAME] | Staclot Lupus Anticoagulant, Plasma | Staclot LA, P | 1 | 85598 | No | No
F_11 | [NAME] | Coagulation Factor XI Activity Assay, Plasma | Coag Factor XI Assay, P | 1 | 85270 | No | Yes
DRVTC | [NAME] | DRVVT Confirmation | DRVVT Confirmation | 1 | 85613 | No | No
DRVTM | [NAME] | DRVVT Mix | DRVVT Mix | 1 | 85613 | No | No
FACTV | [NAME] | Coagulation Factor V Activity Assay, Plasma | Coag Factor V Assay, P | 1 | 85220 | No | Yes
F_7 | [NAME] | Coagulation Factor VII Activity Assay, Plasma | Coag Factor VII Assay, P | 1 | 85230 | No | Yes
F_9 | [NAME] | Coagulation Factor IX Activity Assay, Plasma | Coag Factor IX Assay, P | 1 | 85250 | No | Yes
APTTM | [NAME] | APTT Mix 1:1 | APTT Mix 1:1 | 1 | 85732 | No | No
F_2 | [NAME] | Coagulation Factor II Activity Assay, Plasma | Coag Factor II Assay, P | 1 | 85210 | No | Yes
F_10 | [NAME] | Coagulation Factor X Activity Assay, Plasma | Coag Factor X Assay, P | 1 | 85260 | No | Yes
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
F_12 | [NAME] | Coagulation Factor XII Activity Assay, Plasma | Coag Factor XII Assay, P | 1 | 85280 | No | Yes
RPTL | [NAME] | Reptilase Time, Plasma | Reptilase Time, P | 1 | 85635 | No | Yes
F8A | [NAME] | Coagulation Factor VIII Activity Assay, Plasma | Coag Factor VIII Activity Assay, P | 1 | 85240 | No | Yes
F8IS | [NAME] | Coagulation Factor VIII Inhibitor Screen, Plasma | Coag Factor VIII Assay [NAME],P | 1 | 85335 | No | No
PSTF | Test | Protein S Antigen, Plasma | Protein S Ag, P | 1 | 85306 |  |  | If this test is abnormal, then total plasma protein S antigen will be performed at an additional charge.
PSF | Component | Protein S Antigen, Free, Plasma | Protein S Ag, Free, P | 1 | 85306 | Yes | No
PST | [NAME] | Protein S Antigen, Total, Plasma | Protein S Ag, Total, P | 1 | 85305 | No | No
PTP | Test | Porphyrins, Total, Plasma | Porphyrins, Total, P | 1 | 84311 |  |  | If total porphyrins are >1.0 mcg/[NAME], then PFP/8733 [NAME], Fractionation, [NAME] will be performed at an additional charge.
PFP | [NAME] | Porphyrins, Fractionation, Plasma | Porphyrins, Fractionation, P | 1 | 82492 | No | No
PWDNA | Test | Prader-Willi/Angelman Syndrome, Molecular Analysis | [NAME] | 1 | 81331 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
REPU | Test | Electrophoresis, Protein, Random, [NAME] | Electrophoresis, Protein, Random, U |  | PROFILE |  |  | If a discrete electrophoresis band is identified, the laboratory will evaluate the urine protein electrophoresis and, if necessary, perform immunofixation at an additional charge.
PTCON | Component | Protein, Total, Random, U | Protein, Total, Random, U | 1 | 84156 | Yes | No
REPU | Component |  | Protein, Total, Random, U | 1 | 84156 | No | No
RPEU | Component | Electrophoresis, Protein, Random, [NAME] | Protein Electrophoresis, Random, U | 1 | 84166 | Yes | No
RIFXU | [NAME] | Immunofixation, Random, U | Immunofixation, Random, U | 1 | 86335 | No | No
REVP | Test | Erythrocytosis Evaluation | Erythrocytosis Evaluation |  | PROFILE |  |  | This is a consultative evaluation in which the case will be evaluated at Mayo Medical Laboratories, the appropriate tests performed at an additional charge, and the results interpreted.
IEF | Component | IEF Confirms | IEF Confirms | 1 | 82664 | Yes | No
REVP | Component |  | [NAME]. P50, Blood | 1 | 82820 | No | No
REV | Component | Erythrocytosis Interpretation | Erythrocytosis Interpretation |  |  | Yes | No
A2F | Component | [NAME] and F, Blood | [NAME] and F | 1 | 83021 | Yes | Yes
P50C | Component | P50 Interpretation | P50 Interpretation |  |  | Yes | No
HBEL | Component | [NAME], Blood | [NAME], B | 1 | 83020 | Yes | No
P50X | Component | Oxygen Dissociation P50 | Oxygen Dissociation P50 |  |  | Yes | No
HEMP | [NAME] | Hereditary Erythrocytosis Mutations | Hereditary Erythrocytosis Mut, B | 1 | 81479 | No | Yes
HPFH | [NAME] | [NAME], Red Cell Distribution, Blood | [NAME], Red Cell Distrib, B | 1 | 88184 | No | Yes
MASS | [NAME] | [NAME] by Mass Spectrometry | [NAME] by [NAME], B | 1 | 83789 | No | No
HGBMO | [NAME] | [NAME], Molecular | HGB Electrophoresis, Molecular |  | PROFILE | No | No
UNHB | [NAME] | Hemoglobin, Unstable, Blood | Hemoglobin, Unstable, B | 1 | 83068 | No | Yes
SDEX | [NAME] | [NAME], Screen, Blood | [NAME], Scrn, B | 1 | 85660 | No | Yes
[NAME] | Test | HIV Antibody Rapid Test Confirmatory Profile, Serum | HIV Ab Rapid Test Confirm Prof, S |  | PROFILE |  |  | When this test is ordered, both HIV-1/-2 antibody screen and HIV-1/-2 antibody confirmatory testing will always be performed.   If HIV-1/-2 antibody confirmatory evaluation is negative, then HIV-2 antibody evaluation is performed at an additional charge.   If HIV-1/-2 antibody confirmatory evaluation is indeterminate or uninterpretable, then HIV-1 antibody confirmation by immunofluorescence and HIV-2 antibody evaluation are performed at an additional charge.   If [NAME] antibody evaluation is reactive, then HIV-2 antibody confirmation will be performed at an additional charge.
WBAR | Component | HIV-1/-2 Antibody Confirmatory Evaluation, Serum | HIV-1/-2 Ab Confirm Eval, S | 1 | 86689 | Yes | Yes
CTHIV | Component | HIV Types 1 and 2 Antibody Screen, Serum | HIV-1/-2 [NAME], S | 1 | 86703 | Yes | No
HIVFA | [NAME] | HIV-1 Antibody Confirmation by Immunofluorescence, Serum | HIV-1 Ab Confirm by IFA, S | 1 | 86689 | No | Yes
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
HIV2 | [NAME] | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 | No | Yes
RUA | Test | Urinalysis, [NAME], Includes Microscopic | Urinalysis Complete w/ Microscopic | 1 | 81000 |  |  | When this test is ordered, either automated or manual microscopic examination will always be performed at no additional charge.
GLUC | Component | Glucose | Glucose |  |  | Yes | Yes
PRO5 | Component | Protein | Protein |  |  | Yes | Yes
UBIL | Component | [NAME] | [NAME] |  |  | No | Yes
CMT51 | Component | Comment | Comment |  |  | Yes | No
PHU_ | Component | pH, [NAME] | pH, U | 1 | 83986 | Yes | Yes
P24HP | Component | Predicted 24 Hr Protein | Predicted 24 Hr Protein |  |  | Yes | No
P_RGE | Component | Predicted Range | Predicted Range |  |  | Yes | No
HGBQL | Component | Hemoglobin, QL | Hemoglobin, QL |  |  | Yes | Yes
PR_OS | Component | Protein/Osmolality | Protein/Osmolality |  |  | Yes | No
UREDU | Component | [NAME], U | [NAME], U |  |  | No | Yes
SRC3 | Component | Source | Source |  |  | Yes | No
[NAME] | Component | Appearance | Appearance |  |  | Yes | No
UOSMU | Component | Osmolality, [NAME] | Osmolality, U | 1 | 83935 | Yes | Yes
MICM | [NAME] | Microscopic Manual | Microscopic Manual |  |  | No | No
MICA | [NAME] | [NAME] | [NAME] |  |  | No | No
SCRYP | Test | Cryptococcus Antigen Screen, Serum | Cryptococcus Ag Screen, S | 1 | 87327 |  |  | If EIA results are reactive, latex agglutination testing (Cryptococcus Ag) will be performed at an additional charge.
SCRYR | [NAME] | [NAME], Serum | Cryptococcus Ag, S | 1 | 86403 | No | No
SDHSP | Test | Succinate Dehydrogenase (SDH) Gene Analysis | SDH Gene Analysis |  | PROFILE |  |  | If SDH gene sequencing does not identify a mutation, then SDH deletion detection will be performed at an additional charge.
SDHMS | Component | Succinate Dehydrogenase (SDH) Gene, Complete Gene Analysis | SDH Gene Analysis |  |  | Yes | No
SDHSP | Component |  | MOPATH PROCEDURE LEVEL 5 | 1 | 81404 | No | No
SDHSP | Component |  | MOPATH PROCEDURE LEVEL 6 | 1 | 81405 | No | No
SDHSQ | Component | Succinate Dehydrogenase (SDH) [NAME] | SDH Gene Sequencing |  |  | Yes | No
SHDD | [NAME] | Succinate Dehydrogenase (SDH) Deletion Detection | SDH Deletion Detection | 1 | 81403 | No | Yes
SFMON | Test | [NAME] and [NAME] for Therapeutic Monitoring, Blood | Hb S/F Therapeutic Monitoring, B | 1 | 83021 |  |  | If hemoglobin S is detected, hemoglobin S screen will be performed, when appropriate, at an additional charge.
SDEX | [NAME] | [NAME], Screen, Blood | [NAME], Scrn, B | 1 | 85660 | No | Yes
SMART | Test | Mayo Stratification for Myeloma and Risk-Adapted Therapy Report | mSMART Evaluation, Marrow |  | PROFILE |  |  | When this test is ordered, Plasma Cell Proliferation, Marrow will always be performed at additional charge.
SMART | Component |  | Interpretation and Report | 1 | 88291 | No | No
SMART | Component |  | Cytogenetic Interp/Report | 1 | 88291 | No | No
FPCPD | Component | [NAME] Proliferative Disorder (PCPD), FISH | [NAME], FISH |  | PROFILE | Yes | Yes
SMART | Component |  | Cryopreservation,freezing | 1 | 88240 | No | No
MBM | Component | Chromosomes, mSMART Evaluation, Bone Marrow | Chromosomes, mSMART Eval, Marrow |  |  | Yes | No
SMART | Component |  | Chromosome Analysis | 1 | 88264 | No | No
SMART | Component |  | Tissue Culture for Bone Marrow | 1 | 88237 | No | No
SMART | Component |  | Analyze 100-300 Cells | 2 | 88275 | No | No
SMART | Component |  | DNA Probe, each | 12 | 88271 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | Yes | No
PCPRO | [NAME] | [NAME], Bone Marrow | [NAME], Marrow |  | PROFILE | Yes | Yes
[NAME] | Test | Sphingomyelinase, Fibroblasts | Sphingomyelinase, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
SPSM | Test | Morphology Evaluation (Special Smear) | Morphology Eval (special smear) | 1 | 85007 |  |  | For MML patients, a physician review is included if clinically abnormal results are identified by microscopic examination.   For Mayo patients, a consultant evaluation is performed if clinically abnormal results are identified by microscopic examination (at an additional charge).
SPSM_ | Component | Morphology Review Member | Special Smear |  |  | Yes | No
DIFFS | Component | Morphology Evaluation (Special Smear) | Morphology Eval (Special Smear) |  |  | Yes | No
CE | [NAME] | Consultant Evaluation | Consultant Eval. |  |  | No | No
SYPGR | Test | [NAME] with [NAME], Serum | [NAME] w/Reflex, S | 1 | 86780 |  |  | If syphilis IgG is positive, RRPR/34511 Rapid Plasma Reagin w/ Reflex, S will be performed at an additional charge.
RTPPA | [NAME] | [NAME], TP-PA, Serum | [NAME], TP-PA, S | 1 | 86780 | No | No
RRPR | [NAME] | Rapid [NAME] with Reflex, Serum | Rapid [NAME] w/ Reflex, S | 1 | 86592 | No | No
TAE | Test | Therapeutic Antibody by Flow Cytometry | Therapeutic Antibody Evaluation |  | PROFILE |  |  | When a blood or bone marrow is ordered, a panel specific to desired antibody and a professional interpretation will always be charged. The panel will be charged based on number of makers tested (80997 for first marker, 81047 for each additional marker). The interpretation will be set based on markers tested in increments of 2 to 8, 9 to 15, or 16 and greater.
TAE | Component |  | Each additional marker | 3 | 88185 | No | No
TAE | Component |  | Additional Marker | 1 | 88184 | No | No
80997 | [NAME] | Flow Cytometry, Cell Surface, First | Flow Cytometry, Cell Surface, First | 1 | 88184 | No | No
81047 | [NAME] | Flow Cytometry, Cell Surface, Additional | Flow Cytometry, Cell Surface, [NAME] | 1 | 88185 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | No | No
88466 | [NAME] | Flow Cytometry Interpretation, 9 to 15 Markers | Flow Cytometry Interp, 9-15 Markers | 1 | 88188 | No | No
88467 | [NAME] | Flow Cytometry Interpretation, 16 or More Markers | Flow Cytometry Interp,16 or greater | 1 | 88189 | No | No
THCU | Test | Tetrahydrocannabinol (THC) Confirmation, [NAME] | [NAME], U | 1 | 80299 |  |  | An evaluation to detect the presence of adulterants will be performed and reported at no additional charge.
ADULT | [NAME] | Adulterants Survey, [NAME] | Adulterants Survey, U |  |  | Yes | No
THEVP | Test | Thalassemia and Hemoglobinopathy Evaluation | Thalassemia and [NAME] |  | PROFILE |  |  | This is a consultative evaluation in which the case will be evaluated at Mayo Medical Laboratories, the appropriate tests performed at an additional charge, and the results interpreted. For information on thalassemias and appropriate test ordering, see Thalassemia Tests in Special Instructions.
[NAME] | Component | Hemoglobinopathy Interpretation | Hemoglobinopathy Interpretation |  |  | Yes | No
A2F | Component | [NAME] and F, Blood | [NAME] and F | 1 | 83021 | Yes | Yes
FERR | Component | Ferritin, Serum | Ferritin, S | 1 | 82728 | Yes | Yes
HBEL | Component | [NAME], Blood | [NAME], B | 1 | 83020 | Yes | No
MASS | [NAME] | [NAME] by Mass Spectrometry | [NAME] by [NAME], B | 1 | 83789 | No | No
HGBMO | [NAME] | [NAME], Molecular | HGB Electrophoresis, Molecular |  | PROFILE | No | No
SDEX | [NAME] | [NAME], Screen, Blood | [NAME], Scrn, B | 1 | 85660 | No | Yes
UNHB | [NAME] | Hemoglobin, Unstable, Blood | Hemoglobin, Unstable, B | 1 | 83068 | No | Yes
HPFH | [NAME] | [NAME], Red Cell Distribution, Blood | [NAME], Red Cell Distrib, B | 1 | 88184 | No | Yes
IEF | [NAME] | IEF Confirms | IEF Confirms | 1 | 82664 | No | No
AGPBT | [NAME] | Alpha-Globin Gene Analysis | Alpha-Globin Gene Analysis | 1 | 81404 | No | Yes
THRMP | Test | Thrombophilia Profile | Thrombophilia Prof |  | PROFILE |  |  | Initial testing includes: prothrombin time (PT); activated partial thromboplastin time (APTT); dilute Russells viper venom time (DRVVT); thrombin time (bovine); fibrinogen; D-dimer; soluble fibrin monomer; antithrombin activity; protein C activity; protein S antigen, free; prothrombin G20210A mutation; activated protein resistance V; and, if appropriate, special coagulation interpretation.   If PT is > or =14 seconds, PT mix will be performed.     If APTT is >36 seconds, APTT mix will be performed.     If APTT mix is >36 seconds with no evidence of heparin in samples, platelet neutralization procedure will be performed.     If DRVVT ratio is > or =1.2, DRVVT mix will be performed.     If DRVVT mix ratio is > or =1.2, DRVVT confirmation will be performed.     If thrombin time is >23 seconds, reptilase time will be performed.     If protein S antigen, free is <65% for males and females > or =50 years of age and <50% for females <50 years of age, protein S antigen, total will be performed.     If protein C activity is <70% with no evidence for an acquired decrease in protein C activity, protein C antigen may be performed.     If antithrombin activity is <80% with no evidence of an acquired decrease in antithrombin activity, antithrombin antigen will be performed.     If activated protein C resistance (APC) ratio is <2.3 or baseline APC APTT is prolonged, factor V leiden (R506Q) mutation analysis will be performed.   If appropriate, protein S activity, plasminogen, coagulation factor assays, or Staclot LA will be performed at an additional charge to clarify significant abnormalities in the screening clotting times.   If factor VIII result is <55%, the factor VIII inhibitor screen may be performed along with the Bethesda titering assay, if inhibitor screen is positive.
CCC | Component | Special Coagulation Interpretation | Special Coagulation Interpretation | 1 | 85390 | Yes | No
PSF | Component | Protein S Antigen, Free, Plasma | Protein S Ag, Free, P | 1 | 85306 | Yes | Yes
THRMP | Component |  | F2 GENE | 1 | 81240 | No | No
PTC | Component | Prothrombin Time (PT), Plasma | Prothrombin Time (PT), P | 1 | 85610 | Yes | Yes
SFM | Component | Soluble [NAME] | Soluble [NAME] | 1 | 85366 | Yes | No
CFX | Component | Protein C Activity, Plasma | Protein C Activity, P | 1 | 85303 | Yes | Yes
PTNT | Component | Prothrombin G20210A Mutation, Blood | Prothrombin G20210A Mutation, B | 1 | 81240 | Yes | Yes
FIBC | Component | Fibrinogen, Plasma | Fibrinogen, P | 1 | 85384 | Yes | Yes
ATTF | Component | [NAME], Plasma | [NAME], P | 1 | 85300 | Yes | Yes
DRVT | Component | [NAME] Viper Venom Time (DRVVT), Plasma | Dilute Russells Viper Venom Time, P | 1 | 85613 | Yes | No
TT | Component | Thrombin Time (Bovine), Plasma | Thrombin Time (Bovine), P | 1 | 85670 | Yes | Yes
APCRV | Component | Activated Protein C Resistance V (APCRV), Plasma | Activated Protein Resistance V, P | 1 | 85307 | Yes | Yes
DIRM | Component | D-Dimer, Plasma | D-Dimer, P | 1 | 85379 | Yes | Yes
APTTB | Component | Activated Partial Thromboplastin Time (APTT), Plasma | Activated Partial Thrombopl Time, P | 1 | 85730 | Yes | Yes
PNP | [NAME] | Platelet Neutralization Procedure | Platelet Neutralization Procedure | 1 | 85597 | No | No
PTMX | [NAME] | PT Mix 1:1 | PT Mix 1:1 | 1 | 85611 | No | No
F5DNA | [NAME] | Factor [NAME] (R506Q) Mutation, Blood | Factor [NAME] (R506Q) Mutation, B | 1 | 81241 | No | Yes
F_10 | [NAME] | Coagulation Factor X Activity Assay, Plasma | Coag Factor X Assay, P | 1 | 85260 | No | Yes
S_FX | [NAME] | Protein S Activity, Plasma | Protein S Activity, P | 1 | 85306 | No | Yes
STLA | [NAME] | Staclot Lupus Anticoagulant, Plasma | Staclot LA, P | 1 | 85598 | No | No
DRVTC | [NAME] | DRVVT Confirmation | DRVVT Confirmation | 1 | 85613 | No | No
F_2 | [NAME] | Coagulation Factor II Activity Assay, Plasma | Coag Factor II Assay, P | 1 | 85210 | No | Yes
F_11 | [NAME] | Coagulation Factor XI Activity Assay, Plasma | Coag Factor XI Assay, P | 1 | 85270 | No | Yes
DRVTM | [NAME] | DRVVT Mix | DRVVT Mix | 1 | 85613 | No | No
APTTM | [NAME] | APTT Mix 1:1 | APTT Mix 1:1 | 1 | 85732 | No | No
PST | [NAME] | Protein S Antigen, Total, Plasma | Protein S Ag, Total, P | 1 | 85305 | No | No
FACTV | [NAME] | Coagulation Factor V Activity Assay, Plasma | Coag Factor V Assay, P | 1 | 85220 | No | Yes
F_7 | [NAME] | Coagulation Factor VII Activity Assay, Plasma | Coag Factor VII Assay, P | 1 | 85230 | No | Yes
F8IS | [NAME] | Coagulation Factor VIII Inhibitor Screen, Plasma | Coag Factor VIII Assay [NAME],P | 1 | 85335 | No | No
ATTI | [NAME] | [NAME], Plasma | [NAME], P | 1 | 85301 | No | Yes
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
F_12 | [NAME] | Coagulation Factor XII Activity Assay, Plasma | Coag Factor XII Assay, P | 1 | 85280 | No | Yes
PSGN | [NAME] | Plasminogen Activity, Plasma | Plasminogen Activity, P | 1 | 85420 | No | Yes
PCAG | [NAME] | Protein C Antigen, Plasma | Protein C Ag, P | 1 | 85302 | No | Yes
F8A | [NAME] | Coagulation Factor VIII Activity Assay, Plasma | Coag Factor VIII Activity Assay, P | 1 | 85240 | No | Yes
RPTL | [NAME] | Reptilase Time, Plasma | Reptilase Time, P | 1 | 85635 | No | Yes
F_9 | [NAME] | Coagulation Factor IX Activity Assay, Plasma | Coag Factor IX Assay, P | 1 | 85250 | No | Yes
THSCM | Test | Thyroid Function Cascade, Serum | Thyroid Function Cascade, S | 1 | 84443 |  |  | If thyroid-stimulating hormone (TSH) is <0.3 mIU/L, then free T4 (FT4) is performed at an additional charge.    If [NAME] is normal and the TSH is <0.1 mIU/L, then T3 is performed at an additional charge.    If TSH is >5.0 mIU/L, then [NAME] and thyroperoxidase antibodies are performed at an additional charge.
STSHC | Component | Thyroid-Stimulating Hormone- Sensitive (S-TSH), Serum | TSH, Sensitive, S |  |  | Yes | Yes
T3C | [NAME] | T3 (Triiodothyronine), Total, Serum | T3 (Triiodothyronine), Total, S | 1 | 84480 | No | Yes
FRT4C | [NAME] | T4 (Thyroxine), Free, Serum | T4 (Thyroxine), Free, S | 1 | 84439 | No | Yes
TPOC | [NAME] | Thyroperoxidase (TPO) Antibodies, Serum | [NAME], S | 1 | 86376 | No | Yes
TICKS | Test | [NAME], Serum | [NAME], S |  | PROFILE |  |  | If Lyme disease screen is positive or equivocal, then the Lyme disease antibody confirmation (by Western blot) will be performed at an additional charge.
EHRC | Component | Ehrlichia chaffeensis (HME) Antibody, IgG, Serum | Ehrlichia Chaffeensis (HME) Ab, IgG | 1 | 86666 | Yes | Yes
ANAP | Component | Anaplasma phagocytophilum (Human Granulocytic Ehrlichiosis) Antibody, Serum | Anaplasma phagocytophilum Ab, IgG,S | 1 | 86666 | Yes | Yes
LYME | Component | Lyme Disease Serology, Serum | Lyme Disease Serology, S | 1 | 86618 | Yes | Yes
BABG | Component | Babesia microti IgG Antibodies, Serum | Babesia microti IgG Ab, S | 1 | 86753 | Yes | Yes
LYWB | [NAME] | Lyme Disease Antibody, Immunoblot, Serum | Lyme Disease Ab, Immunoblot, S | 2 | 86617 | No | Yes
TPPTF | Test | [NAME] (TPP1) and Palmitoyl-Protein Thioesterase 1 (PPT1), Fibroblasts | TPP1 and PPT1, Fibroblasts | 1 | 82657 |  |  | When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only 1 culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
CRYOB | [NAME] | Cryopreservation for Biochemical Studies | Cryopreserve for Biochem Studies | 1 | 88240 | Yes | No
FIBR | [NAME] | Fibroblast Culture | Fibroblast Culture | 1 | 88233 | Yes | Yes
TSD | Test | Tay-Sachs Disease, Mutation Analysis, HEXA | Tay-Sachs, Mutation Analysis | 1 | 81255 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately. For any prenatal specimen that is received, maternal cell contamination studies will be added.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
TTRX | Test | Amyloidosis, Transthyretin-Associated Familial, [NAME], Blood | Familial Amyloidosis Reflex | 1 | 83788 |  |  | If familial amyloidosis by liquid chromatography-mass spectrometry is abnormal, DNA sequence will be performed and charged separately.
AMYL | [NAME] | Amyloidosis, Transthyretin-Associated Familial, DNA Sequence, Blood | Familial Amyloidosis, DNA Sequence | 1 | 81404 | No | Yes
TXBU | Test | 11-Dehydro-Thromboxane B2, [NAME] | 11-Dehydro-Thromboxane B2, U | 1 | 84431 |  |  | When 11-dehydro-thromboxane B2 testing is performed, [NAME], Urine will always be performed at no additional charge.
AACT | [NAME] | Creatinine, [NAME] | Creatinine, U |  |  | Yes | No
UBEKM | Test | [NAME], Known Mutation | [NAME], Known Mutation | 1 | 81403 |  |  | If skin biopsy is received, fibroblast culture for genetic test will be added and charged separately.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
MCC | [NAME] | Maternal Cell Contamination, Molecular Analysis | Maternal Cell Contamination, B | 1 | 81265 | No | Yes
UBEMS | Test | [NAME], Full Gene Analysis | [NAME], Full Gene Analysis | 1 | 81406 |  |  | If skin biopsy is received, fibroblast culture will be added and charged separately.
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
UMIC | Test | Urinalysis, Microscopic, Osmolality, and pH | Urinalysis, Microscop,Osmolality,pH | 1 | 81001 |  |  | When this test is ordered, either automated or manual microscopic examination will always be performed at no additional charge.
HGBQL | Component | Hemoglobin, QL | Hemoglobin, QL |  |  | Yes | Yes
CMT51 | Component | Comment | Comment |  |  | Yes | No
UREDU | Component | [NAME], U | [NAME], U |  |  | No | Yes
UBIL | Component | [NAME] | [NAME] |  |  | No | Yes
[NAME] | Component | Appearance | Appearance |  |  | Yes | No
PHU_ | Component | pH, [NAME] | pH, U | 1 | 83986 | Yes | Yes
UOSMU | Component | Osmolality, [NAME] | Osmolality, U | 1 | 83935 | Yes | Yes
SRC3 | Component | Source | Source |  |  | Yes | No
MICA | [NAME] | [NAME] | [NAME] |  |  | No | No
MICM | [NAME] | Microscopic Manual | Microscopic Manual |  |  | No | No
UPD | Test | Uniparental Disomy | Uniparental Disomy | 1 | 81402 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes
VASC | Test | Antineutrophil Cytoplasmic Antibodies Vasculitis Panel, Serum | ANCA Panel for Vasculitis, S |  | PROFILE |  |  | If myeloperoxidase (MPO) antibody or proteinase 3 (PR3) antibody is >=0.4 U, then cytoplasmic neutrophilic antibodies will be performed at an additional charge.
MPO | Component | Myeloperoxidase Antibodies, IgG, Serum | [NAME], S | 1 | 83516 | Yes | Yes
PR3 | Component | Proteinase 3 Antibodies, IgG, Serum | Proteinase 3 Ab (PR3), S | 1 | 83516 | Yes | Yes
ANCA | [NAME] | Cytoplasmic Neutrophil Antibodies, Serum | [NAME], S | 1 | 86255 | No | Yes
VHLSP | Test | [NAME] (VHL) Gene, Full Gene Analysis | VHL Full Gene Analysis | 1 | 81404 |  |  | If reason for referral is diagnosis of [NAME] (VHL) syndrome or it is not known both VHL full gene analysis (amplification) and VHL gene sequencing will be performed.
VHLMS | Component | [NAME] (VHL) Gene, Full Gene Analysis | VHL Full Gene Analysis |  |  | Yes | No
VHLGQ | Component | [NAME] | [NAME] |  |  | Yes | No
VHDD | [NAME] | VHL Deletion Detection | VHL Deletion Detection | 1 | 81403 | No | Yes
VWFX | Test | von Willebrand Factor Activity, Plasma | von Willebrand Factor Activity, P | 1 | 85397 |  |  | If [NAME] factor activity is <55%, then the [NAME] factor ristocetin cofactor activity assay will be performed at an additional charge.
RIST | [NAME] | [NAME], Plasma | [NAME], P | 1 | 85245 | No | No
VWPR | Test | von Willebrand Profile | von Willebrand Prof |  | PROFILE |  |  | Initial testing includes: coag factor VIII activity assay, [NAME] factor (VWF) antigen, and VWF activity.
F8A | Component | Coagulation Factor VIII Activity Assay, Plasma | Coag Factor VIII Activity Assay, P | 1 | 85240 | Yes | Yes
VWFX | Component | von Willebrand Factor Activity, Plasma | von Willebrand Factor Activity, P | 1 | 85397 | Yes | Yes
CCC1 | Component | Interpretation | Interpretation |  |  | Yes | No
VWAG | Component | von Willebrand Factor [NAME], Plasma | von Willebrand Factor Ag, P | 1 | 85246 | Yes | Yes
VWFM | [NAME] | von WillebrandFactor Multimer Analysis, Plasma | von Willebrand Factor Multimer, P | 1 | 85247 | No | Yes
CCC2 | [NAME] | Special Coagulation Interpretation | Special Coagulation Interpretation | 1 | 85390 | No | No
IBETH | [NAME] | Bethesda Units | Bethesda Units | 1 | 85335 | No | No
F8IS | [NAME] | Coagulation Factor VIII Inhibitor Screen, Plasma | Coag Factor VIII Assay [NAME],P | 1 | 85335 | No | No
RIST | [NAME] | [NAME], Plasma | [NAME], P | 1 | 85245 | No | No
WBANF | Test | HIV-1/-2 Antibody Confirmation Without Immunofluorescence Assay, Serum | HIV-1/-2 Ab Confirmation w/o IFA, S | 1 | 86689 |  |  | This HIV-1/-2 antibody confirmatory evaluation begins with HIV-1 antibody by Western blot (WB) assay. If WB is negative, indeterminate or unreadable, then HIV-2 antibody evaluation is performed at an additional charge. If HIV-2 antibody evaluation is reactive, then HIV-2 antibody confirmation testing will be added at an additional charge.
HIV2 | [NAME] | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 | No | Yes
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
WBAR | Test | HIV-1/-2 Antibody Confirmatory Evaluation, Serum | HIV-1/-2 Ab Confirm Eval, S | 1 | 86689 |  |  | This HIV-1/-2 antibody confirmatory evaluation begins with HIV-1 antibody by Western blot (WB) assay.   If WB is negative, then HIV-2 antibody evaluation is performed at an additional charge.   If WB is indeterminate or unreadable, then both HIV-1 antibody confirmation by immunofluorescence and HIV-2 antibody evaluation are performed at an additional charge.   If [NAME] antibody evaluation is reactive, then HIV-2 antibody confirmation will be added at an additional charge.
HIV2 | [NAME] | HIV-2 Antibody Evaluation, Serum | HIV-2 Ab Eval, S | 1 | 86702 | No | Yes
HIV2L | [NAME] | HIV-2 Antibody Confirmation, Serum | HIV-2 Ab Confirmation, S | 1 | 86689 | No | Yes
HIVFA | [NAME] | HIV-1 Antibody Confirmation by Immunofluorescence, Serum | HIV-1 Ab Confirm by IFA, S | 1 | 86689 | No | Yes
ZAP70 | Test | ZAP-70, Chronic Lymphocytic Leukemia (CLL) Prognosis | ZAP-70 |  | PROFILE |  |  | When this test is ordered, flow cytometry interpretation, 2 to 8 markers will always be performed at an additional charge.
ZAP70 | Component |  | Flow cytometry, nuc mark | 1 | 88184 | No | No
ZAP70 | Component |  | Each add'l marker | 2 | 88185 | No | No
88465 | [NAME] | Flow Cytometry Interpretation, 2 to 8 Markers | Flow Cytometry Interp, 2-8 Markers | 1 | 88187 | Yes | No
ZMMLS | Test | Antimicrobial Susceptibility, [NAME], MIC | Susceptibility, Aerobic, MIC | 1 | 87186 |  |  | When this test is ordered, the additional tests may be performed and charged.   Antimicrobial agent appropriate to the organism and specimen source will be chosen from the panels listed below.   Gram-negative bacillus: amikacin, ampicillin, ampicillin/sulbactam, cefazolin, cefdinir, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, ertapenem, fosfomycin, gentamicin, [NAME], meropenem, nitrofurantoin, piperacillin/tazobactam, ticarcillin/clavulanic acid, tobramycin, and trimethoprim/sulfamethoxazole (TMP/SMX). The 2011 CLSI breakpoints for cephalosporins and carbapenems have been implemented. Confirmation testing for extended spectrum beta-lactamases is performed on Escherichia coli, Klebsiella species, and [NAME] isolates by request. KPC molecular testing and/or modified Hodge testing are available for individual order.
SUS | [NAME] | Susceptibility | Susceptibility | 1 | 87186 | No | No
MIC | [NAME] | Sensitivity, MIC | Sensitivity, MIC | 1 | 87186 | Yes | No
BLA | [NAME] | Beta Lactamase ([NAME] Only) | Beta Lactamase | 1 | 87185 | No | No
KPC1 | [NAME] | KPC PCR | KPC PCR | 1 | 87150 | No | No
HODGB | [NAME] | Carbapenemase-Modified Hodge Test | Carbapenamase-Modified Hodge Test | 1 | 87185 | No | No
ZYG | Test | [NAME] (Multiple Births) | [NAME] (Multiple Births) | 1 | 81265 |  |  | For prenatal specimens only: If amniotic fluid (non-confluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (non-confluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately.
AFC | [NAME] | Amniotic Fluid Culture for Genetic Testing | Amniotic Fluid Culture/Genetic Test |  | PROFILE | No | Yes
FBC | [NAME] | Fibroblast Culture for Genetic Testing | Fibroblast Culture for Genetic Test |  | PROFILE | No | Yes